
<html lang="en"     class="pb-page"  data-request-id="05770fbe-a0f0-4238-852c-28c9b2940135"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00071;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-11;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site" /></meta><meta name="dc.Creator" content="Yan-Na  Liu" /></meta><meta name="dc.Creator" content="Jing-Jing  Wang" /></meta><meta name="dc.Creator" content="Ya-Ting  Ji" /></meta><meta name="dc.Creator" content="Guo-Dong  Zhao" /></meta><meta name="dc.Creator" content="Long-Qian  Tang" /></meta><meta name="dc.Creator" content="Cheng-Mei  Zhang" /></meta><meta name="dc.Creator" content="Xiu-Li  Guo" /></meta><meta name="dc.Creator" content="Zhao-Peng  Liu" /></meta><meta name="dc.Description" content="By targeting a new binding region at the interface between αβ-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-c]pyrazoles a..." /></meta><meta name="Description" content="By targeting a new binding region at the interface between αβ-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-c]pyrazoles a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 20, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00071" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00071" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00071" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00071" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00071" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0013.jpeg" /></meta><meta property="og:description" content="By targeting a new binding region at the interface between αβ-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-c]pyrazoles as potential tubulin polymerization inhibitors. Among the compounds synthesized, 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)acetamide 6a and 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)-N-hydroxyacetamide 6n showed noteworthy low nanomolar potency against HepG2, Hela, PC3, and MCF-7 cancer cell lines. In mechanism studies, 6a inhibited tubulin polymerization and disorganized microtubule in A549 cells by binding to tubulin colchicine binding site. 6a arrested A549 cells in G2/M phase that was related to the alterations in the expression of cyclin B1 and p-cdc2. 6a induced A549 cells apoptosis through the activation of caspase-3 and PARP. In addition, 6a inhibited capillary tube formation in a concentration-dependent manner. In nonsmall cell lung cancer xenografts mouse model, 6a suppressed tumor growth by 59.1% at a dose of 50 mg/kg (ip) without obvious toxicity, indicating its in vivo potential as anticancer agent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00071"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00071">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00071&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00071&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00071&amp;href=/doi/10.1021/acs.jmedchem.6b00071" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5341-5355</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00057" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00212" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan-Na++Liu">Yan-Na Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing-Jing++Wang">Jing-Jing Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ya-Ting++Ji">Ya-Ting Ji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guo-Dong++Zhao">Guo-Dong Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Long-Qian++Tang">Long-Qian Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Mei++Zhang">Cheng-Mei Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiu-Li++Guo">Xiu-Li Guo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhao-Peng++Liu">Zhao-Peng Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Institute of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences and <sup>‡</sup>Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: +86 (0)531 88382006. E-mail: <a href="/cdn-cgi/l/email-protection#87ebeef2fdefe6e8f7c7f4e3f2a9e2e3f2a9e4e9"><span class="__cf_email__" data-cfemail="1f73766a65777e706f5f6c7b6a317a7b6a317c71">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: +86 (0)531 88382490. E-mail: <a href="/cdn-cgi/l/email-protection#3e594b5146527e4d5a4b105b5a4b105d50"><span class="__cf_email__" data-cfemail="761103190e1a3605120358131203581518">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00071&amp;href=/doi/10.1021%2Facs.jmedchem.6b00071" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5341–5355</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 12, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 January 2016</li><li><span class="item_label"><b>Published</b> online</span>20 May 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 June 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00071" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00071</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5341%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYan-Na%2BLiu%252C%2BJing-Jing%2BWang%252C%2BYa-Ting%2BJi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D11%26contentID%3Dacs.jmedchem.6b00071%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2B1-Methyl-1%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazole%2BAnalogues%2Bas%2BPotential%2BAnticancer%2BAgents%2BTargeting%2BTubulin%2BColchicine%2BBinding%2BSite%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5355%26publicationDate%3DJune%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00071"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2370</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00071" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yan-Na&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jing-Jing&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ya-Ting&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Guo-Dong&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Long-Qian&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Cheng-Mei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xiu-Li&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Zhao-Peng&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;5341-5355&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00071&quot;},&quot;abstract&quot;:&quot;By targeting a new binding region at the interface between αβ-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-c]pyrazoles as potential tubulin polymerization inhibitors. Among the compounds synthesized, 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)acetamide 6a and 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)-N-hydroxyacetamide 6n showed noteworthy low nanomolar potency against HepG2, Hela, PC3, and MCF-7 cancer cell lines. In mechanism studies, 6a inhibited tubulin polymerization and disorganized microtubule in A549 cells by binding to tubulin colchicine binding site. 6a arrested A549 cells in G2/M phase that was related to the alterations in the expression of cyclin B1 and p-cdc2. 6a induced A549 cells apoptosis through the activation of caspase-3 and PARP. In addition, 6a inhibited capillary tube formation in a concentration-dependent manner. In nonsmall &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00071&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00071" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00071&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00071" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00071&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00071" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00071&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00071&amp;href=/doi/10.1021/acs.jmedchem.6b00071" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00071" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00071" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00071%26sid%3Dliteratum%253Aachs%26pmid%3D27172319%26genre%3Darticle%26aulast%3DLiu%26date%3D2016%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2B1-Methyl-1%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazole%2BAnalogues%2Bas%2BPotential%2BAnticancer%2BAgents%2BTargeting%2BTubulin%2BColchicine%2BBinding%2BSite%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D11%26spage%3D5341%26epage%3D5355%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (10)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=292232" title="Polymerization">Polymerization</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/jmcmar.2016.59.issue-11/20160609/jmcmar.2016.59.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">By targeting a new binding region at the interface between αβ-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles as potential tubulin polymerization inhibitors. Among the compounds synthesized, 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide <b>6a</b> and 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-hydroxyacetamide <b>6n</b> showed noteworthy low nanomolar potency against HepG2, Hela, PC3, and MCF-7 cancer cell lines. In mechanism studies, <b>6a</b> inhibited tubulin polymerization and disorganized microtubule in A549 cells by binding to tubulin colchicine binding site. <b>6a</b> arrested A549 cells in G2/M phase that was related to the alterations in the expression of cyclin B1 and p-cdc2. <b>6a</b> induced A549 cells apoptosis through the activation of caspase-3 and PARP. In addition, <b>6a</b> inhibited capillary tube formation in a concentration-dependent manner. In nonsmall cell lung cancer xenografts mouse model, <b>6a</b> suppressed tumor growth by 59.1% at a dose of 50 mg/kg (ip) without obvious toxicity, indicating its in vivo potential as anticancer agent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Microtubules are cytoskeleton protein polymers comprised of α- and β-tubulin heterodimers that are vital components of all cells and play important roles in cell division, cell structure maintenance, cell signaling as well as transport of organelles inside the cell.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Because the rapid dividing cancer cells are highly dependent on tubulin polymerization/depolymerization, interfering with tubulin dynamics becomes a well-verified strategy for the development of antimitotic drugs.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8 ref9">(3-9)</a> There are at least four known binding domains on tubulin. The taxane site (on the microtubule interior) and the laulimalide site (on the microtubule exterior) binding agents are microtubule stabilizers that prevent the depolymerization of microtubules to form stable, nonfunctional microtubules, represented by paclitaxel, epothilones, discodermolide, and laulimalide, while the colchicine site binding agents, such as colchicine (<b>1</b>),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> podophyllotoxin (<b>2</b>),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and combretastatin A-4 (CA-4; <b>3</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and the vinca site binding agents, such as vincristine and vinblastine,<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> are microtubule disrupters that inhibit tubulin polymerization to interfere with the formation of the necessary mitotic assembly required for cell division.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Currently, a number of antitubulin agents binding to the taxane or vinca alkaloid sites have been approved by the Food and Drug Administration (FDA) and achieved notable success in cancer chemotherapy, however, the emergence of multidrug resistance (MDR) due to the overexpression of the P-glycoprotein (P-gp) drug transporter and the class III β-tubulin limits their efficiency and long-term use.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> Unlike the taxane or vinca alkaloid sites binding drugs, the colchicine site binding agents are generally not P-gp substrate and are still active in cells overexpressing class III β-tubulin and, therefore, are hopeful to overcome resistant phenotypes of carcinoma.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> In addition, the colchicine site binding agents also exhibit vascular disrupting effects on tumor endothelial cells required for the growth of the cancer and thus act as vascular disrupting agents (VDAs).<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29">(25-29)</a> Extensive efforts have been made in the discovery of natural or synthetic small-molecule tubulin inhibitors targeting the colchicine binding site, and a number of drug candidates are under clinical investigation as potential new anticancer agents.<a onclick="showRef(event, 'ref27 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref30 ref31 ref32 ref33 ref34">(27, 30-34)</a></div><div class="NLM_p">Based on the X-ray crystal structures of tubulin in complex with colchicine site ligands, the colchicine domain can be divided into three zones and a bridge.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> Zone 1 is a mostly hydrophobic pocket boxed by α-tubulin Asn101, Thr179, Ala180, Val181, and β-tubulin Lys254, Leu255, Asn258, Met259, Thr314, Val315, Ala316, Asn350, Val351, Lys352. The 2-methoxytropolone moiety in <b>1</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UT5">3UT5</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E22">3E22</a>),<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> or the benzodioxole ring in <b>2</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA1">1SA1</a>)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> is accommodated in this pocket. Zone 2 is hydrophobic pocket formed by β-tubulin Tyr202, Val238, Thr240, Cys241, Leu242, Ala250, Asp251, Leu252, Lys254, Leu255, Asn258, Met259, Ala316, Lys352, Thr353, Ala354, Ile378. In zone 2, Asp251 and Leu255 can adopt two alternative dispositions, one of which forms a common pocket that can accommodate the larger trimethoxyphenyl ring in <b>1</b>, <b>2</b> and other structurally related ligands, while the second one opens the groove leading to zone 3, and as a result, the space available for zone 2 is reduced to host only smaller moieties. The zone 3 is a deep hydrophobic pocket formed by β-tubulin Ile4, Tyr52, Gln136, Asn167, Phe169, Glu200, Val238, Thr239, Thr240, Leu242, and Leu252, connected with zone 2 by a polar groove formed by Glu200, Tyr202, Cys241, Leu248, Ala250, Leu255, Ala256, Met259, Phe268, Ala316, Val318, and Ile378. In general, the typical colchicine site binding inhibitor (<b>1</b>, <b>2</b>, <b>3</b> and their related analogues) features two aryl systems that occupy either zone 1 or zone 2 and a bridge with different lengths that determines their relative orientations.<a onclick="showRef(event, 'ref36 ref40'); return false;" href="javascript:void(0);" class="ref ref36 ref40">(36, 40)</a> The pyrrolidindione TN16 (<b>4</b>; PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD">3HKD</a>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> represents another kind of colchicine site binding inhibitor that only interacts with zone 2 and zone 3. The sulfonamide derivative ABT-751 (<b>5</b>),<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> an orally active antimitotic agent discovered by Eisai Company, is in clinical trials for cancer treatment.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a><b>5</b> is currently the only known ligand contacting all the three zones in its X-ray structure (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Colchicine site ligands (<b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b> and the designed indenopyrazoles) with their binding modes with tubulin (zone 1 in red, zone 2 in blue, zone 3 in pink, the predicted new binding region in zone 1 in green, and the bridge in thin black).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">1,4-Dihydroindeno[1,2-<i>c</i>]pyrazole is a core scaffold found in a number of inhibitors, including cyclin dependent kinase (CDK),<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> platelet-derived growth factor receptor (PDGFR) tyrosine kinase,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> checkpoint kinase 1 (Chk1),<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR)-2 tyrosine kinases,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and hypoxia inducible factor 1 (HIF-1).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> To prevent the pyrazole tautomerisation, we placed a methyl group at the N1 position and used the 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole framework for the design of novel tubulin polymerization inhibitors binding to the colchicine site. Based on the X-ray crystal structures of tubulin in complex with <b>5</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC">3HKC</a>),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> we made docking simulations of the designed indenopyrazoles, and the preliminary results indicated that they may interact with tubulin in a similar way as that of <b>5</b>. As shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, the <i>m</i>-ethoxyaniline moiety occupies the zone 3, the 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole portion is accommodated at the zone 2 pocket, and the ethyl group in the ethoxy substituent at the 6-position is partially located in the zone 1. Moreover, the substituent at the 7-position may form additional interactions with tubulin in an open cavity up to the α-tubulin subunit in the interfacial region. As far as we know, this new binding region in zone 1 has not been explored in the design of tubulin inhibitors. In this report, we focused on the substituents at the 7-position to investigate their effects on antiproliferative activities and discovered two indenopyrazole analogues as potent tubulin polymerization inhibitors targeting the colchicine binding site. It is of note that during the progress of our project, Nakamura’s group just recently identified a 1,4-dihydroindeno[1,2-<i>c</i>]pyrazole analogue, methyl 3-((6-methoxy-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-3-yl)amino)benzoate (GN39482), as a tubulin polymerization inhibitor without confirming its binding site.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole derivatives <b>6a</b>–<b>p</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. After selective ethyl ether formation by the treatment of the readily available 5,6-dihydroxy-1-indenone <b>7</b> with diethyl sulfate in DMF in the presence of K<sub>2</sub>CO<sub>3</sub>, the resulting 5-ethoxy-6-hydroxy-1-indenone <b>8</b> was reacted with TBSCl to protect its hydroxyl group. Deprotonation of α-proton of carbonyl in indanone <b>9</b> was carried out using lithium hexamethyldisilazide (LHMDS), and the resulting enolate was reacted with 3-ethoxyphenylisothiocyanate to give a thioamide intermediate, which underwent condensation with 1-methylhydrazine to form the 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole <b>10</b> in a moderate yield (54%). Deprotection of the TBS group in <b>10</b> with TBAF in THF provided indenopyrazole <b>11</b>, which was reacted with methyl chloroacetate and K<sub>2</sub>CO<sub>3</sub> as a base in acetone under reflux conditions to generate the methyl ester <b>12</b> in 74% yield. Finally, aminolysis of the ester <b>12</b> with a variety of amines, including ammonia (<b>a</b>), methylamine (<b>b</b>), dimethylamine (<b>c</b>), ethylamine (<b>d</b>), 2-hydroxyethylamine (<b>e</b>), 2-cyanoethylamine (<b>f</b>), 2-aminoethylamine (<b>g</b>), 2-dimethylaminoethylamine (<b>h</b>), 2-methoxyethylamine (<b>i</b>), cyclopropylamine (<b>j</b>), cyclopropylmethylamine (<b>k</b>), 2-propynylamine (<b>l</b>), allylamine (<b>m</b>), hydroxyamine (<b>n</b>), methoxyamine (<b>o</b>), hydrazine monohydrate (<b>p</b>), provided the corresponding amides <b>6a</b>–<b>p</b>. All the newly synthesized compounds were identified by <sup>1</sup>H NMR, <sup>13</sup>C NMR, MS spectra, and elemental analysis.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1-Methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles <b>6a</b>–<b>p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (EtO)<sub>2</sub>SO<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C, 9 h; (b) TBSCl, imidazole, DMF, 1 h; (c) LHMDS, 3-EtOPhNCS, THF, −78 °C to rt, 16 h; (d) CH<sub>3</sub>NHNH<sub>2</sub>, 1,4-dioxane/EtOH (1:1), 0 °C to rt, 84 h; (e) TBAF, THF, 1 h; (f) ClCH<sub>2</sub>CO<sub>2</sub>Me, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 14 h; (g) R<sup>1</sup>R<sup>2</sup>NH, MeOH, reflux, 1–12 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vitro Cell Growth Inhibitory Activity</h3><div class="NLM_p">The newly synthesized 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles <b>6a</b>–<b>p</b> were initially evaluated for their antiproliferative activity against four human cancer cell lines, HepG2 (human liver carcinoma), Hela (human cervical carcinoma), PC3 (human prostate cancinoma), and MCF-7 (human breast adenocarcinoma), by the conventional MTT assay, using <b>1</b>, <b>3</b>, <b>5</b>, and paclitaxel as reference drugs. The results are shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Growth Inhibitory Activities of Compounds <b>6a</b>–<b>p</b> against Human Cancer Cell Lines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> mean ± SD<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">HepG2</th><th class="colsep0 rowsep0" align="center">Hela</th><th class="colsep0 rowsep0" align="center">PC3</th><th class="colsep0 rowsep0" align="center">MCF-7</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.026 ± 0.003</td><td class="colsep0 rowsep0" align="char" char="±">0.0074 ± 0.0005</td><td class="colsep0 rowsep0" align="char" char="±">0.019 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.0323 ± 0.0032</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.142 ± 0.013</td><td class="colsep0 rowsep0" align="char" char="±">0.090 ± 0.005</td><td class="colsep0 rowsep0" align="char" char="±">0.640 ± 0.022</td><td class="colsep0 rowsep0" align="char" char="±">0.892 ± 0.041</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">0.920 ± 0.045</td><td class="colsep0 rowsep0" align="char" char="±">0.720 ± 0.015</td><td class="colsep0 rowsep0" align="char" char="±">1.78 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">6.16 ± 0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.31 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">0.623 ± 0.033</td><td class="colsep0 rowsep0" align="char" char="±">3.74 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">1.47 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">2-hydroxyethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.80 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">0.415 ± 0.017</td><td class="colsep0 rowsep0" align="char" char="±">3.68 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">0.662 ± 0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">2-cyanoethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.42 ± 0.44</td><td class="colsep0 rowsep0" align="char" char="±">1.45 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">8.60 ± 0.70</td><td class="colsep0 rowsep0" align="char" char="±">4.61 ± 0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">2-aminoethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.40 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">0.865 ± 0.017</td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">1.85 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">2-dimethylaminoethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.340 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">0.375 ± 0.016</td><td class="colsep0 rowsep0" align="char" char="±">0.460 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">2.99 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="left">2-methoxyethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.447 ± 0.017</td><td class="colsep0 rowsep0" align="char" char="±">0.490 ± 0.010</td><td class="colsep0 rowsep0" align="char" char="±">0.800 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6j</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.653 ± 0.013</td><td class="colsep0 rowsep0" align="char" char="±">0.720 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">1.40 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">3.07 ± 0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="left">cyclopropylmethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.70 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">3.20 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">4.60 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">>50.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6l</b></td><td class="colsep0 rowsep0" align="left">2-propynyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.587 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">0.505 ± 0.012</td><td class="colsep0 rowsep0" align="char" char="±">1.78 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">2.11 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6m</b></td><td class="colsep0 rowsep0" align="left">allyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.853 ± 0.014</td><td class="colsep0 rowsep0" align="char" char="±">0.690 ± 0.022</td><td class="colsep0 rowsep0" align="char" char="±">1.94 ± 0.024</td><td class="colsep0 rowsep0" align="char" char="±">0.765 ± 0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6n</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.0164 ± 0.0011</td><td class="colsep0 rowsep0" align="char" char="±">0.0132 ± 0.0021</td><td class="colsep0 rowsep0" align="char" char="±">0.0235 ± 0.0010</td><td class="colsep0 rowsep0" align="char" char="±">0.0335 ± 0.0020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6o</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.853 ± 0.034</td><td class="colsep0 rowsep0" align="char" char="±">0.470 ± 0.010</td><td class="colsep0 rowsep0" align="char" char="±">2.90 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">1.67 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6p</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.400 ± 0.010</td><td class="colsep0 rowsep0" align="char" char="±">0.350 ± 0.010</td><td class="colsep0 rowsep0" align="char" char="±">0.760 ± 0.012</td><td class="colsep0 rowsep0" align="char" char="±">0.579 ± 0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.019 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.0076 ± 0.0007</td><td class="colsep0 rowsep0" align="char" char="±">0.015 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">0.047 ± 0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.0021 ± 0.0005</td><td class="colsep0 rowsep0" align="char" char="±">0.0093 ± 0.0009</td><td class="colsep0 rowsep0" align="char" char="±">0.0034 ± 0.0002</td><td class="colsep0 rowsep0" align="char" char="±">0.0125 ± 0.0006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.447 ± 0.018</td><td class="colsep0 rowsep0" align="char" char="±">0.355 ± 0.020</td><td class="colsep0 rowsep0" align="char" char="±">0.460 ± 0.010</td><td class="colsep0 rowsep0" align="char" char="±">3.79 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTX<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.0101 ± 0.0050</td><td class="colsep0 rowsep0" align="char" char="±">0.018 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">0.021 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">0.0124 ± 0.0050</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">SD: standard deviation.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">PTX: paclitaxel. All experiments were independently performed at least three times.</p></div></div></div><div class="NLM_p">The acetamide <b>6a</b> exhibited excellent growth inhibitory activity against all the four cancer cell lines, with IC<sub>50</sub> values ranging from 7.4 to 32.3 nM. It was 17- to 123-fold more potent than <b>5</b> and was just as potent as <b>1</b> and paclitaxel. In comparison with <b>6a</b>, the amide <i>N</i>-methylation (<b>6b</b>) led to 5.5- to 27-fold decrease in potency, while the amide <i>N</i>-dimethylation (<b>6c</b>) further deteriorated its activity. <i>N</i>-Methylacetamide <b>6b</b> was still more potent than <b>5</b> against cancer HepG2, Hela, and MCF-7 cell lines, but was slight less active against PC3 cells. Replacing the <i>N</i>-methyl by an ethyl (<b>6d</b>) group also reduced its potency. However, further introducing a hydroxyl (<b>6e</b>), an amino (<b>6g</b>), a dimethylamino (<b>6h</b>), or a methoxy (<b>6i</b>) group at the β-position of ethyl substituent improved the sensitivity of <b>6d</b> toward some cancer cell lines in different degrees, but a cyano group at the same position was not tolerated. Compounds <b>6h</b> and <b>6i</b> exhibited a similar level of potency as that of <b>5</b>. The <i>N</i>-cyclopropylacetamide <b>6j</b> maintained considerable potency (IC<sub>50</sub> = 0.65–3.07 μM), while its counterpart <b>6k</b> with one carbon elongation displayed much reduced activity. Introduction of an unsaturated 2-propnyl (<b>6l</b>) or allyl (<b>6m</b>) group was considerable tolerated, though the resulting analogues <b>6l</b> and <b>6m</b> were less potent than the unsubstituted acetamide <b>6a</b>. The <i>N</i>-hydroxyacetamide <b>6n</b> exhibited potency comparable to that of <b>6a</b> with IC<sub>50</sub> values ranging from 13.2 to 33.5 nM, but the methylation of <b>6n</b> greatly reduced its activity. Though the hydrazide <b>6p</b> was as potent as <b>5</b>, it was much weaker than <b>6a</b> and <b>6n</b>. In addition, these indenopyrazoles were generally more sensitive toward human breast cancer MCF-7 cells than <b>5</b>, except the <i>N</i>-dimethyacetamide <b>6c</b>, the <i>N</i>-(2-cyanoethyl)acetamide <b>6f</b>, and the <i>N</i>-cyclopropylmethylacetamide <b>6k</b>. It is of note that <b>6a</b> and <b>6n</b> were 17- to 122-fold more potent than <b>5</b> and just as potent as the drug paclitaxel and <b>1</b> against these four cancer cell lines, though they were less active than <b>3</b>.</div><div class="NLM_p">In summary, we investigated the antiproliferative activities of a series of 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles with 7-oxoacetamides of 4- to 8-atom lengths. The substituents at the acetamide nitrogen had great influence on their tumor cell growth inhibitory potency. The 7-oxoacetamides with a 4- or 5-atom length gave the best results, possibly due to the limited distance and space at the interface between the α- and β-subunit of tubulin heterodimers. In general, a hydrogen-bond-donor/-acceptor atom (O, N) at or near the terminal of the substituents is preferred for the better antiproliferative activity.</div><div class="NLM_p">In growth inhibitory test against two representative nonsmall cell lung cancer (NSCLC) cell lines, A549 and NCI-H460, <b>6a</b> displayed higher or comparable potency as <b>1</b> and <b>3</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Growth Inhibitory Effects of <b>6a</b> on NSCLC Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> mean ± SD (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A549</th><th class="colsep0 rowsep0" align="center">NCI-H460</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char="±">41.46 ± 0.86</td><td class="colsep0 rowsep0" align="char" char="±">37.32 ± 2.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">59.06 ± 3.48</td><td class="colsep0 rowsep0" align="char" char="±">49.29 ± 2.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">49.05 ± 2.63</td><td class="colsep0 rowsep0" align="char" char="±">35.81 ± 1.14</td></tr></tbody></table></div></div><div class="NLM_p">Colony formation assay was used to test the sensitivity of NSCLC cells to <b>6a</b> over a relatively long exposure time (9 days). In the concentrations ranging from 2 to 10 nM, <b>6a</b> significantly and dose dependently reduced the colony formation in A549 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) and NCI-H460 cells (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). At the concentration of 10 nM, <b>6a</b> inhibited the colony formation by 91.05% in A549 and by 97.34% in NCI-H460.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Growth inhibitory effects of <b>6a</b> on NSCLC cell lines by colony formation assay and trypan blue staining. Representative colony formation images on A549 cells (A) and NCI-H460 cells (B) after exposed to <b>6a</b> for 9 days. The results were denoted as a percentage of the vehicle-treated cells. (C) The cytotoxicity of <b>6a</b> on A549 cells was estimated by trypan blue exclusion. After exposed to <b>6a</b> for 24 h, A549 cells were harvested and stained with trypan blue solution. Arrows indicated the dead cells. The results were expressed as a percentage based on the ratio of the number of viable treated cells to that of vehicle control. Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Trypan blue staining was further used to investigate the cytotoxicity of <b>6a</b>. In the presence of <b>6a</b> at concentrations ranging from 5 nM to 80 nM, the density of cells slightly decreased, but the dead cells were negligible (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). These results indicated that <b>6a</b> had a strong antiproliferative activity on NSCLC cells in the absence of evident cytotoxicity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Inhibition of Tubulin Polymerization and Colchicine Binding</h3><div class="NLM_p">To investigate whether the activities of the synthetic 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles were related to the interactions with microtubule systems, the most cytotoxic compounds <b>6a</b> and <b>6n</b>, the medium potent <b>6b</b>, the least active <b>6k</b>, and reference compounds <b>1</b>, <b>3</b>, and <b>5</b> were evaluated as tubulin polymerization inhibitors. Both <b>6a</b> and <b>6n</b> produced a concentration-dependent inhibition of tubulin polymerization (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), with calculated IC<sub>50</sub> values of 4.62 μM and 5.33 μM, respectively (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The medium cytotoxic <b>6b</b> exhibited weak tubulin polymerization inhibition (IC<sub>50</sub> = 22.0 μM), while <b>6k</b> showed no inhibitory activity (Figure 1S, Table 1S; <a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf" class="ext-link">Supporting Information</a>). In addition, <b>6a</b> and <b>6n</b> competed with [<sup>3</sup>H]colchicine in binding to tubulin. The binding potency of <b>6a</b> and <b>6n</b> to the tubulin colchicine binding site was as strong as that of <b>1</b> or <b>5</b> but less than that of <b>3</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>6a</b> and <b>6n</b> on tubulin polymerization in vitro. Purified tubulin protein at 2 mg/mL in a reaction buffer was incubated at 37 °C in the presence of 1% DMSO, test compounds (<b>6a</b> or <b>6n</b> at 1.25, 2.5, 5, or 10 μM) or <b>1</b> (20 μM). Polymerizations were followed by an increase in fluorescence emission at 460 nm over a 60 min period at 37 °C. The experiments were performed three times.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of Tubulin Polymerization<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> and Colchicine Binding to Tubulin<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">inhibition of colchicine binding (%) inhibition ± SD</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">inhibition of tubulin polymerization IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">1 μM</th><th class="colsep0 rowsep0" align="center">5 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char=".">4.62</td><td class="colsep0 rowsep0" align="char" char="±">37 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">67 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6n</b></td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char="±">31 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">63 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">1.65</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">72 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">2.48</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">2.79</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">68 ± 0.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The tubulin assembly assay measured the extent of assembly of 2 mg/mL tubulin after 60 min at 37 °C. Data are presented as mean from three independent experiments.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Tubulin, 1 μM; [<sup>3</sup>H]colchicine, 5 μM; and inhibitors, 1 or 5 μM.</p></div></div></div><div class="NLM_p">The inhibitory effects of <b>6a</b> on microtubules organization were then confirmed by immunofluorescence staining of α-tubulin in A549 cells. In the vehicle-treated cells, the microtubule networks exhibited a normal arrangement with slim and fibrous microtubules wrapped around the cell nucleus. However, when cells were treated with <b>6a</b> (40 nM) for 24 h, the microtubule networks became disorganized and shrunk to the cell border, similar to the disruption produced by <b>1</b> at 40 nM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of <b>6a</b> on the organizations of cellular microtubule network. A549 cells were treated with (a) 0.1% DMSO, (b) <b>6a</b> (40 nM), (c) <b>1</b> (40 nM) for 24 h. Microtubules were visualized with an anti-α-tubulin antibody (red), and the cell nucleus was visualized with Hoechst 33342 (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Modeling</h3><div class="NLM_p">The molecular docking study was carried out to elucidate the binding features of the 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles with tubulin. Since the αβ-tubulin heterodimers complex with different ligands in certain flexibility at the colchicine site, we performed the docking studies of <b>6a</b> with five representative crystal structures in which the ligands interacted with tubulin in the typical zones 1 and 2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA1">1SA1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKE">3HKE</a>),<a onclick="showRef(event, 'ref39 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref41">(39, 41)</a> zones 2 and 3 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD">3HKD</a>),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and all the three zones (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC">3HKC</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The 3D structure of each ligand was built using the Sybyl sketch module followed by energy minimization using the Tripos force field. The Surflex docking program was used to automatically dock the selected compounds into the binding pocket of tubulin.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The docking of <b>6a</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC">3HKC</a> generated a higher Surflex docking score of 9.09, while that for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD">3HKD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA1">1SA1</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD">3HKD</a> was 7.99, 7.81, 5.64, and 5.49, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf" class="ext-link">Supporting Information</a>), indicating that <b>6a</b> tended to bind most favorably to the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC">3HKC</a> model. With the full consideration of the hydrophobic interactions with the three zones in the tubulin binding pocket, the hydrogen bindings, and the Surflex docking scores, we concluded that <b>6a</b> could bind to tubulin in the similar way as that of <b>5</b>.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, in comparison with <b>1</b> that only occupied zones 1 and 2, <b>6a</b> formed hydrophobic interaction with all the three zones. The <i>m</i>-ethoxyaniline group of <b>6a</b> superimposed with the phenol substituent of <b>5</b>, which protruded into zone 3 more deeply, formed the same hydrogen bonding with Tyrβ202. Like the <i>o</i>-aminopyridine core in <b>5</b>, the 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole portion was accommodated at the zone 2 pocket. The amino group in the <i>m</i>-ethoxyaniline moiety formed hydrogen bonding with Valβ238 in zone 2. Though the ethoxy substituent at the 6-position in <b>6a</b> occupied only partial hydrophobic cavity in zone 1, the acetamide substituent at the 7-position interacted additionally with tubulin in an open cavity up to the α-tubulin subunit in the interfacial region, and its amide nitrogen formed a critical hydrogen bonding with Serα178 at the interfacial surface.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking of <b>6a</b> (gray) and <b>1</b> (green) into the tubulin colchicine binding site and overlapping with <b>5</b> (red). In comparison with <b>1</b>, which only occupied the zones 1 and 2, <b>6a</b> formed hydrophobic interaction with all the three zones. In addition, the 7-oxoacetamide substituent occupied an additional region in zone 1, and its amide nitrogen formed critical hydrogen bonding with Serα178 at the interfacial surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The medium potent <b>6b</b> and the least active <b>6k</b> showed similar binding modes as that of <b>6a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf" class="ext-link">Supporting Information</a>, Figures 8S and 9S). However, in comparison with <b>6a</b>, the amino group in the <i>m</i>-ethoxyaniline moiety of <b>6b</b> did not have hydrogen bonding with Valβ238. For compound <b>6k</b>, the amide nitrogenat the 7-position could not form hydrogen bonding with Serα178. Moreover, the cyclopropylmethyl group in <b>6k</b> protruded out of the interfacial surface that might account for its loss of tubulin polymerization inhibitory activity.</div><div class="NLM_p last">It is apparent that the substituents at the 7-position of 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles have great influences on their conformations and bindings with the tubulin. Besides the hydrophobic interactions, this modeling investigation stressed the hydrogen bondings with Valβ238, Tyrβ202, and Serα178 that seemed to be critical for the anticancer potency of these indenopyrazole derivatives. However, due to the limited resolution of the known crystal structures (3.58–4.20 Å), this docking modeling was just speculative. Further high-resolution crystal structure studies of <b>6a</b> or related indenopyrazole derivatives will provide true interactions of these inhibitors with tubulin. Other computational methods in combination with HINT scores were succefully used for the rational prediction of the binding mode of colchicine site ligands and for the SAR analysis.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> By isolating the HINT score for hydrogen-bonding interactions involving Cysβ241 as the parameter, Kellogg’s group proposed a molecular modeling for a series of novel C-4 analogues of pyrrole-based antitubulin agents that could rationalize the observed SAR with a linear correlation between the antiproliferative activity and the microtubule inhibitory activity. Besides the hydrophobic interactions, a weak hydrogen bond with Cysβ241 was found to be critical for the microtubule depolymerizing activity.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> A549 Cell Cycle Arrest and G2/M-Related Proteins Regulation</h3><div class="NLM_p">Both microtubule stabilizers and destabilizers alter the tubulin–microtubule equilibrium causing mitotic arrest at G2/M phase and ultimately apoptotic cell death. The most active compound <b>6a</b> was therefore examined for its effect on cell cycle progression of A549 cells by flow cytometry. Treatment of <b>6a</b> resulted in a gradual accumulation of cells in the G2/M phase of the cell cycle in a concentration-dependent manner, whereas the control cells were mainly in the G1 phase (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). At a concentration of 40 nM, the percentage of cells in the G2/M phase increased to 68.1%. This result compares favorably to 37.0% in the G2/M phase for cells treated with <b>1</b> at the same concentration.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Effects of <b>6a</b> on A549 cell cycle progress. Cells were treated with different concentrations of <b>6a</b> or <b>1</b> (40 nM) for 24 h and then analyzed by flow cytometry. (B) Effects of <b>6a</b> on G2/M regulatory protein. A549 cells were treated for 24 h with the indicated concentration of <b>6a</b>. The cells were harvested and lysed for the detection of cyclin B1, p-cdc2. Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We next studied the association between <b>6a</b>-induced G2/M arrest and alterations in expression of proteins that regulate cell division. The mitosis promoting factor, a complex formed between cyclin B1 and cdc2, plays an important role in the transition from interphase to mitotic phase and governs cell cycle progression by enhancing cell cycle distribution in the G2/M fraction.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B, <b>6a</b> caused concentration-dependent increases in cyclin B1. In contrast, p-cdc2, the inactive form of cdc2, was down-regulated in a concentration-dependent manner. These alterations were consistent with G2/M phase arrest induced by <b>6a</b>.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> A549 and NCI-H460 Cell Apoptosis and Caspase-3 Activation</h3><div class="NLM_p">Mitotic arrest of tumor cells by tubulin-directed agents is generally associated with cellular apoptosis. The effects of <b>6a</b> on A549 and NCI-H460 cell apoptosis were evaluated by observation of cellular morphology and Annexin V-FITC cell surface binding. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A, the vehicle-treated cells were polygon and attached to the plate bottom, while the <b>6a</b> or <b>1</b> treated cells were round with cytoplasmic membrane blebbing and cell shrinkage. In comparison with the compact rounded nucleus of the vehicle-treated cells, <b>6a</b> or <b>1</b> treated cells exhibited evident apoptosis features with nucleus fragmentation and chromatin condensation (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>6a</b> induces cell apoptosis. Exposed to <b>6a</b> or <b>1</b> at 40 nM for 24 h, A549 and NCI-H460 cellular (A) and nuclear (B) morphological changes were imaged. Arrows indicated characteristics of apoptotic cells. (C) Detection of apoptotic cells after Annexin-V/PI staining by flow cytometry analysis. Exposed to <b>6a</b> or <b>1</b> for 24 h, A549 cells were harvested and stained with Annexin-V/PI for analysis. The different cell stages were assigned as live (Q1-LL), early apoptotic (Q1-LR), late apoptotic (Q1-UR), and necrotic cells (Q1-UL). (D) Western blotting analysis of the expression of cleaved caspase-3 and cleaved PARP. Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the morphological evaluation, the effect of <b>6a</b> on apoptosis was confirmed by flow cytometric analysis. In normal live cells, plasma membrane is integrated, with phosphatidylserine (PS) located on the cytoplasmic surface. At an early stage of apoptosis, PS is translocated to the extrocytoplasmic surface. Annexin V-FITC is used to detect the externalization of PS. Propidium iodide (PI) is impermeable to live and apoptotic cells due to plasma membrane integrity, but can bind tightly to the nucleic acids in necrotic cells. The cell populations can be differentiated using the Annexin V and the PI double-staining system. After exposure to <b>6a</b> at 10, 20, and 40 nM for 24 h, the number of apoptotic cells was increased by 3.4%, 8.0% and 13.7%, respectively (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C). <b>6a</b> and <b>1</b> demonstrated no significant difference in inducing cell apoptosis at the same concentration of 40 nM.</div><div class="NLM_p last">Caspase activation is a critical step in the final execution of the apoptotic cellular death process and can be induced by a variety of cellular stimuli including growth factor withdrawal or growth factor receptor inhibition or through disruption of the microtubule apparatus involved in cell division. The expressions of cleaved caspase-3 and cleaved PARP in A549 cells were both enhanced significantly by exposure to <b>6a</b> for 24 h in a concentration-dependent manner (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D). These effects on the cleavage of caspase-3 and PARP with <b>6a</b> are consistent with concentrations at which it induces the G2/M cell cycle arrest in A549 cell lines.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Inhibition of Capillary Tube Formation of HUVECs</h3><div class="NLM_p">Angiogenesis, the growth of the new blood vessels, is essential for human cancer progression, development, and metastasis. Colchicine site binding agents could act as VDAs that cause vascular shutdown within solid tumors, and a number of them have been in clinical investigations.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The HUVEC tube formation assays are a dynamic in vitro assay representative of the key steps in angiogenesis, including proliferation, adhesion, and the formation of tube-like vascular structures. In an in vitro endothelial cell tube formation assay on 3-D Matrigel, <b>6a</b> inhibited HUVEC cord formation in a concentration-dependent manner at concentrations that had minimal effects on HUVEC proliferation over the 8 h time course of the tube formation assay (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Tube formation was inhibited by nearly 39, 58, and 69% at concentrations of 10, 20, and 40 nM, respectively.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>6a</b> inhibits capillary tube formation of HUVECs. HUVECs were plated on Matrigel and allowed to form capillary tubes followed by exposure to different concentrations of compound <b>6a</b>. HUVECs were seeded into 96-well plate which had been precoated with Matrigel and incubated with <b>6a</b> for 8 h. Cultures were photographed, and the number of capillary tube networks was counted under a microscope (original magnification of 100×). Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Growth Inhibition of Human NSCLC Xenografts in Vivo</h3><div class="NLM_p">To validate further antitumor activity in vivo, nude mouse NSCLC xenograft models were established. Once a tumor was approximately 100–200 mm<sup>3</sup> in size and was palpable, the mice were randomized into blank, vehicle control and treatment groups (6 mice per group). Control mice received the vehicle [PEG 400:ethanol:5% dextrose in water (D5W) = 4:1:5]. In two treatment groups, <b>6a</b> was administrated by intraperitoneal injection (ip) at a dose of 12.5 mg/kg or 50 mg/kg every day for 21 consecutive days. As shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, no significant differences between blank group and vehicle group were observed in the body weight, tumor volumes, and weight, so the vehicle had neither toxicity nor inhibitory effect. Compared with the vehicle group, administration of <b>6a</b> at 12.5 and 50 mg/kg by ip resulted in 33.8% and 59.1% reduction of tumor growth, respectively (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B). The antitumor effect of <b>6a</b> was also observed by a delayed increase in the volume of xenografts (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C). No significant differences in body weight or other adverse effects were observed upon treatment with compound <b>6a</b> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>D). Hence, compound <b>6a</b> showed strong antitumor activity on a well-tolerated dose schedule.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <b>6a</b> inhibits the growth of human NSCLC xenografts in athymic mice. The images (A) and weights (B) of excised tumors from each group. Inhibition rates were defined as a percentage of vehicle-treated tumor weight. The tumor volumes (C) and body weights (D) were detected every 3 days. Data are presented as mean ± SD of 6 mice. *<i>P</i> < 0.05 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">By targeting an unexplored new binding region at the interface between both the α- and β-subunit of tubulin heterodimers in zone 1, a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles (<b>6a</b>–<b>p</b>) were designed, efficiently synthesized, and evaluated in cellular and tubulin inhibition assays, resulting in the discovery of a new class of antitumor agents as tubulin polymerization inhibitors. The most potent compounds, <b>6a</b> and <b>6n</b>, exhibited noteworthy low nanomolar potency against a set of cancer cell lines and significant inhibition of tubulin polymerization and competed with <b>1</b> at the tubulin colchicine binding site. <b>6a</b> arrested most cells in the G2/M phase of the cell cycle and disrupted cellular microtubules and induced A549 cell apoptosis, thus providing evidence that these active compounds are a new kind of tubulin polymerization inhibitors acting at the colchicine site. Mechanism considerations suggested that the blockade in G2/M phase of cell cycle was associated with alterations in the expression of cyclin B1 and p-cdc2, and the induction of apoptosis was related to activation of caspase-3 and PARP. Furthermore, <b>6a</b> inhibited capillary tube formation in a concentration-dependent manner and has the potential as a vascular disrupting agent. In NSCLC xenograft mouse models, <b>6a</b> displayed strong in vivo antitumor activity, suppressing tumor growth by 59.1% at a dose of 50 mg/kg (ip) with no obvious signs of toxicity. Molecular modeling results suggested the acetamide substituent at the 7-position might be responsible for the high potency of <b>6a</b> by occupying an additional open cavity up to the α-tubulin subunit in the interfacial region and forming critical hydrogen bonding with Serα178 at the interfacial surface. In summary, these newly developed compounds with a novel 7-substituted 1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole skeleton showed marked biological activity both in vitro and in vivo and have potential for further development as a novel class of anticancer agents.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">Melting points were determined on an X-6 micromelting point apparatus (Beijing Tech. Co., Ltd.). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Bruker-400 NMR or Bruker-600 NMR spectrometers, using tetramethylsilane (TMS) as the internal standard. The solvent was CDCl<sub>3</sub> unless otherwise indicated. <sup>1</sup>H spectra were recorded relative to DMSO-<i>d</i><sub>6</sub> (2.50 ppm) or TMS (0.00 ppm) as internal standard, and <sup>13</sup>C NMR spectra were recorded relative to DMSO-<i>d</i><sub>6</sub> (39.52 ppm). All spectra were recorded at room temperature for DMSO or CDCl<sub>3</sub> solutions. Electrospray ionization mass spectrometry (ESI-MS) was performed on an API 4000 instrument. Thin-layer chromatography (TLC) was performed on silica gel GF254 plates. Silica gel GF254 and silica gel (200–300 mesh) from Qingdao Haiyang Chemical Company were used for TLC and column chromatography, respectively. All reagents are commercially available and were used as purchased without further purification. All reactions involving oxygen- or moisture-sensitive compounds were carried out under a dry N<sub>2</sub> atmosphere. Unless otherwise noted, reagents were added by syringe. THF was distilled from sodium/benzophenone immediately prior to use. Elemental analyses were recorded with CHN model on FLASH 2000 organic elemental analyzer, and the observed values were considered acceptable within ±0.3% of calculated values, supporting >95% purity.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 5-Ethoxy-6-hydroxyl-1-indanone (<b>8</b>)</h3><div class="NLM_p last">To a mixture of 5,6-dihydroxy-1-indenone <b>7</b> (125 g, 0.76 mol) and K<sub>2</sub>CO<sub>3</sub> (105 g, 0.76 mol) in DMF (1000 mL), diethyl sulfate (88 mL, 0.76 mol) was added. The mixture was heated to 50 °C and stirred vigorously for 9 h. The mixture was cooled to room temperature and poured slowly into 2 M HCl (800 mL). The resulting precipitate was filtered, washed with a small amount of petroleum ether, and dried to give 112 g (77%) of <b>8</b> as a yellow solid, mp 157–159 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.37 (t, <i>J</i> = 10.2 Hz, 3H), 2.5 (s, 2H), 2.94 (s, 2H), 4.13 (q, <i>J</i> = 10.2 Hz, 2H), 6.94 (s, 1H), 7.04 (s, 1H), 9.33 (s, 1H); MS (ESI) <i>m</i>/<i>z</i> 193.4 (M + H)<sup>+</sup>, 215.4 (M + Na)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-Ethoxy-6-<i>tert</i>-butyldimethylsiloxy-1-indanone (<b>9</b>)</h3><div class="NLM_p last">To a solution of 5-ethoxy-6-hydroxyl-1-indanone (<b>8</b>, 3.20 g, 16.6 mmol) in DMF (25 mL) were added TBSCl (3.76 g, 24.9 mmol) and imidazole (1.70 g, 24.9 mmol). The mixture was stirred at room temperature for 1 h. Aqueous 10% citric acid solution (100 mL) was added. The resulting precipitate was filtered, washed with a small amount of petroleum ether, and dried to give 4.65 g (91%) of <b>9</b> as a yellow solid, mp 142–143 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.16 (s, 6H), 1.00 (s, 9H), 1.49 (t, <i>J</i> = 10.2 Hz, 3H), 2.65 (t, <i>J</i> = 8.4 Hz, 2H), 3.02 (t, <i>J</i> = 8.4 Hz, 2H), 4.11 (q, <i>J</i> = 10.2 Hz, 2H), 6.83 (s, 1H), 7.18 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 204.9, 156.7, 151.6, 144.7, 129.7, 120.1, 113.3, 109.9, 64.5, 36.7, 26.0, 25.6, 18.6, 15.0, −4.33; MS (ESI) <i>m</i>/<i>z</i> 307.5 (M + H)<sup>+</sup>, 329.5 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>17</sub>H<sub>26</sub>O<sub>3</sub>Si: C, 66.62; H, 8.55. Found: C, 66.32; H, 8.23.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 7-(<i>tert</i>-Butyldimethylsilyloxy)-6-ethoxy-<i>N</i>-(3-ethoxyphenyl)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-3-amine (<b>10</b>)</h3><div class="NLM_p last">A solution of 5-ethoxy-6-<i>tert</i>-butyldimethylsiloxy-1-indanone (<b>9</b>, 4.65 g, 15.2 mmol) in anhydrous THF (60 mL) was cooled to −78 °C under nitrogen atmosphere. LHMDS (18.2 mL, 1.0 M THF solution) was added dropwise. The mixture was stirred at −78 °C for 2 h and then warmed to −45 °C in 45 min. After a solution of 1-ethoxy-3-isothiocyanatobenzene (3.17 g, 17.7 mmol) in anhydrous THF (200 mL) was added, the resulting mixture was stirred at room temperature overnight. Acetic acid (2 mL) was added, and the mixture was stirred at room temperature for 10 min then evaporated via rotary evaporation. The resulting residue was dissolved in dichloromethane (500 mL), washed with 1 M HCl, distilled water, and brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration and evaporation, the resulting crude brown oil was dissolved in 1,4-dioxane (100 mL) and ethanol (100 mL) and cooled to 0 °C. Methylhydrazine (4 mL,74.1 mmol) was added dropwise. After stirring at 0 °C for 2 h, the mixture was moved to room temperature and stirred for 82 h. After the solvent was evaporated, the residue was extracted with dichloromethane (100 mL), washed with brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration and evaporation, the residue was purified by column chromatography on silica gel (50–100% EtOAc in hexane) to afford 3.91 g of <b>10</b> (54%) as a light yellow solid, mp 110–112 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.17 (s, 6H), 1.00 (s, 9H), 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H), 3.37 (s, 2H), 3.91 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.06 (q, <i>J</i> = 7.2 Hz, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.82 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.96 (t, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.12 (s, 1H), 7.22 (s, 1H), 8.36 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.1, 150.0, 149.5, 144.7, 144.1, 142.7, 129.8, 124.7, 113.3, 111.5, 111.3, 108.8, 105.9, 102.6, 64.2, 63.3, 37.1, 30.0, 25.8, 18.5, 15.0, 14.9, −4.57; MS (ESI) <i>m</i>/<i>z</i> 480.5 (M + H)<sup>+</sup>, 502.5 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>27</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub>Si: C, 67.60; H, 7.77; N, 8.76. Found: C, 67.52; H, 7.66; N, 8.60.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-ol (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>10</b> (3.91 g, 8.39 mmol) in THF (70 mL) was added TBAF (2.63 g, 10.1 mmol). The mixture was stirred at room temperature for 1 h, and the reaction was completed monitored by TLC. EtOAc (150 mL) was added, and the organic solution was washed with saturated aqueous NH<sub>4</sub>Cl solution and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration and evaporation, the residue was purified by column chromatography on silica gel (hexane/AcOEt = 5:1–3:1) to give 2.68 g of <b>11</b> (91%) as a light yellow solid, mp 153–155 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H), 3.32 (s, 2H), 3.89 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.06 (q, <i>J</i> = 7.2 Hz, 2H), 6.27 (dd, <i>J</i> = 7.8,1.2 Hz, 1H), 6.83 (dd, <i>J</i> = 7.8,1.2 Hz, 1H), 6.96 (t, <i>J</i> = 1.2 Hz, 1H), 7.05 (t, <i>J</i> = 7.8 Hz, 1H), 7.11 (s, 1H), 7.15 (s, 1H), 8.34 (s, 1H), 8.83 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d6</i>) δ 159.7, 148.9, 146.3, 146.0, 145.4, 144.8, 140.1, 129.8, 125.1, 112.7, 112.6, 108.3, 106.7, 104.3, 101.8, 64.7, 63.0, 37.3, 29.3, 15.3, 15.2. MS (ESI) <i>m</i>/<i>z</i> 366.4 (M + H)<sup>+</sup>, 388.4 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>: C, 69.02; H, 6.34; N, 11.50. Found: C, 69.28; H, 6.31; N, 11.45.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Methyl 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetate (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>11</b> (1.10 g, 3.13 mmol) in acetone (35 mL) were added methyl chloroacetate (0.55 mL, 6.26 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.87 g, 6.26 mmol). The mixture was refluxed for 14 h, and distilled water (35 mL) was added. The reaction mixture was extracted with EtOAc (200 mL), washed with 1 M HCl (6 mL), distilled water (80 mL), and brine (80 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration and evaporation, the residue was purified by column chromatography on silica gel (hexane/AcOEt = 2:1–1:1) to give 1.02 g of <b>12</b> (74%) as a white solid, mp 139–141 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 10.2 Hz, 3H), 1.35(t, <i>J</i> = 10.2 Hz, 3H), 3.38 (s, 2H), 3.72 (s, 3H), 3.93 (s, 3H), 3.98 (q, <i>J</i> = 10.2 Hz, 2H), 4.09 (q, <i>J</i> = 10.2 Hz, 2H), 4.88 (s, 2H), 6.29 (d, <i>J</i> = 6.8 Hz, 1H), 6.83 (d, <i>J</i> = 8.0 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 8.0 Hz, 1H), 7.24 (s, 1H), 7.27 (s, 1H), 8.38 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.9, 159.7, 148.6, 147.6, 146.9, 145.4, 144.9, 142.9, 129.8, 124.9, 113.1, 112.7, 108.3, 106.2, 104.4, 101.9, 66.4, 64.7, 63.1, 52.2, 37.5, 29.4, 15.3, 15.2; MS (ESI) <i>m</i>/<i>z</i> 438.5 (M + H)<sup>+</sup>, 460.5 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>5</sub>: C, 65.89; H, 6.22; N, 9.60. Found: C, 65.72; H, 6.31; N, 9.45.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6a</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (15.0 g, 34.0 mmol) in MeOH (50 mL) was added aqueous ammonia (25%, 52 mL). The reaction mixture was heated to 65 °C and stirred for 12 h. A white solid was precipitated out, filtered, washed with distilled water and a small amount of MeOH, and dried to give 11.3 g of <b>6a</b> (80%) as a white solid, mp 186–188 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H), 3.39 (s, 2H), 3.94 (s, 3H), 3.98 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.53 (s, 2H), 6.30 (dd, <i>J</i> = 8.4,1.8 Hz, 1H), 6.83 (dd, <i>J</i> = 8.4,1.8 Hz, 1H), 6.98 (t, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.27 (s, 1H), 7.37 (s, 1H), 7.39 (s, 1H), 7.50 (s, 1H), 8.38 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 159.7, 148.6, 147.9, 147.2, 145.4, 144.9, 143.4, 129.8, 124.9, 112.8, 112.7, 108.3, 107.6, 104.4, 101.9, 69.8, 64.7, 63.1, 37.5, 29.5, 15.3; MS (ESI) <i>m</i>/<i>z</i> 423.4 (M + H)<sup>+</sup>, 445.5 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>23</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>: C, 65.39; H, 6.20; N, 13.26. Found: C, 65.43; H, 6.19; N, 13.18.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-methylacetamide (<b>6b</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (111.5 mg, 0.25 mmol) in MeOH (2.5 mL) was added aqueous methylamine solution (40%, 4.0 mL). The mixture was heated to 65 °C and stirred for 2 h. After the completion of the reaction indicated by TLC, the solvent was evaporated. The residue was purified by column chromatography on silica gel (hexane/AcOEt = 1:1) to give 88.5 mg of <b>6b</b> (81%) as a light yellow solid, mp 163–165 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.30 (t, <i>J</i> = 7.2 Hz, 3H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H), 2.68 (d, <i>J</i> = 4.8 Hz, 3H), 3.36 (s, 2H), 3.91 (s, 3H), 3.94 (q, <i>J</i> = 7.2 Hz, 2H), 4.08 (q, <i>J</i> = 7.2 Hz, 2H), 4.52 (s, 2H), 6.26 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.80 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.95 (t, <i>J</i> = 1.8 Hz, 1H), 7.03 (t, <i>J</i> = 8.4 Hz, 1H), 7.24 (s, 1H), 7.36 (s, 1H), 7.88 (s, 1H), 8.36 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.3, 160.1, 149.4, 148.3, 146.8, 144.5, 144.3, 144.2, 128.8, 125.1, 113.5, 111.8, 108.8, 107.7, 106.0, 102.7, 70.9, 64.7, 63.3, 37.2, 30.1, 25.7, 14.93, 14.90; MS (ESI) <i>m</i>/<i>z</i> 437.6 (M + H)<sup>+</sup>, 459.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>: C, 66.04; H, 6.47; N, 12.84. Found: C, 66.15; H, 6.26; N, 12.70.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>,<i>N</i>-dimethylacetamide (<b>6c</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (95 mg, 0.22 mmol) in MeOH (2 mL) was added aqueous dimethylamine solution (30%, 2 mL). The mixture was heated to 65 °C and stirred for 4 h. After the solvent was evaporated, the residue was purified by column chromatography on silica gel (hexane/AcOEt = 1:1–1:4) to give 65.2 mg of <b>6c</b> (67%) as a light yellow solid, mp 137–139 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H), 2.87 (s, 3H), 3.06 (s, 3H), 3.37 (s, 2H), 3.93 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.09 (q, <i>J</i> = 7.2 Hz, 2H), 4.86 (s, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.84 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.99 (t, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.23 (s, 1H), 7.25 (s, 1H), 8.38 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.2, 160.1, 149.7, 148.5, 147.0, 144.7, 144.2, 143.7, 129.8, 125.0, 113.4, 112.1, 108.7, 107.5, 105.9, 102.5, 70.2, 64.8, 63.3, 37.2, 36.8, 35.8, 30.0, 14.94, 14.90; MS (ESI) <i>m</i>/<i>z</i> 451.6 (M + H)<sup>+</sup>, 473.4 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>25</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>: C, 66.65; H, 6.71; N, 12.44. Found: C, 66.85; H, 6.66; N, 12.30.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-ethylacetamide (<b>6d</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (70 mg, 0.16 mmol) in MeOH (2 mL) was added aqueous ethylamine (70%, 2 mL). The mixture was heated to 65 °C and stirred for 2 h. After the solvent was evaporated, the resulting residue was purified by column chromatography on silica gel (hexane/AcOEt = 2:1–1:1) to give 49 mg of <b>6d</b> (67%) as a white solid, mp 146–148 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.07 (t, <i>J</i> = 7.2 Hz, 3H), 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 3.20 (q, <i>J</i> = 7.2 Hz, 2H), 3.39 (s, 2H), 3.93 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.55 (s, 2H), 6.29 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (d, <i>J</i> = 8.4 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 8.4 Hz, 1H), 7.27 (s, 1H), 7.38 (s, 1H), 7.93 (s, 1H), 8.38 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>)) δ 168.4, 160.1, 149.4, 148.3, 146.8, 144.5, 144.21, 129.8, 125.1, 113.6, 111.8, 108.8, 107.4, 105.9, 102.7, 70.7, 64.7, 63.3, 37.2, 33.9, 30.1, 14.94, 14.90, 14.8; MS (ESI) <i>m</i>/<i>z</i> 451.6 (M + H)<sup>+</sup>, 473.4 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>25</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>: C, 66.65; H, 6.71; N, 12.44. Found: C, 66.75; H, 6.76; N, 12.30.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-(2-hydroxyethyl)acetamide (<b>6e</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (100 mg, 0.23 mmol) in MeOH (3 mL) was added 2-aminoethanol (0.21 mL, 3.5 mmol). The mixture was heated to 65 °C and stirred for 1 h. A white solid was precipitated out, filtered and washed with distilled water and a small amount of MeOH, and dried to give 93 mg of <b>6e</b> (86%), mp 195–197 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 3.26 (t, <i>J</i> = 5.4 Hz, 2H), 3.39 (s, 2H), 3.46 (q, <i>J</i> = 5.4 Hz, 2H), 3.94 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.58 (s, 2H), 4.77 (t, <i>J</i> = 5.4 Hz, 1H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 7.00 (t, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.27 (s, 1H), 7.38 (s, 1H), 7.90 (t, <i>J</i> = 5.4 Hz, 1H), 8.38 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.5, 159.7, 148.6, 148.0, 147.1, 145.4, 144.9, 143.4, 129.8, 124.9, 112.7, 108.3, 107.6, 104.4, 101.9, 70.0, 64.7, 63.0, 60.2, 41.6, 37.5, 29.5, 15.3; MS (ESI) <i>m</i>/<i>z</i> 467.5 (M + H)<sup>+</sup>, 489.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>25</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub>: C, 64.36; H, 6.48; N, 12.01. Found: C, 64.66; H, 6.62; N, 11.96.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(2-Cyanoethyl)-2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6f</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (100 mg, 0.23 mmol) in MeOH (2.5 mL) was added 3-aminopropanenitril (0.25 mL, 0.35 mmol). The mixture was heated to 65 °C and stirred for 10 h. After the solvent was evaporated, the resulting residue was purified by column chromatography on silica gel (hexane/AcOEt = 1:1–1:2) to give 70 mg of <b>6f</b> (64%) as a white solid, mp 175–177 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 2.73 (t, <i>J</i> = 7.2 Hz, 2H), 3.39 (s, 2H), 3.43 (q, <i>J</i> = 7.2 Hz, 2H), 3.93 (s, 3H), 3.96 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.60 (s, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.97 (t, <i>J</i> = 1.8 Hz, 1H), 7.07 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (s, 1H), 7.37 (s, 1H), 8.33 (t, <i>J</i> = 6.0 Hz, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.1, 159.7, 148.5, 148.1, 147.1, 145.4, 144.8, 143.6, 129.8, 124.9, 119.6, 112. 9, 112.73, 108.3, 107.9, 104.4, 101.9, 70.0, 64.7, 63.0, 37.5, 35.0, 29.5, 18.1 15.3; MS (ESI) <i>m</i>/<i>z</i> 476.4 (M + H)<sup>+</sup>, 498.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>26</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>: C, 65.67; H, 6.15; N, 14.73. Found: C, 65.55; H, 6.27; N, 14.88.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(2-Aminoethyl)-2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6g</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (63 mg, 0.14 mmol) in MeOH (2.0 mL) was added ethane-1,2-diamine (0.15 mL, 2.2 mmol). The mixture was heated to 65 °C and stirred for 5 h. After the solvent was evaporated, the residue was crystallized from MeOH/H<sub>2</sub>O (20:1) to give 53 mg of <b>6g</b> (77%) as a light yellow solid, mp 175–177 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 1.47 (br s, 2H), 2.62 (t, <i>J</i> = 6.0 Hz, 2H), 3.17 (q, <i>J</i> = 6.0 Hz, 2H), 3.39 (s, 2H), 3.94 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.57 (s, 2H), 6.29 (d, <i>J</i> = 7.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.27 (s, 1H), 7.37 (s, 1H), 7.93 (br s, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d6</i>) δ 168.8, 159.7, 157.9, 148.6, 148.1, 147.1, 145.3, 144.9, 143.5, 129.8, 124.9, 112.8, 112.7, 108.3, 107.9, 104.4, 101.8, 70.1, 64.7, 63.0, 39.1, 37.4, 29.5, 15.3; MS (ESI) <i>m</i>/<i>z</i> 466.5 (M + H)<sup>+</sup>, 488.5 [M + Na]<sup>+</sup>; Anal. calcd for C<sub>25</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>: C, 64.50; H, 6.71; N, 15.04. Found: C, 64.65; H, 6.76; N, 15.20.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(2-(Dimethylamino)ethyl)-2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6h</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (85 mg, 0.19 mmol) in MeOH (3.0 mL) was added <i>N</i>,<i>N</i>-dimethylethane-1,2-diamine (0.26 mL, 2.9 mmol). The mixture was heated to 65 °C and stirred for 4 h. After the solvent was evaporated, the residue was crystallized from MeOH/H<sub>2</sub>O (10:1) to give 65 mg of <b>6h</b> (72%) as a light yellow solid, mp 192–194 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 2.15 (s, 6H), 2.34 (t, <i>J</i> = 6.6 Hz, 2H), 3.27 (q, <i>J</i> = 6.6 Hz, 2H), 3.39 (s, 2H), 3.95 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.58 (s, 2H), 6.29 (d, <i>J</i> = 7.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.27 (s, 1H), 7.37 (s, 1H), 7.77 (t, <i>J</i> = 6.6 Hz, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.6, 160.1, 149.4, 148.1, 146.6, 144.7, 144.2, 143.8, 129.8, 125.1, 113.7, 112.0, 108.7, 106.6, 105.78, 102.5, 69.9, 64.8, 63.3, 58.0, 45.3, 37.3, 36.6, 30.0, 14.9; MS (ESI) <i>m</i>/<i>z</i> 494.6 (M + H)<sup>+</sup>, 516.7 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>27</sub>H<sub>35</sub>N<sub>5</sub>O<sub>4</sub>: C, 65.70; H, 7.15; N, 14.19. Found: C, 65.93; H, 7.22; N, 13.95.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-(2-methoxyethyl)acetamide (<b>6i</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (85 mg, 0.20 mmol) in MeOH (3.0 mL) was added 2-methoxyethylamine (0.25 mL, 2.9 mmol). The mixture was heated to 65 °C and stirred for 6 h. After the solvent was evaporated, the residue was crystallized from MeOH/H<sub>2</sub>O (20:1) to give 74 mg of <b>6i</b> (79%) as a light yellow solid, mp 197–199 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 3.25 (s, 3H), 3.35 (t, <i>J</i> = 5.4 Hz, 2H), 3.39 (s, 2H), 3.40 (t, <i>J</i> = 5.4 Hz, 2H), 3.94 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.59 (s, 2H), 6.29 (d, <i>J</i> = 7.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.27 (s, 1H), 7.38 (s, 1H), 7.91 (t, <i>J</i> = 4.8 Hz, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.7, 160.1, 149.6, 148.5, 146.7, 144.3, 144.2, 129.9, 124.8, 113.2, 111.8, 109.0, 107.2, 106.2, 102.9, 71.2, 70.3, 64.7, 63.4, 58.8, 38.8, 37.2, 30.2, 14.9, 14.8; MS (ESI) <i>m</i>/<i>z</i> 481.5 (M + H)<sup>+</sup>, 503.4 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>26</sub>H<sub>32</sub>N<sub>4</sub>O<sub>5</sub>: C, 64.98; H, 6.71; N, 11.66. Found: C, 64.76; H, 6.71; N, 11.43.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-Cyclopropyl-2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6j</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (90 mg, 0.21 mmol) in MeOH (3.0 mL) was added cyclopropylamine (0.21 mL, 3.1 mmol). The mixture was heated to 65 °C and stirred for 12 h. After the solvent was evaporated, the residue was recrystallized from MeOH/H<sub>2</sub>O (20:1) to give 60 mg of <b>6j</b> (63%) as a light yellow solid, mp 175–177 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.47–0.49 (m, 2H), 0.66–0.68 (m, 2H), 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H), 2.70–2.73 (m, 1H), 3.38 (s, 2H), 3.93 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.53 (s, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.26 (s, 1H), 7.34 (s, 1H), 8.01 (d, <i>J</i> = 3.6 Hz, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.1, 160.1, 149.3, 148.2, 146.7, 144.6, 144.3, 144.2, 129.0, 125.2, 113.6, 111.9, 108.8, 107.5, 105.9, 102.7, 70.8, 64.8, 63.3, 37.2, 30.1, 22.1, 14.94, 14.91, 6.4; MS (ESI) <i>m</i>/<i>z</i> 463.5 (M + H)<sup>+</sup>, 485.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>: C, 67.51; H, 6.54; N, 12.11. Found: C, 67.28; H, 6.64; N, 11.91.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(Cyclopropylmethyl)-2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6k</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (90 mg, 0.21 mmol) in MeOH (3 mL) was added cyclopropanemethylamine (0.27 mL, 3.1 mmol). The mixture was heated to 65 °C and stirred for 10 h. After the solvent was evaporated, the residue was recrystallized from MeOH/H<sub>2</sub>O (20:1) to give 71 mg of <b>6k</b> (77%) as a light yellow solid, mp 192–194 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.18–0.21 (m, 2H), 0.40–0.43 (m, 2H), 0.94–0.97 (m, 1H), 1.32 (t, <i>J</i> = 7.2 Hz, 3H),1.39 (t, <i>J</i> = 7.2 Hz, 3H), 3.06 (t, <i>J</i> = 6.0 Hz, 2H), 3.39 (s, 2H), 3.94 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.58 (s, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (s, 1H), 7.38 (s, 1H), 7.95 (t, <i>J</i> = 6.0 Hz, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.3, 159.7, 148.6, 147.9, 147.1, 145.3, 144.9, 143.4, 129.8, 124.9, 112.8, 112.7, 108.30, 107.5, 104.4, 101.9, 69.9, 64.7, 63.0, 43.0, 37.5, 29.5, 15.30, 15.26, 11.3, 3.59; MS (ESI) <i>m</i>/<i>z</i> 477.5 (M + H)<sup>+</sup>, 499.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>: C, 68.05; H, 6.77; N, 11.76. Found: C, 67.95; H, 6.76; N, 11.50.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-(prop-2-ynyl)acetamide (<b>6l</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (102 mg, 0.23 mmol) in MeOH (3.5 mL) was added prop-2-yn-1-amine (0.24 mL, 3.5 mmol). The mixture was heated to 65 °C and stirred for 12 h. After the solvent was evaporated, the resulting residue was recrystallized from MeOH/H<sub>2</sub>O (20:1) to give 70 mg of <b>6l</b> (69%) as a light yellow solid, mp 195–197 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 3.16 (t, <i>J</i> = 2.4 Hz, 1H), 3.39 (s, 2H), 3.94 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 4H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.61 (s, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (s, 1H), 7.35 (s, 1H), 8.39 (s, 1H), 8.42 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.6, 160.1, 149.3, 148.3, 146.7, 144.6, 144.6 144.3, 129.9, 125.2, 113.7, 111.8, 108.8, 108.0, 105. 9, 102.7, 79.1, 71.6, 71.0, 64.7, 63.3, 37.2, 30.1, 28.7, 14.93, 14.91; MS (ESI) <i>m</i>/<i>z</i> 461.5 (M + H)<sup>+</sup>, 483.5 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>: C, 67.81; H, 6.13; N, 12.17. Found: C, 67.54; H, 6.14; N, 11.99.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-Allyl-2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetamide (<b>6m</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (95 mg, 0.22 mmol) in MeOH (3.0 mL) was added allylamine (0.25 mL, 3.3 mmol). The mixture was heated to 65 °C and stirred for 12 h. The solvent was evaporated. The residue was recrystallized from MeOH/H<sub>2</sub>O (20:1) to give 69 mg of <b>6m</b> (69%) as a light yellow solid, mp 172–174 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H), 3.39 (s, 2H), 3.81 (br s, 2H), 3.93 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.62 (s, 2H), 5.07 (d, <i>J</i> = 10.2 Hz, 1H), 5.16 (d, <i>J</i> = 17.4 Hz, 1H), 5.82–5.86 (m, 1H), 6.28 (d, <i>J</i> = 7.8 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (s, 1H), 7.39 (s, 1H), 8.01 (br s, 1H), 8.39 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.6, 160.1, 149.4, 148.3, 146.7, 144.5, 144.3, 144.2, 133.9, 129.8, 125.1, 116.5, 113.6, 111.7, 108.8, 107.6, 106.0, 102.7, 70.8, 64.7, 63.3, 41.3, 37.2, 30.1, 14.9; MS (ESI) <i>m</i>/<i>z</i> 463.5 (M + H)<sup>+</sup>, 485.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>: C, 67.51; H, 6.54; N, 12.11. Found: C, 67.54; H, 6.57; N, 11.98.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-hydroxyacetamide (<b>6n</b>)</h3><div class="NLM_p last">To a solution of hydroxylamine hydrochloride (1.6 g, 24 mmol) in MeOH (60 mL) was added 28% MeONa/MeOH solution (5.0 mL). After stirring for 30 min, the resulting sodium chloride was filtered. The filtrate was added to the solution of <b>12</b> (1.0 g, 2 mmol) in MeOH (15 mL). The mixture was heated to 65 °C and stirred for 6 h. A white solid was precipitated out, filtered, washed with distilled water and a small amount of MeOH, and dried to give 0.78 g of <b>6n</b> (77%) as a white solid, mp 183–185 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (t, <i>J</i> = 7.2 Hz, 3H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H), 3.38 (s, 2H), 3.94 (s, 3H), 3.97 (q, <i>J</i> = 7.2 Hz, 2H), 4.09 (q, <i>J</i> = 7.2 Hz, 2H), 4.54 (s, 2H), 6.29 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.98 (s, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 (s, 1H), 7.35 (s, 1H), 8.39 (s, 1H), 9.04 (s, 1H), 10.74 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.1, 159.7, 148.6, 147.9, 147.3, 145.4, 144.9, 143.2, 129.8, 124.9, 112.9, 112.7, 108.3, 107.2, 104.4, 101.9, 68.5, 64.7, 63.1, 37.5, 29.5, 15.29, 15.27; MS (ESI) <i>m</i>/<i>z</i> 439.5 (M + H)<sup>+</sup>, 461.5 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>23</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>: C, 63.00; H, 5.98; N, 12.78. Found: C, 62.86; H, 6.07; N, 12.62.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)-<i>N</i>-methoxyacetamide (<b>6o</b>)</h3><div class="NLM_p last">To a solution of methoxylamine hydrochloride (2.5 g, 30 mmol) in MeOH (20 mL) was added 28% MeONa/MeOH solution (7.0 mL). After stirring for 30 min, the resulting sodium chloride was filtered. The filtrate was added to the solution of <b>12</b> (100 mg, 0.23 mmol) in MeOH (15 mL). The mixture was heated to 65 °C and stirred for 12 h. The solvent was evaporated. The residue was purified by column chromatography on silica gel (hexane/AcOEt = 1:4) to give 60 mg of <b>6o</b> (58%) as a white solid, mp 146–148 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.28 (t, <i>J</i> = 7.2 Hz, 3H), 1.33 (t, <i>J</i> = 7.2 Hz, 3H), 3.39 (s, 2H), 3.64 (s, 3H), 3.90 (s, 3H), 3.94 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.54 (s, 2H), 6.26 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.83 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.95 (t, <i>J</i> = 1.8 Hz, 1H), 7.06 (t 1H, <i>J</i> = 7.8 Hz), 7.24 (s, 1H), 7.31 (s, 1H), 8.36 (s, 1H), 11.36 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.2, 159.7, 148.6, 148.0, 147.1, 145.4, 144.9, 143.5, 129.8, 124.9, 113.0, 112.7, 108.3, 107.5, 104.4, 101.9, 68.6, 64.7, 63.8, 63.1, 37.4, 29.5, 15.3; MS (ESI) <i>m</i>/<i>z</i> 453.5 (M + H)<sup>+</sup>, 475.4 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>: C, 63.70; H, 6.24; N, 12.38. Found: C, 63.67; H, 6.28; N, 12.40.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(6-Ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-7-yloxy)acetohydrazide (<b>6p</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (90 mg, 0.21 mmol) in MeOH (3.0 mL) was added hydrazine hydrate (1 mL). The mixture was heated to 65 °C and stirred for 1 h, and the solvent was evaporated. The residue was recrystallized from MeOH/H<sub>2</sub>O (20:1) to give 76 mg of <b>6p</b> (84%) as light yellow solid, mp 178–180 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.29 (t, <i>J</i> = 7.2 Hz, 3H),1.35 (t, <i>J</i> = 7.2 Hz, 3H), 3.35 (s, 2H), 3.91 (s, 3H), 3.94 (q, <i>J</i> = 7.2 Hz, 2H), 4.07 (q, <i>J</i> = 7.2 Hz, 2H), 4.34 (s, 2H), 4.56 (s, 2H), 6.26 (dd, <i>J</i> = 7.8,1.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.8,1.8 Hz, 1H), 6.95 (s, 1H), 7.03 (t, <i>J</i> = 7.8 Hz, 1H), 7.23 (s, 1H), 7.35 (s, 1H), 8.36 (s, 1H), 9.12 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.6, 159.7, 148.6, 147.9, 147.3, 145.4, 144.9, 143.3, 129.8, 124.9, 112.8, 112.7, 108.3, 107.5, 104.4, 101.9, 69.3, 64.7, 63.1, 37.5, 29.5, 15.3; MS (ESI) <i>m</i>/<i>z</i> 438.5 (M + H)<sup>+</sup>, 460.6 (M + Na)<sup>+</sup>; Anal. calcd for C<sub>25</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>: C, 63.14; H, 6.22; N, 16.01. Found: C, 63.34; H, 6.19; N, 16.23.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Cell Growth Inhibitory Assay</h3><div class="NLM_p">Target compounds were assayed by conventional 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2<i>H</i>-tetrazolium bromide (MTT) method. In brief, the exponentially growing cells were seeded into 96-well cell plates at density of 1–6 × 10<sup>3</sup> cells per well and allowed to adhere overnight. Cells were incubated with various concentrations of the test compounds for 48 h (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) or 72 h (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Then 20 μL of MTT (5 mg/mL) was added, the cells were incubated at 37 °C for another 4 h. The reduced MTT crystals were dissolved in DMSO, and the absorbance was measured at 570 nm by a microplate spectrophotometer. The growth inhibitory effects of each compound were expressed as IC<sub>50</sub> values, which represent the molar drug concentrations required to cause 50% tumor cell growth inhibition.</div><div class="NLM_p">In colony formation assay, A549 and NCI-H460 cells (500 per well) grown in 6-well plates were exposed to different concentrations of <b>6a</b> at 37 °C for 9 days. The colonies (>50 cells) were fixed, stained with 0.5% crystal violet, and then counted.</div><div class="NLM_p last">In trypan blue staining assay, A549 cells were seeded in 6-well plates at density of 2 × 10<sup>5</sup> cells per well, and after overnight adherence, they were exposed to increasing concentrations of <b>6a</b> for 24 h. Afterward, cell suspension was mixed with 0.4% trypan blue solution at a 1:9 ratio. The number of viable cells (clear) vs dead cells (blue) was determined by a hemocytometer.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Cell Morphology</h3><div class="NLM_p last">A549 and NCI-H460 cells were seeded in 24-well plates at a density of 5 × 10<sup>4</sup> cells per well. After overnight adherence, they were exposed to increasing concentrations of <b>6a</b> for 24 h. Cells were imaged using fluorescence microscope. In order to visualized nuclear morphological changes, cells were stained with Hoechst 33342 (Sigma, USA).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> in Vitro Tubulin Polymerization Assay</h3><div class="NLM_p last">The fluorescence-based in vitro tubulin polymerization assay was performed using the Tubulin Polymerization Assay Kit (BK011P, Cytoskeleton, USA) according to the manual. The tubulin reaction mix contained 2 mg/mL porcine brain tubulin (>99% pure), 2 mM MgCl<sub>2</sub>, 0.5 mM EGTA, 1 mM GTP, and 15% glycerol. First, 96-well plate was incubated with 5 μL of inhibitors in various concentrations at 37 °C for 1 min. Then 50 μL of the tubulin reaction mix was added. Immediately, the increase in fluorescence was monitored by excitation at 355 nm and emission at 460 nm in a multimode reader.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Competitive Inhibition Assays</h3><div class="NLM_p last">The competitive binding activity of inhibitors was evaluated using a radiolabeled [<sup>3</sup>H]colchicine competition scintillation proximity (SPA) assay.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In brief, 0.08 μM [<sup>3</sup>H]colchicine was mixed with the test compound and biotinylated porcine tubulin (0.5 μg) in a buffer of 100 μL containing 80 mM PIPES (pH 6.8), 1 mM EGTA, 10% glycerol, 1 mM MgCl<sub>2</sub>, and 1 mM GTP for 2 h at 37 °C. Then streptavidin-labeled SPA beads (80 μg) were added to each mixture. The radioactive counts were measured directly with a scintillation counter.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Immunofluorescent Staining</h3><div class="NLM_p last">A549 cells were seeded in 24-well plate (with coverslips plated) at density of 5 × 10<sup>4</sup> cells. After overnight adherence, they were exposed to <b>6a</b> and <b>1</b> at 40 nM, respectively, for 24 h. The coverslips were fixed in ice-cold methanol/acetic acid (3:1) for 10 min and blocked with 3% bovine serum albumin for 20 min at room temperature. Then they were incubated with mouse anti-α-tubulin antibody (T5168, sigma, USA) overnight at 4 °C and incubated with goat antimouse IgG-TRITC antibody (ZF-0313, ZSGB-BIO, China) at 37 °C for 2 h. Hoechst 33342 was used to counterstain the nuclear. The coverslips were visualized under fluorescence microscope.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Molecular Modeling</h3><div class="NLM_p">The crystal structure of tubulin in complex with different ligands (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA1">1SA1</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC">3HKC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD">3HKD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD">3HKD</a>) was used as the template in the docking study. The protein structure was prepared using the SYBYL-X suite (version 1.3, Tripos). After extracting the ligand, hydrogen atoms were added to the crystal. Charges were added to biopolymer by AMBER7 FF99 force field and ligand by Gasteiger–Huckel force field. The extracted ligand was used to generate the protomol with threshold of 0.99 and bloat of 0 Å.</div><div class="NLM_p last">The 3D structure of each ligand was constructed by the Sketch module of Sybyl, and energy minimization was performed using the Tripos force field. A nonbonded cutoff distance of 8 Å was adopted to consider the intramolecular interaction. The Surflex-dock module was used for the docking studies, and the related parameters implied in the program were kept at default.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Cell Cycle Analysis</h3><div class="NLM_p last">A549 cells were seeded in 6-well plates at density of 2 × 10<sup>5</sup> cells per well, and after overnight adherence, they were exposed to increasing concentrations of <b>6a</b> and positive control (<b>1</b>) for 24 h. Then cells were harvested, fixed in cold 70% ethanol overnight, treated with RNase A at 37 °C for 30 min, and incubated with PI solution (Solarbio, China) at 4 °C for 15 min. Cell cycle distribution was analyzed using a FACS flow cytometer.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Annexin V-FITC/PI Staining Assay</h3><div class="NLM_p last">A549 cells were treated as cell cycle analysis mentioned above. The percentage of apoptotic cells was quantitatively estimated by using Annexin V-FITC kit (ydjmbio, China) according to the manufacturer’s instructions. The analysis was performed on a FACS flow cytometer (Beckman coulter, USA).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Western Blotting Analysis</h3><div class="NLM_p last">A549 cells were treated as cell cycle analysis mentioned above. Then cells were homogenized in cell lysis buffer for Western and IP (Beyotime, China), and the protein concentrations were determined by a BCA Protein Assay Kit (Thermo Scientific, USA). The protein extracts were reconstituted in loading buffer (Beyotime, China) and inactivated at 100 °C for 5 min. 30 μg of proteins were fractionated by 10% or 12% SDS-PAGE and were transferred to PVDF membranes (Millipore, USA), and then the protein levels were estimated by using the primary antibodies with appropriate dilution. The primary antibodies included those to cyclin B1 (1495-S, Eptomics, USA), p-cdc2 (9111), cleaved caspase-3 (9661), cleaved PARP (9541s, Cell Signaling Technology, USA), and β-actin (ZF-0313, ZSGB-BIO, China). The primary antibodies were washed and then incubated with HRP-conjugated secondary antibody (ZSGB-BIO, China). Immunoreactive bands were visualized using an enhanced chemiluminescence reagent (Millipore, USA) and quantified by densitometry using a ChemiDoc XRS + molecular imager. The intensities of the blots were quantified by AlphaEaseFC 4.0.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Capillary Tube Formation Assay</h3><div class="NLM_p last">Matrigel (50 μL, Corning, USA) at 4 °C was used to coat each well of a 96-well plate and allowed to polymerize for 1 h at 37 °C. 50 μL of HUVECs (4 × 10<sup>5</sup> cells/mL) were seeded on Matrigel-coated 96-well plate, together with increasing concentrations of <b>6a</b>. HUVECs were incubated for 8 h to allow formation of tube-like structures at 37 °C. The formed tubes were counted in three random observations under fluorescence microscope.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Antitumor Activity in Vivo</h3><div class="NLM_p last">The experimental procedures conformed to the animal experiment guidelines of the Animal Care and Welfare Committee of Shandong University. Five-week-old pathogen-free female Balb/c-nu mice were purchased from the Animal Centre of China Academy of Medical Sciences (Beijing, China). The nude mice were housed under pathogen-free conditions. Human NSCLC xenografts were established by inoculating human NSCLC tissue pieces, provided by the Second Hospital of Shandong University, into the armpits of mice by trocar. When the tumors were proliferating exuberantly, they were extracted and cut into 1 mm<sup>3</sup> fragments (about 20 mg/fragment). The fragments were subcutaneously inoculated into the armpits of each nude mouse. When the tumor volume reached approximately 100 mm<sup>3</sup> to 200 mm<sup>3</sup>, the mice were randomly divided into four groups (<i>n</i> = 6): blank group, vehicle group [PEG 400:ethanol:dextrose 5% in water (D5W)] = 4:1:5), <b>6a</b> (12.5 mg/kg) group, and <b>6a</b> (50 mg/kg) group. Both drugs and vehicle were administrated ip every day for 21 consecutive days. Tumor volume and body weight were measured every 3 days. Tumor volumes were calculated with a formula of <i>W</i><sup>2</sup> × <i>L</i>/2, where <i>W</i> is width (short axis) and <i>L</i> is length (long axis). At the end of the experiment, the mice were sacrificed, and the tumors were removed and weighed. Therapeutic effect of the <b>6a</b> on xenografts growth was expressed as a percentage of the vehicle group.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00071">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00071" class="ext-link">10.1021/acs.jmedchem.6b00071</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_007.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Additional compound data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_008.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">In vitro tubulin polymerization assay, molecular modeling, NMR spectra for all screening compounds and synthetic intermediates (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_010.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_001.pdb">jm6b00071_si_001.pdb (122.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_002.pdb">jm6b00071_si_002.pdb (112.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_003.pdb">jm6b00071_si_003.pdb (111.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_004.pdb">jm6b00071_si_004.pdb (124.35 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_005.pdb">jm6b00071_si_005.pdb (117.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_006.pdb">jm6b00071_si_006.pdb (118.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_007.pdb">jm6b00071_si_007.pdb (121.82 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_008.csv">jm6b00071_si_008.csv (1.24 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf">jm6b00071_si_009.pdf (8.11 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_010.pdb">jm6b00071_si_010.pdb (125.93 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00071" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiu-Li Guo</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6304160c1b0f231007164d0607164d000d"><span class="__cf_email__" data-cfemail="a7c0d2c8dfcbe7d4c3d289c2c3d289c4c9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhao-Peng Liu</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d21243837252c223d0d3e293863282938632e23"><span class="__cf_email__" data-cfemail="0b67627e71636a647b4b786f7e256e6f7e256865">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan-Na Liu</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing-Jing Wang</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ya-Ting Ji</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guo-Dong Zhao</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Long-Qian Tang</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Mei Zhang</span> - <span class="hlFld-Affiliation affiliation">†Institute of Medicinal
Chemistry, Key Laboratory of Chemical Biology
(Ministry of Education), School of Pharmaceutical Sciences and ‡Department of
Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d49e4488-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (NSFC, Grant No. 81573275).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i53" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i53"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> Abbreviations Used</h2><tr><td class="NLM_term">LHMDS</td><td class="NLM_def"><p class="first last">lithium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">D5W</td><td class="NLM_def"><p class="first last">5 % dextrose in water</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal injection</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">ESI-MS</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide)</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Heald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogales, E.</span><span> </span><span class="NLM_article-title">Microtubule dynamics</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=11801717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVejsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2002&pages=3-4&author=R.+Healdauthor=E.+Nogales&title=Microtubule+dynamics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule dynamics</span></div><div class="casAuthors">Heald, Rebecca; Nogales, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-4</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDLiwcMnFurbVg90H21EOLACvtfcHk0ljPyWIf1N0P4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVejsg%253D%253D&md5=6a9501a826ccf37961fda924297e75b7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeald%26aufirst%3DR.%26aulast%3DNogales%26aufirst%3DE.%26atitle%3DMicrotubule%2520dynamics%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2002%26volume%3D115%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">McIntosh, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishchuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R. R.</span><span> </span><span class="NLM_article-title">Chromosome–microtubule interactions during mitosis</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1146/annurev.cellbio.18.032002.132412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1146%2Fannurev.cellbio.18.032002.132412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=193-219&author=J.+R.+McIntoshauthor=E.+Grishchukauthor=R.+R.+West&title=Chromosome%E2%80%93microtubule+interactions+during+mitosis&doi=10.1146%2Fannurev.cellbio.18.032002.132412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.18.032002.132412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.18.032002.132412%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BR.%26aulast%3DGrishchuk%26aufirst%3DE.%26aulast%3DWest%26aufirst%3DR.%2BR.%26atitle%3DChromosome%25E2%2580%2593microtubule%2520interactions%2520during%2520mitosis%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2002%26volume%3D18%26spage%3D193%26epage%3D219%26doi%3D10.1146%2Fannurev.cellbio.18.032002.132412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Vindya, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethiraj, K. R.</span><span> </span><span class="NLM_article-title">Tubulins–the target for anticancer therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.2174/1568026615666150112115805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F1568026615666150112115805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=25579568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=73-82&author=N.+G.+Vindyaauthor=N.+Sharmaauthor=M.+Yadavauthor=K.+R.+Ethiraj&title=Tubulins%E2%80%93the+target+for+anticancer+therapy&doi=10.2174%2F1568026615666150112115805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulins - The Target for Anticancer Therapy</span></div><div class="casAuthors">Vindya, N. G.; Sharma, Nishant; Yadav, Mukesh; Ethiraj, K. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Tubulin has picked up great focus as a major target in drug discovery and consequently, tubulin inhibitors have pulling in a considerable attention as anticancer agents.  Numerable naturally occurring agents have focused on tubulin system act as an imperative target of cancer chemotherapy.  Substantial no. of tubulin inhibitors has been discovered so far and these agents are classified as indicated by their interaction.  They are colchicine site binder, vinca- alkaloid related drugs and those interacting with the Taxol binding site and functioning as stabilizing agents.  We review the recent advances in the advancement of tubulin interfering agents and will render the current trend in the improvement of tubulin inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tIyc1PffELVg90H21EOLACvtfcHk0ljPyWIf1N0P4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKgsbo%253D&md5=8805a32e1f038693336ceb464c67193d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150112115805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150112115805%26sid%3Dliteratum%253Aachs%26aulast%3DVindya%26aufirst%3DN.%2BG.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DYadav%26aufirst%3DM.%26aulast%3DEthiraj%26aufirst%3DK.%2BR.%26atitle%3DTubulins%25E2%2580%2593the%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D73%26epage%3D82%26doi%3D10.2174%2F1568026615666150112115805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Barbier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsvetkov, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuzard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devred, F.</span><span> </span><span class="NLM_article-title">Deciphering the molecular mechanisms of anti-tubulin plant derived drugs</span> <span class="citation_source-journal">Phytochem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1007/s11101-013-9302-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1007%2Fs11101-013-9302-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislCksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=157-169&author=P.+Barbierauthor=P.+O.+Tsvetkovauthor=G.+Breuzardauthor=F.+Devred&title=Deciphering+the+molecular+mechanisms+of+anti-tubulin+plant+derived+drugs&doi=10.1007%2Fs11101-013-9302-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the molecular mechanisms of anti-tubulin plant derived drugs</span></div><div class="casAuthors">Barbier, P.; Tsvetkov, P. O.; Breuzard, G.; Devred, F.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-169</span>CODEN:
                <span class="NLM_cas:coden">PRHEBS</span>;
        ISSN:<span class="NLM_cas:issn">1568-7767</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Even though commercialized anticancer drugs are now produced by pharmaceutical companies, most of them were originally obtained from natural sources, and more particularly from plants.  Indeed, many structurally diverse compds. isolated from plants or marine flora have been purified and synthesized for their anticancer bioactivity.  Among these, several mols. belong to the class of anticancer drugs which target the microtubule cytoskeleton, either by stabilizing it or destabilizing it.  To characterize the activity of these drugs and to understand in which physiol. context they are more likely to be used as therapeutic agents, it is necessary to fully det. their interaction with tubulin.  Understanding the mol. basis of their effects on microtubule cytoskeleton is an important step in designing analogs with greater pharmacol. activity and with fewer side effects.  In addn., knowing the mol. mechanism of action of each drug that is already used in chemotherapy protocols will also help to find strategies to circumvent resistance.  By taking examples of known anti-tubulin plant derived drugs, we show how identification of microtubule targeting agents and further characterization of their activity can be achieved combining biophys. and biochem. approaches.  We also illustrate how continuing in depth study of mols. with already known primary mechanisms of action can lead to the discovery of new targets or biomarkers which can open new perspectives in anticancer strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi3RE25Y1WjLVg90H21EOLACvtfcHk0ljPyWIf1N0P4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislCksb0%253D&md5=080159383138e7ed1f86783ed272d360</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs11101-013-9302-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11101-013-9302-8%26sid%3Dliteratum%253Aachs%26aulast%3DBarbier%26aufirst%3DP.%26aulast%3DTsvetkov%26aufirst%3DP.%2BO.%26aulast%3DBreuzard%26aufirst%3DG.%26aulast%3DDevred%26aufirst%3DF.%26atitle%3DDeciphering%2520the%2520molecular%2520mechanisms%2520of%2520anti-tubulin%2520plant%2520derived%2520drugs%26jtitle%3DPhytochem.%2520Rev.%26date%3D2014%26volume%3D13%26spage%3D157%26epage%3D169%26doi%3D10.1007%2Fs11101-013-9302-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mukhtar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhami, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhtar, H.</span><span> </span><span class="NLM_article-title">Targeting microtubules by natural agents for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1158%2F1535-7163.MCT-13-0791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=24435445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=275-284&author=E.+Mukhtarauthor=V.+M.+Adhamiauthor=H.+Mukhtar&title=Targeting+microtubules+by+natural+agents+for+cancer+therapy&doi=10.1158%2F1535-7163.MCT-13-0791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Microtubules by Natural Agents for Cancer Therapy</span></div><div class="casAuthors">Mukhtar, Eiman; Adhami, Vaqar Mustafa; Mukhtar, Hasan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-284</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Natural compds. that target microtubules and disrupt the normal function of the mitotic spindle have proven to be one of the best classes of cancer chemotherapeutic drugs available in clinics to date.  There is increasing evidence showing that even minor alteration of microtubule dynamics can engage the spindle checkpoint, arresting cell-cycle progression at mitosis and subsequently leading to cell death.  Our improved understanding of tumor biol. and our continued appreciation for what the microtubule targeting agents (MTAs) can do have helped pave the way for a new era in the treatment of cancer.  The effectiveness of these agents for cancer therapy has been impaired, however, by various side effects and drug resistance.  Several new MTAs have shown potent activity against the proliferation of various cancer cells, including resistance to the existing MTAs.  Sustained investigation of the mechanisms of action of MTAs, development and discovery of new drugs, and exploring new treatment strategies that reduce side effects and circumvent drug resistance could provide more effective therapeutic options for patients with cancer.  This review focuses on the successful cancer chemotherapy from natural compds. in clin. settings and the challenges that may abort their usefulness.  Mol Cancer Ther; 13(2); 275-84. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSZOcnk6gaB7Vg90H21EOLACvtfcHk0ljAOOPKBBAOgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLg%253D&md5=0a14655cff81c9d3a73c0b4514e45112</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0791%26sid%3Dliteratum%253Aachs%26aulast%3DMukhtar%26aufirst%3DE.%26aulast%3DAdhami%26aufirst%3DV.%2BM.%26aulast%3DMukhtar%26aufirst%3DH.%26atitle%3DTargeting%2520microtubules%2520by%2520natural%2520agents%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D275%26epage%3D284%26doi%3D10.1158%2F1535-7163.MCT-13-0791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nepali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, P. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, K. L.</span><span> </span><span class="NLM_article-title">Tubulin inhibitors: A patent survey</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.2174/15748928113089990042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F15748928113089990042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=176-220&author=K.+Nepaliauthor=R.+Ojhaauthor=S.+Sharmaauthor=P.+M.+S.+Bediauthor=K.+L.+Dhar&title=Tubulin+inhibitors%3A+A+patent+survey&doi=10.2174%2F15748928113089990042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F15748928113089990042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15748928113089990042%26sid%3Dliteratum%253Aachs%26aulast%3DNepali%26aufirst%3DK.%26aulast%3DOjha%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBedi%26aufirst%3DP.%2BM.%2BS.%26aulast%3DDhar%26aufirst%3DK.%2BL.%26atitle%3DTubulin%2520inhibitors%253A%2520A%2520patent%2520survey%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D176%26epage%3D220%26doi%3D10.2174%2F15748928113089990042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Prota, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargsten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurwerra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Díaz, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetz, M. O.</span><span> </span><span class="NLM_article-title">Molecular mechanism of action of microtubule-stabilizing anticancer agents</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1126/science.1230582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1126%2Fscience.1230582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23287720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=587-590&author=A.+E.+Protaauthor=K.+Bargstenauthor=D.+Zurwerraauthor=J.+J.+Fieldauthor=J.+F.+D%C3%ADazauthor=K.-H.+Altmannauthor=M.+O.+Steinmetz&title=Molecular+mechanism+of+action+of+microtubule-stabilizing+anticancer+agents&doi=10.1126%2Fscience.1230582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents</span></div><div class="casAuthors">Prota, Andrea E.; Bargsten, Katja; Zurwerra, Didier; Field, Jessica J.; Diaz, Jose Fernando; Altmann, Karl-Heinz; Steinmetz, Michel O.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6119</span>),
    <span class="NLM_cas:pages">587-590</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer.  Despite the importance of MSAs for medical applications and basic research, their mol. mechanisms of action on tubulin and microtubules remain elusive.  We detd. high-resoln. crystal structures of αβ-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A.  Both compds. were bound to the taxane pocket of β-tubulin and used their resp. side chains to induce structuring of the M-loop into a short helix.  Because the M-loop establishes lateral tubulin contacts in microtubules, these findings explain how taxane-site MSAs promote microtubule assembly and stability.  Further, our results offer fundamental structural insights into the control mechanisms of microtubule dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_p8NfCWTU-rVg90H21EOLACvtfcHk0ljAOOPKBBAOgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrw%253D&md5=b253c015f75f5eac4857d01e34d65f54</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1230582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1230582%26sid%3Dliteratum%253Aachs%26aulast%3DProta%26aufirst%3DA.%2BE.%26aulast%3DBargsten%26aufirst%3DK.%26aulast%3DZurwerra%26aufirst%3DD.%26aulast%3DField%26aufirst%3DJ.%2BJ.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BF.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DSteinmetz%26aufirst%3DM.%2BO.%26atitle%3DMolecular%2520mechanism%2520of%2520action%2520of%2520microtubule-stabilizing%2520anticancer%2520agents%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D587%26epage%3D590%26doi%3D10.1126%2Fscience.1230582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Stanton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aneja, R.</span><span> </span><span class="NLM_article-title">Drugs that target dynamic microtubules: A new molecular perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1002/med.20242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1002%2Fmed.20242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=21381049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=443-481&author=R.+A.+Stantonauthor=K.+M.+Gernertauthor=J.+H.+Nettlesauthor=R.+Aneja&title=Drugs+that+target+dynamic+microtubules%3A+A+new+molecular+perspective&doi=10.1002%2Fmed.20242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs that target dynamic microtubules: A new molecular perspective</span></div><div class="casAuthors">Stanton, Richard A.; Gernert, Kim M.; Nettles, James H.; Aneja, Ritu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-481</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle app.  As such, there is a wide variety of compds. currently in clin. use and in development that act as antimitotic agents by altering microtubule dynamics.  Although these diverse mols. are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research.  In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biol. function relative to the mol. vectors of microtubule assembly or disassembly.  These "biol. vectors" can thus be used as a spatiotemporal context to describe mol. mechanisms by which microtubule-targeting drugs work. © 2011 Wiley Periodicals, Inc.  Med Res Rev, 31, No. 3, 443-481, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6_lcUQbXYrVg90H21EOLACvtfcHk0ljAOOPKBBAOgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D&md5=acce5b9cc89581a7dab0236072b68c72</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.20242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20242%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DGernert%26aufirst%3DK.%2BM.%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DAneja%26aufirst%3DR.%26atitle%3DDrugs%2520that%2520target%2520dynamic%2520microtubules%253A%2520A%2520new%2520molecular%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2011%26volume%3D31%26spage%3D443%26epage%3D481%26doi%3D10.1002%2Fmed.20242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span> </span><span class="NLM_article-title">Microtubule-binding agents: a dynamic field of cancer therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1038/nrd3253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnrd3253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=20885410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=790-803&author=C.+Dumontetauthor=M.+A.+Jordan&title=Microtubule-binding+agents%3A+a+dynamic+field+of+cancer+therapeutics&doi=10.1038%2Fnrd3253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-binding agents: a dynamic field of cancer therapeutics</span></div><div class="casAuthors">Dumontet, Charles; Jordan, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">790-803</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an important therapeutic target in tumor cells.  Agents that bind to microtubules have been part of the pharmacopoeia of anticancer therapy for decades and until the advent of targeted therapy, microtubules were the only alternative to DNA as a therapeutic target in cancer.  The screening of a range of botanical species and marine organisms has yielded promising new antitubulin agents with novel properties.  In the current search for novel microtubule-binding agents, enhanced tumor specificity, reduced neurotoxicity and insensitivity to chemoresistance mechanisms are the three main objectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ43DyXjdN7rVg90H21EOLACvtfcHk0lhjSV5uf8Gr0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI&md5=9fc6fd966859785605936ecbe6dca44e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3253%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DMicrotubule-binding%2520agents%253A%2520a%2520dynamic%2520field%2520of%2520cancer%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D790%26epage%3D803%26doi%3D10.1038%2Fnrd3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1038/nature02393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+tubulin+regulation+from+a+complex+with+colchicine+and+a+stathmin-like+domain&doi=10.1038%2Fnature02393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lhjSV5uf8Gr0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520tubulin%2520regulation%2520from%2520a%2520complex%2520with%2520colchicine%2520and%2520a%2520stathmin-like%2520domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202%26doi%3D10.1038%2Fnature02393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bohlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, B.</span><span> </span><span class="NLM_article-title">Podophyllotoxin derivatives: drug discovery and development</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1016/1359-6446(96)10028-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2F1359-6446%2896%2910028-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADyaK28XlvVWkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=343-351&author=L.+Bohlinauthor=B.+Rosen&title=Podophyllotoxin+derivatives%3A+drug+discovery+and+development&doi=10.1016%2F1359-6446%2896%2910028-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Podophyllotoxin derivatives: Drug discovery and development</span></div><div class="casAuthors">Bohlin, Lars; Rosen, Boerje</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">343-351</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The exploration and exploitation of podophyllin formulations provide an example of how a plant ext. with established ethnomedical use, but also causing toxicity, can provide a basis for new drug discovery and development.  Applications and potential applications include the treatment of venereal warts, psoriasis, rheumatoid arthritis, malaria and Alzheimer's disease.  This review, with 64 refs., addresses the history and pharmacol. action of these natural products and outlines the preclin. development and clin. trials of drugs in the pipeline and with marketing approval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiOJLfQu7z7bVg90H21EOLACvtfcHk0lhjSV5uf8Gr0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvVWkt7k%253D&md5=8d7f0d6a912eb1d5aeba253a25d685c3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2F1359-6446%2896%2910028-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1359-6446%252896%252910028-3%26sid%3Dliteratum%253Aachs%26aulast%3DBohlin%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DB.%26atitle%3DPodophyllotoxin%2520derivatives%253A%2520drug%2520discovery%2520and%2520development%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1996%26volume%3D1%26spage%3D343%26epage%3D351%26doi%3D10.1016%2F1359-6446%2896%2910028-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herald, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohavanijaya, P.</span><span> </span><span class="NLM_article-title">Isolation and structure of combretastatin</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1374</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span><span class="refDoi"> DOI: 10.1139/v82-202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1139%2Fv82-202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1982&pages=1374-1376&author=G.+R.+Pettitauthor=G.+M.+Craggauthor=D.+L.+Heraldauthor=J.+M.+Schmidtauthor=P.+Lohavanijaya&title=Isolation+and+structure+of+combretastatin&doi=10.1139%2Fv82-202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1139%2Fv82-202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv82-202%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DLohavanijaya%26aufirst%3DP.%26atitle%3DIsolation%2520and%2520structure%2520of%2520combretastatin%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1982%26volume%3D60%26spage%3D1374%26epage%3D1376%26doi%3D10.1139%2Fv82-202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Neuss, N.; Neuss, M. N.</span><span> </span><span class="NLM_article-title">The therapeutic use of bisindole alkaloids from Catharanthus</span>. In  <span class="citation_source-book">The Alkaloids</span>; <span class="NLM_contrib-group">Brossi, A.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">37</span>, pp  <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=229-240&author=N.+Neuss&author=M.+N.+Neussauthor=A.+Brossi&title=The+Alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNeuss%26aufirst%3DN.%26atitle%3DThe%2520therapeutic%2520use%2520of%2520bisindole%2520alkaloids%2520from%2520Catharanthus%26btitle%3DThe%2520Alkaloids%26aulast%3DBrossi%26aufirst%3DA.%26pub%3DAcademic%2520Press%26date%3D1990%26volume%3D37%26spage%3D229%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Pearce, H. L.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of bisindole alkaloids from Catharanthus</span>. In  <span class="citation_source-book">The Alkaloids</span>; <span class="NLM_contrib-group">Brossi, A.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">37</span>, pp  <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=145-204&author=H.+L.+Pearceauthor=A.+Brossi&title=The+Alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DH.%2BL.%26atitle%3DMedicinal%2520chemistry%2520of%2520bisindole%2520alkaloids%2520from%2520Catharanthus%26btitle%3DThe%2520Alkaloids%26aulast%3DBrossi%26aufirst%3DA.%26pub%3DAcademic%2520Press%26date%3D1990%26volume%3D37%26spage%3D145%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kuehne, M. E.; Marko, I.</span><span> </span><span class="NLM_article-title">Syntheses of vinblastine-type alkaloids</span>. In  <span class="citation_source-book">The Alkaloids</span>; <span class="NLM_contrib-group">Brossi, A.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">37</span>, pp  <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=77-132&author=M.+E.+Kuehne&author=I.+Markoauthor=A.+Brossi&title=The+Alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKuehne%26aufirst%3DM.%2BE.%26atitle%3DSyntheses%2520of%2520vinblastine-type%2520alkaloids%26btitle%3DThe%2520Alkaloids%26aulast%3DBrossi%26aufirst%3DA.%26pub%3DAcademic%2520Press%26date%3D1990%26volume%3D37%26spage%3D77%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Negi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luqman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konwar, R.</span><span> </span><span class="NLM_article-title">Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmc.2014.12.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=373-389&author=A.+S.+Negiauthor=Y.+Gautamauthor=S.+Alamauthor=D.+Chandaauthor=S.+Luqmanauthor=J.+Sarkarauthor=F.+Khanauthor=R.+Konwar&title=Natural+antitubulin+agents%3A+Importance+of+3%2C4%2C5-trimethoxyphenyl+fragment&doi=10.1016%2Fj.bmc.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DNegi%26aufirst%3DA.%2BS.%26aulast%3DGautam%26aufirst%3DY.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DLuqman%26aufirst%3DS.%26aulast%3DSarkar%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DF.%26aulast%3DKonwar%26aufirst%3DR.%26atitle%3DNatural%2520antitubulin%2520agents%253A%2520Importance%2520of%25203%252C4%252C5-trimethoxyphenyl%2520fragment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D373%26epage%3D389%26doi%3D10.1016%2Fj.bmc.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">An overview of tubulin inhibitors that interact with the colchicine binding site</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2943</span><span class="NLM_x">–</span> <span class="NLM_lpage">2971</span><span class="refDoi"> DOI: 10.1007/s11095-012-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1007%2Fs11095-012-0828-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=22814904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2943-2971&author=Y.+Luauthor=J.+Chenauthor=M.+Xiaoauthor=W.+Liauthor=D.+D.+Miller&title=An+overview+of+tubulin+inhibitors+that+interact+with+the+colchicine+binding+site&doi=10.1007%2Fs11095-012-0828-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span></div><div class="casAuthors">Lu, Yan; Chen, Jianjun; Xiao, Min; Li, Wei; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2943-2971</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tubulin dynamics is a promising target for new chemotherapeutic agents.  The colchicine binding site is one of the most important pockets for potential tubulin polymn. destabilizers.  Colchicine binding site inhibitors (CBSI) exert their biol. effects by inhibiting tubulin assembly and suppressing microtubule formation.  A large no. of mols. interacting with the colchicine binding site have been designed and synthesized with significant structural diversity.  CBSIs have been modified as to chem. structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers.  CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin.  The present review is a synopsis of compds. that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrFQVgeCbBbVg90H21EOLACvtfcHk0liHBeCFVIoCfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN&md5=dfe42e8eb1f0ff22b256641aaa8c17ab</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DAn%2520overview%2520of%2520tubulin%2520inhibitors%2520that%2520interact%2520with%2520the%2520colchicine%2520binding%2520site%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D2943%26epage%3D2971%26doi%3D10.1007%2Fs11095-012-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkoshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, M.</span><span> </span><span class="NLM_article-title">Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2378</span><span class="NLM_x">–</span> <span class="NLM_lpage">2389</span><span class="refDoi"> DOI: 10.1021/jm501859j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501859j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2ntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2378-2389&author=K.+Nakagawa-Gotoauthor=A.+Odaauthor=E.+Hamelauthor=E.+Ohkoshiauthor=K.-H.+Leeauthor=M.+Goto&title=Development+of+a+novel+class+of+tubulin+inhibitor+from+desmosdumotin+B+with+a+hydroxylated+bicyclic+B-ring&doi=10.1021%2Fjm501859j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel class of tubulin inhibitors from desmosdumotin B with a hydroxylated bicyclic B-ring</span></div><div class="casAuthors">Nakagawa-Goto, Kyoko; Oda, Akifumi; Hamel, Ernest; Ohkoshi, Emika; Lee, Kuo-Hsiung; Goto, Masuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2378-2389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of newly synthesized hydroxylated analogs of triethyldesmosdumotin B (TEDB) with a bicyclic B-ring exhibited a significantly different mode of action for affecting microtubule dynamics and spindle formation but had the same antiproliferative activity spectrum, including activity against multidrug-resistant tumors.  These analogs efficiently induced cell cycle arrest at prometaphase and caused formation of immature multipolar spindles.  6'-Hydroxyl TEDB-TB (8) disrupted bipolar spindle formation but had a negligible effect on interphase microtubules.  On the basis of the predicted binding modes of the new compds. with tubulin dimer, one particular compd. forms three hydrogen bonds (H-bonds) only with α-tubulin at the colchicine site; in contrast, 8 forms H-bonds with both α- and β-tubulin.  We predict that, when a compd./ligand, such as 8, forms H-bonds to both α- and β-tubulins, spindle formation is disrupted more than the dynamics of interphase microtubules.  This result may reflect the well-known greater dynamicity of spindle microtubules as compared with interphase microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCp6JiuXiVrbVg90H21EOLACvtfcHk0liHBeCFVIoCfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2ntro%253D&md5=a0ba9cf3db85402c4f14b6084e3780bf</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm501859j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501859j%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DOhkoshi%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DGoto%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520class%2520of%2520tubulin%2520inhibitor%2520from%2520desmosdumotin%2520B%2520with%2520a%2520hydroxylated%2520bicyclic%2520B-ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2378%26epage%3D2389%26doi%3D10.1021%2Fjm501859j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Taipalensuu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornblom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einarsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjoqvist, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melhus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjostrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=11561076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=164-170&author=J.+Taipalensuuauthor=H.+Tornblomauthor=G.+Lindbergauthor=C.+Einarssonauthor=F.+Sjoqvistauthor=H.+Melhusauthor=P.+Garbergauthor=B.+Sjostromauthor=B.+Lundgrenauthor=P.+Artursson&title=Correlation+of+gene+expression+of+ten+drug+efflux+proteins+of+the+ATP-binding+cassette+transporter+family+in+normal+human+jejunum+and+in+human+intestinal+epithelial+Caco-2+cell+monolayers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers</span></div><div class="casAuthors">Taipalensuu, Jan; Tornblom, Hans; Lindberg, Greger; Einarsson, Curt; Sjoqvist, Folke; Melhus, Hakan; Garberg, Per; Sjostrom, Brita; Lundgren, Bo; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">164-170</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This investigation describes the expression and interindividual variability in transcript levels of multiple drug efflux systems in the human jejunum and compares the expression profiles in these cells with that of the commonly used Caco-2 cell drug absorption model.  Transcript levels of ten-drug efflux proteins of the ATP-binding cassette (ABC) transporter family [MDR1, MDR3, ABCB5, MRP1-6, and breast cancer resistance protein (BCRP)], lung resistance-related protein (LRP), and CYP3A4 were detd. using quant. polymerase chain reaction in jejunal biopsies from 13 healthy human subjects and in Caco-2 cells.  All genes except ABCB5 were expressed, and transcript levels varied between individuals only by a factor of 2 to 3.  Surprisingly, BCRP and MRP2 transcripts were more abundant in jejunum than MDR1 transcripts.  Jejunal transcript levels of the different ABC transporters spanned a range of three log units with the rank order: BCRP ≈ MRP2 > MDR1 ≈ MRP3 ≈ MRP6 ≈ MRP5 ≈ MRP1 > MRP4 > MDR3.  Furthermore, transcript levels of 9 of 10 ABC transporters correlated well between jejunum and Caco-2 cells (r2 = 0.90).  However, BCRP exhibited a 100-fold lower transcript level in Caco-2 cells compared with jejunum.  Thus, the expression of a no. of efflux protein transcripts in jejunum are equal to, or even higher than, that of MDR1, suggesting that the roles of these proteins (in particular BCRP and MRP2) in intestinal drug efflux have been underestimated.  Also, we tentatively conclude that the Caco-2 cell line is a useful model of jejunal drug efflux, if the low expression of BCRP is taken into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1f-Z1mGAtjbVg90H21EOLACvtfcHk0lhUn8cdaGsTuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWlt7Y%253D&md5=1a2ef81848fcaafda43d4980f6987856</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaipalensuu%26aufirst%3DJ.%26aulast%3DTornblom%26aufirst%3DH.%26aulast%3DLindberg%26aufirst%3DG.%26aulast%3DEinarsson%26aufirst%3DC.%26aulast%3DSjoqvist%26aufirst%3DF.%26aulast%3DMelhus%26aufirst%3DH.%26aulast%3DGarberg%26aufirst%3DP.%26aulast%3DSjostrom%26aufirst%3DB.%26aulast%3DLundgren%26aufirst%3DB.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DCorrelation%2520of%2520gene%2520expression%2520of%2520ten%2520drug%2520efflux%2520proteins%2520of%2520the%2520ATP-binding%2520cassette%2520transporter%2520family%2520in%2520normal%2520human%2520jejunum%2520and%2520in%2520human%2520intestinal%2520epithelial%2520Caco-2%2520cell%2520monolayers%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D164%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Microtubules as a target for anticancer drugs</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nrc1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+target+for+anticancer+drugs&doi=10.1038%2Fnrc1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0lhUn8cdaGsTuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520target%2520for%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265%26doi%3D10.1038%2Fnrc1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Seve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1016/S1470-2045(08)70029-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2FS1470-2045%2808%2970029-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=18237851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=168-175&author=P.+Seveauthor=C.+Dumontet&title=Is+class+III+beta-tubulin+a+predictive+factor+in+patients+receiving+tubulin-binding+agents%3F&doi=10.1016%2FS1470-2045%2808%2970029-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?</span></div><div class="casAuthors">Seve, Pascal; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-175</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: On the basis of preclin. studies that show overexpression of class III β-tubulin is assocd. with resistance to tubulin-binding agents, several investigators have addressed the relation between class III β-tubulin and outcome in patients treated with such agents.  High expression of class III β-tubulin has been found to be correlated either with low response rates in patients treated with regimens contg. taxanes or vinorelbine or with reduced survival in patients with non-small-cell lung cancer, in breast, ovarian, and gastric cancers, and in cancers of unknown primary site.  Two studies have shown patients with advanced non-small-cell lung cancer receiving paclitaxel whose tumors expressed high levels of class III β-tubulin had a lower response to paclitaxel and shorter survival, whereas this variable was not found to be predictive in patients receiving regimens without tubulin-binding agents.  Conversely, anal. of samples from patients in the JBR-10 trial, which compared adjuvant chemotherapy to no further therapy in operable non-small-cell lung cancer, showed that chemotherapy seemed to overcome the neg. prognostic effect of high levels of expression of class III β-tubulin and the greatest benefit from cisplatin/vinorelbine was seen in patients with high levels of expression of class III β-tubulin.  Further analyses in operable and advanced non-small-cell lung cancer showed a relation between high expression of class III β-tubulin and baseline factors such as age under 60 years, adenocarcinoma and large-cell carcinoma histologies, and advanced stage of disease.  These results suggest that class III β-tubulin could be both a prognostic and a predictive factor.  Large randomized studies are warranted to det. the prognostic or predictive value of class III β-tubulin in different settings and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopsXLbaFHm3LVg90H21EOLACvtfcHk0lhUn8cdaGsTuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D&md5=4d4adaf4db80a5eb71c771c9f09d74b4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2808%2970029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252808%252970029-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeve%26aufirst%3DP.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DIs%2520class%2520III%2520beta-tubulin%2520a%2520predictive%2520factor%2520in%2520patients%2520receiving%2520tubulin-binding%2520agents%253F%26jtitle%3DLancet%2520Oncol.%26date%3D2008%26volume%3D9%26spage%3D168%26epage%3D175%26doi%3D10.1016%2FS1470-2045%2808%2970029-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Eckford, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">ABC efflux pump-based resistance to chemotherapy drugs</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2989</span><span class="NLM_x">–</span> <span class="NLM_lpage">3011</span><span class="refDoi"> DOI: 10.1021/cr9000226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9000226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2989-3011&author=P.+D.+Eckfordauthor=F.+J.+Sharom&title=ABC+efflux+pump-based+resistance+to+chemotherapy+drugs&doi=10.1021%2Fcr9000226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ABC Efflux Pump-Based Resistance to Chemotherapy Drugs</span></div><div class="casAuthors">Eckford, Paul D. W.; Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over 1 million new cases of all types of cancer are diagnosed each year in the United States alone, and 559, 650 cancer-related deaths were expected to occur in 2007.  Chemotherapeutic treatment of cancers is an important tool to combat this devastating disease.  However, chemotherapy can fail due to the development of tumor cell resistance to multiple drugs, a phenomenon known as multidrug resistance (MDR), and essentially all cancer-related deaths are considered to be a result of chemotherapy failure.  MDR can have many causes, but one important mechanism of drug resistance is the expression of active drug efflux pumps in the membranes of cancer cells.  The efflux pump proteins mediating MDR in human cancers belong to the ATP-Binding Cassette (ABC) superfamily of proteins.  This is a diverse group of (primarily) active membrane transporters and is one of the largest known protein families.  Its members include proteins that mediate a variety of transport processes, in both prokaryotes (e.g., membrane-embedded importers for sugars and amino acids, and drug exporters) and eukaryotes, where only ABC exporters are known.  The 49 ABC proteins identified in the human genome (there appear to be 48 functional proteins) are involved in the efflux of substrates such as phospholipids, sterols, bile salts, and amphipathic drugs.  While as many as 15 ABC transporters have been obsd. to export chemotherapy drugs using in vitro exptl. systems, only 3 transporters have thus far been implicated as major contributors to MDR in cancer.  Discovered over 30 years ago, P-glycoprotein (Pgp; MDR1; ABCB1), was the first mammalian ABC protein to be identified.  Multidrug resistance-assocd. protein 1 (MRP1 or ABCC1) and more recently ABCG2 (also termed the breast cancer resistance protein, BCRP, or mitoxantrone resistance protein, MXR) also appear to function as clin. relevant drug efflux pumps.  All three proteins were discovered as factors over-expressed in MDR cell lines in culture, and they have since been detected in MDR tumors in patients.  Considerable effort has been made to understand the structure and function of these three drug pumps, which possess a unique ability to recognize and transport a broad array of structurally diverse compds. out of the cell.  The development of compds. known as modulators, which are able to reverse MDR by blocking or inhibiting the ATP-dependent transport function of these proteins, is also an important goal of researchers in this field.  This review will summarize our understanding of the substrate specificity of the mammalian drug efflux pumps, their structure, the mol. mechanisms by which they exert their function, and the progress made to date in reversing pump-mediated MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZIkwCqe_qg7Vg90H21EOLACvtfcHk0lh5VZ_qtbQKyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D&md5=5009e7a7cac6977a296fd5bbf97d7df7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr9000226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9000226%26sid%3Dliteratum%253Aachs%26aulast%3DEckford%26aufirst%3DP.%2BD.%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520efflux%2520pump-based%2520resistance%2520to%2520chemotherapy%2520drugs%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2989%26epage%3D3011%26doi%3D10.1021%2Fcr9000226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6605489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fsj.bjc.6605489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=20029418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=316-324&author=C.+Stengelauthor=S.+P.+Newmanauthor=M.+P.+Leeseauthor=B.+V.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=Class+III+beta-tubulin+expression+and+in+vitro+resistance+to+microtubule+targeting+agents&doi=10.1038%2Fsj.bjc.6605489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Class III β-tubulin expression and in vitro resistance to microtubule targeting agents</span></div><div class="casAuthors">Stengel, C.; Newman, S. P.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-324</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Class III β-tubulin overexpression is a marker of resistance to microtubule disruptors in vitro, in vivo and in the clinic for many cancers, including breast cancer.  The aims of this study were to develop a new model of class III β-tubulin expression, avoiding the toxicity assocd. with chronic overexpression of class III β-tubulin, and study the efficacy of a panel of clin. and pre-clin. drugs in this model.  Methods: MCF-7 (ER+ve) and MDA-MB-231 (ER-ve) were either transfected with pALTER-TUBB3 or siRNA-tubb3 and 24 h later exposed to test compds. for a further 96 h for proliferation studies.  RT-PCR and immunoblotting were used to monitor the changes in class III β-tubulin mRNA and protein expression.  Results: The model allowed for subtle changes in class III β-tubulin expression to be achieved, which had no direct effect on the viability of the cells.  Class III β-tubulin overexpression conferred resistance to paclitaxel and vinorelbine, whereas downregulation of class III β-tubulin rendered cells more sensitive to these two drugs.  The efficacy of the colchicine-site binding agents, 2-MeOE2, colchicine, STX140, ENMD1198 and STX243 was unaffected by the changes in class III β-tubulin expression.  Conclusion: These data indicate that the effect of class III β-tubulin overexpression may depend on where the drug's binding site is located on the tubulin.  Therefore, this study highlights for the first time the potential key role of targeting the colchicine-binding site, to develop new treatment modalities for taxane-refractory breast cancer.  British Journal of Cancer (2010) 102, 316-324; doi:10.1038/sj.bjc.6605489 www.bjcancer.com Published online 22 Dec. 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hulEpiTJA7Vg90H21EOLACvtfcHk0lh5VZ_qtbQKyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKisQ%253D%253D&md5=02d84566d0f23c1781ba74a1add4fed2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605489%26sid%3Dliteratum%253Aachs%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DClass%2520III%2520beta-tubulin%2520expression%2520and%2520in%2520vitro%2520resistance%2520to%2520microtubule%2520targeting%2520agents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D316%26epage%3D324%26doi%3D10.1038%2Fsj.bjc.6605489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Karki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahabi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span> </span><span class="NLM_article-title">βIII-Tubulin: Biomarker of taxane resistance or drug target</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span><span class="refDoi"> DOI: 10.1517/14728222.2013.766170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1517%2F14728222.2013.766170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23379899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFSkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=461-472&issue=4&author=R.+Karkiauthor=M.+Marianiauthor=M.+Andreoliauthor=S.+Heauthor=S.+Scambiaauthor=S.+Shahabiauthor=C.+Ferlini&title=%CE%B2III-Tubulin%3A+Biomarker+of+taxane+resistance+or+drug+target&doi=10.1517%2F14728222.2013.766170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">βIII-Tubulin: biomarker of taxane resistance or drug target?</span></div><div class="casAuthors">Karki, Roshan; Mariani, Marisa; Andreoli, Mirko; He, Shiquan; Scambia, Giovanni; Shahabi, Shohreh; Ferlini, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-472</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: βIII-Tubulin (TUBB3) is predominantly expressed in neurons of the central and peripheral nervous systems, while in normal non-neoplastic tissues it is barely detectable.  By contrast, this cytoskeletal protein is abundant in a wide range of tumors.  βIII-Tubulin is linked to dynamic instability of microtubules (MTs), weakening the effects of agents interfering with MT polymn.  Based on this principle, early studies introduced the classical theory linking βIII-tubulin with a mechanism of counteracting taxane activity and accordingly, prompted its investigation as a predictive biomarker of taxane resistance.Areas covered: We reviewed 59 translational studies, including cohorts from lung, ovarian, breast, gastric, colorectal and various misc. cancers subject to different chemotherapy regimens.Expert opinion: βIII-Tubulin functions more as a prognostic factor than as a predictor of response to chemotherapy.  We believe this view can be explained by βIII-tubulin's assocn. with prosurvival pathways in the early steps of the metastatic process.  Its prognostic response increases if combined with addnl. biomarkers that regulate its expression, since βIII-tubulin can be expressed in conditions, such as estrogen exposure, unrelated to survival mechanisms and without any predictive activity.  Addnl. avenues for therapeutic intervention could emerge if drugs are designed to directly target βIII-tubulin and its mechanism of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPMrdH0yczD7Vg90H21EOLACvtfcHk0lh5VZ_qtbQKyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFSkt7k%253D&md5=9dfe47636caf65c683e6d067aa6d72b5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F14728222.2013.766170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2013.766170%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DMariani%26aufirst%3DM.%26aulast%3DAndreoli%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DScambia%26aufirst%3DS.%26aulast%3DShahabi%26aufirst%3DS.%26aulast%3DFerlini%26aufirst%3DC.%26atitle%3D%25CE%25B2III-Tubulin%253A%2520Biomarker%2520of%2520taxane%2520resistance%2520or%2520drug%2520target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2013%26volume%3D17%26issue%3D4%26spage%3D461%26epage%3D472%26doi%3D10.1517%2F14728222.2013.766170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fürst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmar, A. M.</span><span> </span><span class="NLM_article-title">A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=478-483&author=R.+F%C3%BCrstauthor=A.+M.+Vollmar&title=A+new+perspective+on+old+drugs%3A+non-mitotic+actions+of+tubulin-binding+drugs+play+a+major+role+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26aulast%3DVollmar%26aufirst%3DA.%2BM.%26atitle%3DA%2520new%2520perspective%2520on%2520old%2520drugs%253A%2520non-mitotic%2520actions%2520of%2520tubulin-binding%2520drugs%2520play%2520a%2520major%2520role%2520in%2520cancer%2520treatment%26jtitle%3DPharmazie%26date%3D2013%26volume%3D68%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kretzschmann, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fürst, R.</span><span> </span><span class="NLM_article-title">Plant-derived vascular disrupting agents: Compounds, actions, and clinical trials</span> <span class="citation_source-journal">Phytochem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1007/s11101-013-9304-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1007%2Fs11101-013-9304-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=191-206&author=V.+K.+Kretzschmannauthor=R.+F%C3%BCrst&title=Plant-derived+vascular+disrupting+agents%3A+Compounds%2C+actions%2C+and+clinical+trials&doi=10.1007%2Fs11101-013-9304-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Plant-derived vascular disrupting agents: compounds, actions, and clinical trials</span></div><div class="casAuthors">Kretzschmann, Verena K.; Fuerst, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-206</span>CODEN:
                <span class="NLM_cas:coden">PRHEBS</span>;
        ISSN:<span class="NLM_cas:issn">1568-7767</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The tumor vasculature of solid tumors offers unique characteristics compared to the normal vasculature and, therefore, represents an attractive target in anti-cancer therapy.  Besides the classic anti-angiogenic agents, which inhibit tumor neovascularization, a novel promising class of anti-tumor drugs has emerged in the last years, the vascular-disrupting agents (VDAs).  In contrast to angiogenesis inhibitors, VDAs act on already established tumor blood vessels of large solid tumors and induce a vascular shutdown by targeting tumor endothelial cells.  This results in extensive necrotic tumor cell death.  The sources of VDAs are quite divers, however, the plant-derived compds. represent the largest and most prominent class.  Plant-derived VDAs have undergone extensive preclin. investigations and are now tested in several advanced clin. trials.  In this review we summarize preclin. data, including drug-target relationships as well as functional in vitro and in vivo assays, discuss their mol. way of action, and update the clin. status of the most prominent plant-derived VDAs: FAA/DMXAA, CA-4-P, OXi4503, AVE8062, and ZD6126.  All these data emphasize the value of secondary plant metabolites and their (semi-)synthetic derivs. for current drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro7gqZKoAc2bVg90H21EOLACvtfcHk0ljuJ90TULI1Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislCht7o%253D&md5=e5563128a501c8c462ad9b5545365fad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs11101-013-9304-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11101-013-9304-6%26sid%3Dliteratum%253Aachs%26aulast%3DKretzschmann%26aufirst%3DV.%2BK.%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26atitle%3DPlant-derived%2520vascular%2520disrupting%2520agents%253A%2520Compounds%252C%2520actions%252C%2520and%2520clinical%2520trials%26jtitle%3DPhytochem.%2520Rev.%26date%3D2014%26volume%3D13%26spage%3D191%26epage%3D206%26doi%3D10.1007%2Fs11101-013-9304-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ji, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-P.</span><span> </span><span class="NLM_article-title">Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span><span class="refDoi"> DOI: 10.2174/0929867322666150114163732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F0929867322666150114163732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=25620094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1348-1360&author=Y.-T.+Jiauthor=Y.-N.+Liuauthor=Z.-P.+Liu&title=Tubulin+colchicine+binding+site+inhibitors+as+vascular+disrupting+agents+in+clinical+developments&doi=10.2174%2F0929867322666150114163732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments</span></div><div class="casAuthors">Ji, Ya-Ting; Liu, Yan-Na; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1348-1360</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor vasculature is an important target in cancer treatment.  Two distinct vasculartargeting therapeutic strategies are applied to attack cancer cells indirectly.  The antiangiogenic approach intervenes in the neovascularization processes and blocks the formation of new blood vessels, while th e antivascular approach targets the established tumor blood vessels, making vascular shutdown and resulting in rapid haemorrhagic necrosis and tumor cell death.  A no. of compds. with diverse structural scaffolds have been designed to target tumor vasculature and they are called vascular disrupting agents (VDAs).  The biol. or ligand-directed VDAs utilize antibodies, peptides or growth factors to deliver toxins or pro-coagulants or proapoptotic affectors to tumor-related blood vessels, while the small-mol. VDAs selectively target tumor blood vessels and have little effects on the normal endothelium.  Among the small-mol. VDAs, the tubulin colchicine binding site inhibitors have been extensively studied and many of them have entered the clin. trials, including CA-4P, CA-1P, AVE8062, OXi4503, CKD-516, BNC105P, ABT-751, CYT- 997, ZD6126, NPI-2358, MN-029 and EPC2407.  This review makes a summary of the small-mol. VDAs in clin. developments and highlights some potential VDA leads or candidates for the treatment of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-aHECQeEv7LVg90H21EOLACvtfcHk0ljuJ90TULI1Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D&md5=65300d3649e348a5c3c66fbc2dac4f07</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150114163732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150114163732%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DY.-T.%26aulast%3DLiu%26aufirst%3DY.-N.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DTubulin%2520colchicine%2520binding%2520site%2520inhibitors%2520as%2520vascular%2520disrupting%2520agents%2520in%2520clinical%2520developments%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D1348%26epage%3D1360%26doi%3D10.2174%2F0929867322666150114163732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mason, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span> </span><span class="NLM_article-title">A perspective on vascular disrupting agents that interact with tubulin: Preclinical tumor imaging and biological assessment</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1039/c0ib00135j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1039%2Fc0ib00135j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=375-387&author=R.+P.+Masonauthor=D.+Zhaoauthor=L.+Liuauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=A+perspective+on+vascular+disrupting+agents+that+interact+with+tubulin%3A+Preclinical+tumor+imaging+and+biological+assessment&doi=10.1039%2Fc0ib00135j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment</span></div><div class="casAuthors">Mason, Ralph P.; Zhao, Dawen; Liu, Li; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment provides a rich source of potential targets for selective therapeutic intervention with properly designed anticancer agents.  Significant physiol. differences exist between the microvessels that nourish tumors and those that supply healthy tissue.  Selective drug-mediated damage of these tortuous and chaotic microvessels starves a tumor of necessary nutrients and oxygen and eventually leads to massive tumor necrosis.  Vascular targeting strategies in oncol. are divided into two sep. groups: angiogenesis inhibiting agents (AIAs) and vascular disrupting agents (VDAs).  The mechanisms of action between these two classes of compds. are profoundly distinct.  The AIAs inhibit the actual formation of new vessels, while the VDAs damage and/or destroy existing tumor vasculature.  One subset of small-mol. VDAs functions by inhibiting the assembly of tubulin into microtubules, thus causing morphol. changes to the endothelial cells lining the tumor vasculature, triggered by a cascade of cell signaling events.  Ultimately this results in catastrophic damage to the vessels feeding the tumor.  The rapid emergence and subsequent development of the VDA field over the past decade has led to the establishment of a synergistic combination of preclin. state-of-the-art tumor imaging and biol. evaluation strategies that are often indicative of future clin. efficacy for a given VDA.  This review focuses on an integration of the appropriate biochem. and biol. tools necessary to assess (preclinically) new small-mol., tubulin active VDAs for their potential to be clin. effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw2V3dKpQSrLVg90H21EOLACvtfcHk0ljuJ90TULI1Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D&md5=b58788fa8f5cdbc4d3abffff4e7eaca5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fc0ib00135j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0ib00135j%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DA%2520perspective%2520on%2520vascular%2520disrupting%2520agents%2520that%2520interact%2520with%2520tubulin%253A%2520Preclinical%2520tumor%2520imaging%2520and%2520biological%2520assessment%26jtitle%3DIntegr.%2520Biol.%26date%3D2011%26volume%3D3%26spage%3D375%26epage%3D387%26doi%3D10.1039%2Fc0ib00135j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span> </span><span class="NLM_article-title">Vascular disrupting agents targeting at tubulin: a novel class of antitumor drug</span> <span class="citation_source-journal">J. Int. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=445-454&author=X.+F.+Wangauthor=L.+Xie&title=Vascular+disrupting+agents+targeting+at+tubulin%3A+a+novel+class+of+antitumor+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DXie%26aufirst%3DL.%26atitle%3DVascular%2520disrupting%2520agents%2520targeting%2520at%2520tubulin%253A%2520a%2520novel%2520class%2520of%2520antitumor%2520drug%26jtitle%3DJ.%2520Int.%2520Pharm.%2520Res.%26date%3D2012%26volume%3D39%26spage%3D445%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liu, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, J.-P.</span><span> </span><span class="NLM_article-title">Tubulin inhibitors: A patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1517/13543776.2014.859247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1517%2F13543776.2014.859247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=24313741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=69-88&author=Y.-M.+Liuauthor=H.-L.+Chenauthor=H.-Y.+Leeauthor=J.-P.+Liou&title=Tubulin+inhibitors%3A+A+patent+review&doi=10.1517%2F13543776.2014.859247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin inhibitors: a patent review</span></div><div class="casAuthors">Liu, Yi-Min; Chen, Hsiao-Ling; Lee, Hsueh-Yun; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-88</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Microtubules play an important role in several cellular processes, particularly in the formation of the mitotic spindle during the process of mitosis.  These highly dynamic mitotic-spindle microtubules have become a successful target of cancer therapy.  Microtubule-targeting agents, such as vinca alkaloids and taxanes, were used in clinic over 50 years.  In past decades, development of new antimicrotubule agents that possess different structure and binding sites of tubulin has shown potent activity against the proliferation of various cancer cells, as well as in multidrug-resistant cancers.  Interestingly, many of these agents represent an attractive ability that targeting the tumor blood vessels results in tumor vascular disruption.  Therefore, exploring new agents and strategies may provide more effective therapeutic options in the related treatment of cancer.  Areas covered: In past few years, there are many chem. compds. that successfully interferes the microtubules and display antitumor effect.  In these, published compds. supply the fresh minds in modification of present drugs and new insights into the development of tubulin inhibitors.  Expert opinion: This article arranges the microtubule-targeting agents that have published in patent in recent years.  It may help in the investigation of new tubulin binding site and development of novel drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtnvpvVK8NmrVg90H21EOLACvtfcHk0lj7QjQAERhU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP&md5=e17a15b0f0538911f2a80035edbf89b7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.859247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.859247%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-M.%26aulast%3DChen%26aufirst%3DH.-L.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DLiou%26aufirst%3DJ.-P.%26atitle%3DTubulin%2520inhibitors%253A%2520A%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D69%26epage%3D88%26doi%3D10.1517%2F13543776.2014.859247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bariwal, J.</span><span> </span><span class="NLM_article-title">Recent developments in tubulin polymerization inhibitors: an overview</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.ejmech.2014.09.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=25240869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=89-124&author=R.+Kaurauthor=G.+Kaurauthor=R.+K.+Gillauthor=R.+Soniauthor=J.+Bariwal&title=Recent+developments+in+tubulin+polymerization+inhibitors%3A+an+overview&doi=10.1016%2Fj.ejmech.2014.09.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in tubulin polymerization inhibitors: An overview</span></div><div class="casAuthors">Kaur, Ramandeep; Kaur, Gurneet; Gill, Rupinder Kaur; Soni, Richard; Bariwal, Jitender</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-124</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Microtubules are protein biopolymers formed through polymn. of heterodimers of α- and β-tubulins.  Disruption of microtubules can induce cell cycle arrest in G2-M phase and formation of abnormal mitotic spindles.  Their importance in mitosis and cell division makes microtubules an attractive target for anticancer drug discovery.  A no. of naturally occurring compds. such as paclitaxel, epothilones, vinblastine, combretastatin, and colchicines exert their effect by changing dynamics of tubulin such as polymn. and depolymn.  During past few years, rapid development of the novel tubulin polymn. inhibitors has been witnessed.  Diverse classes of chem. compds. from the natural as well as from the synthetic origin have been extensively studied.  This review highlights the various classes of synthetically derived chem. compds. those have been reported in last few years as potential tubulin polymn. inhibitors.  A brief synthetic methodol. to access these compds. has been highlighted along with the brief SAR studies.  We strongly believe that this review will provide a platform to the synthetic chemists and biologists to design and synthesize new and potent compds. to inhibit the tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV6nQysY8nvbVg90H21EOLACvtfcHk0lj7QjQAERhU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbzE&md5=2ffd2f9bb073a7830f4aae7c29f070d9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.051%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DGill%26aufirst%3DR.%2BK.%26aulast%3DSoni%26aufirst%3DR.%26aulast%3DBariwal%26aufirst%3DJ.%26atitle%3DRecent%2520developments%2520in%2520tubulin%2520polymerization%2520inhibitors%253A%2520an%2520overview%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D89%26epage%3D124%26doi%3D10.1016%2Fj.ejmech.2014.09.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Nitika, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapil, K.</span><span> </span><span class="NLM_article-title">Microtubule targeting agents: a benchmark in cancer therapy</span> <span class="citation_source-journal">Curr. Drug Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.2174/15748855113086660011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F15748855113086660011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=189-196&author=V.+Nitikaauthor=K.+Kapil&title=Microtubule+targeting+agents%3A+a+benchmark+in+cancer+therapy&doi=10.2174%2F15748855113086660011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F15748855113086660011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15748855113086660011%26sid%3Dliteratum%253Aachs%26aulast%3DNitika%26aufirst%3DV.%26aulast%3DKapil%26aufirst%3DK.%26atitle%3DMicrotubule%2520targeting%2520agents%253A%2520a%2520benchmark%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Drug%2520Ther.%26date%3D2013%26volume%3D8%26spage%3D189%26epage%3D196%26doi%3D10.2174%2F15748855113086660011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Patil, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2115</span><span class="refDoi"> DOI: 10.4155/fmc.12.141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.4155%2Ffmc.12.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23157240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ynsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=2085-2115&author=S.+A.+Patilauthor=R.+Patilauthor=D.+D.+Miller&title=Indole+molecules+as+inhibitors+of+tubulin+polymerization%3A+potential+new+anticancer+agents&doi=10.4155%2Ffmc.12.141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents</span></div><div class="casAuthors">Patil, Shivaputra A.; Patil, Renukadevi; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2085-2115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Agents that interfere with tubulin function have a broad anti-tumor spectrum and they represent one of the most significant classes of anticancer agents.  In the past few years, several small synthetic mols. that have an indole nucleus as a core structure have been identified as tubulin inhibitors.  Among these, several aroylindoles, arylthioindoles, diarylindoles and indolylglyoxyamides have shown good inhibition towards the tubulin polymn.  This article reviews the synthesis, biol. activities and SARs of these main classes of indoles.  Brief mention has also been made about the fused indole analogs as tubulin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-6yFCbyEmnrVg90H21EOLACvtfcHk0lj7QjQAERhU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ynsbjP&md5=341d510a2a4fe59892af97fe3d40fbb7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.141%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BA.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DIndole%2520molecules%2520as%2520inhibitors%2520of%2520tubulin%2520polymerization%253A%2520potential%2520new%2520anticancer%2520agents%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D2085%26epage%3D2115%26doi%3D10.4155%2Ffmc.12.141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ramana Reddy, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallireddigari, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallela, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosenza, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billa, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akula, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkata Subbaiah, D. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijaya Bharathi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgaonkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Premkumar Reddy, E.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of (<i>E</i>)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5562</span><span class="NLM_x">–</span> <span class="NLM_lpage">5586</span><span class="refDoi"> DOI: 10.1021/jm400575x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400575x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5562-5586&author=M.+V.+Ramana+Reddyauthor=M.+R.+Mallireddigariauthor=V.+R.+Pallelaauthor=S.+C.+Cosenzaauthor=V.+K.+Billaauthor=B.+Akulaauthor=D.+R.+C.+Venkata+Subbaiahauthor=E.+Vijaya+Bharathiauthor=A.+Padgaonkarauthor=H.+Lvauthor=J.+M.+Galloauthor=E.+Premkumar+Reddy&title=Design%2C+synthesis%2C+and+biological+evaluation+of+%28E%29-N-aryl-2-arylethenesulfonamide+analogues+as+potent+and+orally+bioavailable+microtubule-targeted+anticancer+agents&doi=10.1021%2Fjm400575x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400575x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400575x%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%2BReddy%26aufirst%3DM.%2BV.%26aulast%3DMallireddigari%26aufirst%3DM.%2BR.%26aulast%3DPallela%26aufirst%3DV.%2BR.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26aulast%3DBilla%26aufirst%3DV.%2BK.%26aulast%3DAkula%26aufirst%3DB.%26aulast%3DVenkata%2BSubbaiah%26aufirst%3DD.%2BR.%2BC.%26aulast%3DVijaya%2BBharathi%26aufirst%3DE.%26aulast%3DPadgaonkar%26aufirst%3DA.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DPremkumar%2BReddy%26aufirst%3DE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520%2528E%2529-N-aryl-2-arylethenesulfonamide%2520analogues%2520as%2520potent%2520and%2520orally%2520bioavailable%2520microtubule-targeted%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5562%26epage%3D5586%26doi%3D10.1021%2Fjm400575x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Massarotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span> </span><span class="NLM_article-title">The tubulin colchicine domain: a molecular modeling perspective</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1002/cmdc.201100361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1002%2Fcmdc.201100361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=21990124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12qt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=33-42&author=A.+Massarottiauthor=A.+Colucciaauthor=R.+Silvestriauthor=G.+Sorbaauthor=A.+Brancale&title=The+tubulin+colchicine+domain%3A+a+molecular+modeling+perspective&doi=10.1002%2Fcmdc.201100361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The Tubulin Colchicine Domain: a Molecular Modeling Perspective</span></div><div class="casAuthors">Massarotti, Alberto; Coluccia, Antonio; Silvestri, Romano; Sorba, Giovanni; Brancale, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Computational approaches have been increasingly applied to drug design over the past three decades and have already provided some useful results in the discovery of anticancer drugs.  Given the increased availability of crystal structures in recent years, a growing no. of mol. modeling studies on tubulin have been reported.  Herein we present a brief overview of the role played by computational methods in anti-tubulin research, specifically in the context of colchicine binding agent research.  An overview of current structures is reported, along with a brief discussion on the issues assocd. with the various tubulin isotypes.  Finally, a summary of the most recent and relevant results is presented, highlighting the challenges and opportunities faced by researchers in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpomkM8Gy2eS7Vg90H21EOLACvtfcHk0lhuPOoQF9m5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12qt7zO&md5=84b4f8c78b635c2b7df31bbd1e4a89de</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100361%26sid%3Dliteratum%253Aachs%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DBrancale%26aufirst%3DA.%26atitle%3DThe%2520tubulin%2520colchicine%2520domain%253A%2520a%2520molecular%2520modeling%2520perspective%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D33%26epage%3D42%26doi%3D10.1002%2Fcmdc.201100361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medarde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaez, R.</span><span> </span><span class="NLM_article-title">New ligands of the tubulin colchicine site based on X-ray structures</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2231</span><span class="NLM_x">–</span> <span class="NLM_lpage">2252</span><span class="refDoi"> DOI: 10.2174/1568026614666141130092637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F1568026614666141130092637" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2231-2252&author=R.+Alvarezauthor=M.+Medardeauthor=R.+Pelaez&title=New+ligands+of+the+tubulin+colchicine+site+based+on+X-ray+structures&doi=10.2174%2F1568026614666141130092637"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F1568026614666141130092637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666141130092637%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DMedarde%26aufirst%3DM.%26aulast%3DPelaez%26aufirst%3DR.%26atitle%3DNew%2520ligands%2520of%2520the%2520tubulin%2520colchicine%2520site%2520based%2520on%2520X-ray%2520structures%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D14%26spage%3D2231%26epage%3D2252%26doi%3D10.2174%2F1568026614666141130092637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ranaivoson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berritt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joullie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Structural plasticity of tubulin assembly probed by vinca-domain ligands</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span><span class="refDoi"> DOI: 10.1107/S0907444912017143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1107%2FS0907444912017143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=22868758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKisrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=927-934&author=F.+M.+Ranaivosonauthor=B.+Gigantauthor=S.+Berrittauthor=M.+Joullieauthor=M.+Knossow&title=Structural+plasticity+of+tubulin+assembly+probed+by+vinca-domain+ligands&doi=10.1107%2FS0907444912017143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural plasticity of tubulin assembly probed by vinca-domain ligands</span></div><div class="casAuthors">Ranaivoson, Fanomezana M.; Gigant, Benoit; Berritt, Simon; Joullie, Madeleine; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Vinca-domain ligands are compds. that bind to tubulin at its inter-heterodimeric interface and favor heterogeneous protofilament-like assemblies, giving rise to helixes and rings.  This is the basis for their inhibition of microtubule assembly, for their antimitotic activities and for their use in anticancer chemotherapy.  Ustiloxins are vinca-domain ligands with a well established total synthesis.  A 2.7 Å resoln. structure of ustiloxin D bound to the vinca domain embedded in the complex of two tubulins with the stathmin-like domain of RB3 (T2R) has been detd.  This finding precisely defines the interactions of ustiloxins with tubulin and, taken together with structures of other vinca-ligand complexes, allows structure-based suggestions to be made for improved activity.  These comparisons also provide a rationale for the large-scale polymorphism of the protofilament-like assemblies mediated by vinca-domain ligands based on local differences in their interactions with the two tubulin heterodimers constituting their binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjBXTOaREF57Vg90H21EOLACvtfcHk0lhuPOoQF9m5Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKisrvP&md5=2e408f348576893527bba21143a01d71</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444912017143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912017143%26sid%3Dliteratum%253Aachs%26aulast%3DRanaivoson%26aufirst%3DF.%2BM.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DBerritt%26aufirst%3DS.%26aulast%3DJoullie%26aufirst%3DM.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DStructural%2520plasticity%2520of%2520tubulin%2520assembly%2520probed%2520by%2520vinca-domain%2520ligands%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D927%26epage%3D934%26doi%3D10.1107%2FS0907444912017143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Cormier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span> </span><span class="NLM_article-title">Structural insight into the inhibition of tubulin by vinca domain peptide ligands</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1106</span><span class="refDoi"> DOI: 10.1038/embor.2008.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fembor.2008.171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1101-1106&author=A.+Cormierauthor=M.+Marchandauthor=R.+B.+Ravelliauthor=M.+Knossowauthor=B.+Gigant&title=Structural+insight+into+the+inhibition+of+tubulin+by+vinca+domain+peptide+ligands&doi=10.1038%2Fembor.2008.171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fembor.2008.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2008.171%26sid%3Dliteratum%253Aachs%26aulast%3DCormier%26aufirst%3DA.%26aulast%3DMarchand%26aufirst%3DM.%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DKnossow%26aufirst%3DM.%26aulast%3DGigant%26aufirst%3DB.%26atitle%3DStructural%2520insight%2520into%2520the%2520inhibition%2520of%2520tubulin%2520by%2520vinca%2520domain%2520peptide%2520ligands%26jtitle%3DEMBO%2520Rep.%26date%3D2008%26volume%3D9%26spage%3D1101%26epage%3D1106%26doi%3D10.1038%2Fembor.2008.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1038/nature02393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+tubulin+regulation+from+a+complex+with+colchicine+and+a+stathmin-like+domain&doi=10.1038%2Fnature02393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lgOTumaN7hSdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520tubulin%2520regulation%2520from%2520a%2520complex%2520with%2520colchicine%2520and%2520a%2520stathmin-like%2520domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202%26doi%3D10.1038%2Fnature02393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nguyen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermone, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span> </span><span class="NLM_article-title">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6107</span><span class="NLM_x">–</span> <span class="NLM_lpage">6116</span><span class="refDoi"> DOI: 10.1021/jm050502t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+common+pharmacophore+for+a+diverse+set+of+colchicine+site+inhibitors+using+a+structure-based+approach&doi=10.1021%2Fjm050502t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0lgOTumaN7hSdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520common%2520pharmacophore%2520for%2520a%2520diverse%2520set%2520of%2520colchicine%2520site%2520inhibitors%2520using%2520a%2520structure-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6107%26epage%3D6116%26doi%3D10.1021%2Fjm050502t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dorleans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Variations in the colchicine-binding domain provide insight into the structural switch of tubulin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">13775</span><span class="NLM_x">–</span> <span class="NLM_lpage">13779</span><span class="refDoi"> DOI: 10.1073/pnas.0904223106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1073%2Fpnas.0904223106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=19666559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=13775-13779&author=A.+Dorleansauthor=B.+Gigantauthor=R.+B.+Ravelliauthor=P.+Maillietauthor=V.+Mikolauthor=M.+Knossow&title=Variations+in+the+colchicine-binding+domain+provide+insight+into+the+structural+switch+of+tubulin&doi=10.1073%2Fpnas.0904223106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Variations in the colchicine-binding domain provide insight into the structural switch of tubulin</span></div><div class="casAuthors">Dorleans, Audrey; Gigant, Benoit; Ravelli, Raimond B. G.; Mailliet, Patrick; Mikol, Vincent; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13775-13779, S13775/1-S13775/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Structural changes occur in the αβ-tubulin heterodimer during the microtubule assembly/disassembly cycle.  Their most prominent feature is a transition from a straight, microtubular structure to a curved structure.  There is a broad range of small mol. compds. that disturbs the microtubule cycle, a class of which targets the colchicine-binding site and prevents microtubule assembly.  This class includes compds. with very different chem. structures, and it is presently unknown whether they prevent tubulin polymn. by the same mechanism.  To address this issue, we have detd. the structures of tubulin complexed with a set of such ligands and show that they interfere with several of the movements of tubulin subunit structural elements upon its transition from curved to straight.  We also detd. the structure of tubulin unliganded at the colchicine site; this reveals that a β-tubulin loop (termed T7) flips into this site.  As with colchicine site ligands, this prevents a helix which is at the interface with α-tubulin from stacking onto a β-tubulin P sheet as in straight protofilaments.  Whereas in the presence of these ligands the interference with microtubule assembly gets frozen, by flipping in and out, the β-subunit T7 loop participates in a reversible way in the resistance to straightening that opposes microtubule assembly.  Our results suggest that it thereby contributes to microtubule dynamic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDUQBAmYNvbVg90H21EOLACvtfcHk0lgOTumaN7hSdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrO&md5=6d18732f78ac484b9db09ad1ec52aa5c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0904223106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0904223106%26sid%3Dliteratum%253Aachs%26aulast%3DDorleans%26aufirst%3DA.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DMailliet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DVariations%2520in%2520the%2520colchicine-binding%2520domain%2520provide%2520insight%2520into%2520the%2520structural%2520switch%2520of%2520tubulin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D13775%26epage%3D13779%26doi%3D10.1073%2Fpnas.0904223106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Koyanagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitoh, K.</span><span> </span><span class="NLM_article-title">In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=1702-1706&author=N.+Koyanagiauthor=T.+Nagasuauthor=F.+Fujitaauthor=T.+Watanabeauthor=K.+Tsukaharaauthor=Y.+Funahashiauthor=M.+Fujitaauthor=T.+Taguchiauthor=H.+Yoshinoauthor=K.+Kitoh&title=In+vivo+tumor+growth+inhibition+produced+by+a+novel+sulfonamide%2C+E7010%2C+against+rodent+and+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoyanagi%26aufirst%3DN.%26aulast%3DNagasu%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DF.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTsukahara%26aufirst%3DK.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DT.%26aulast%3DYoshino%26aufirst%3DH.%26aulast%3DKitoh%26aufirst%3DK.%26atitle%3DIn%2520vivo%2520tumor%2520growth%2520inhibition%2520produced%2520by%2520a%2520novel%2520sulfonamide%252C%2520E7010%252C%2520against%2520rodent%2520and%2520human%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D1702%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yoshimatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitoh, K.</span><span> </span><span class="NLM_article-title">Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3208</span><span class="NLM_x">–</span> <span class="NLM_lpage">3213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=9242451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFKqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=3208-3213&author=K.+Yoshimatsuauthor=A.+Yamaguchiauthor=H.+Yoshinoauthor=N.+Koyanagiauthor=K.+Kitoh&title=Mechanism+of+action+of+E7010%2C+an+orally+active+sulfonamide+antitumor+agent%3A+inhibition+of+mitosis+by+binding+to+the+colchicine+site+of+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin</span></div><div class="casAuthors">Yoshimatsu, Kentaro; Yamaguchi, Atsumi; Yoshino, Hiroshi; Koyanagi, Nozomu; Kitoh, Kyosuke</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3208-3213</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">E7010 (N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide), an orally active sulfonamide antitumor agent that is currently in a Phase I clin. trial, showed rather consistent growth-inhibitory activities against a panel of 26 human tumor cell lines (IC50 = 0.06-0.8 μg/mL), in contrast to vincristine (VCR; IC50 = 0.0002-0.04 μg/mL), 5-fluorouracil (IC50 = 0.2-30 -μg/mL), Adriamycin (IC50 = 0.002-0.7 μg/mL), mitomycin C (IC50 = 0.007-3 μg/mL), 1-β-D-arabionfuranoxylcytosine (IC50 = 0.005 to >30 μg/mL), camptothecin (IC50 = 0.002-0.4 μg/mL), and cisplatin (IC50 = 0.5-20 μg/mL).  It caused a dose-dependent increase in the percentage or mitotic cells in parallel with a decrease in cell proliferation, like VCR.  It also showed a dose-dependent inhibition of tubulin polymn., which correlated well with the cell growth-inhibitory activity.  14C-labeled E7010 bound to purified tubulin, and this binding was inhibited by colchicine but not by VCR.  However, its binding properties were different from those of colchicine, as well as those of VCR.  E7010 was active against two kind of VCR-resistant P388 cell lines, one of which showed multidrug resistance due to the overexpression of P-glycoprotein (resistant to Taxol), and the other did not show multidrug resistance (sensitive to Taxol).  Furthermore, four E7010-resistant P388 cell lines showed no cross-resistance to VCR, a different pattern of resistance to podophyllotoxin, and collateral sensitivity to Taxol.  Therefore, E7010 is a novel tubulin-binding agent that has a wider antitumor spectrum than VCR and has different properties from those of VCR or Taxol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpxr7g_T5H7Vg90H21EOLACvtfcHk0lg2vJIDW3ZGug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFKqs7Y%253D&md5=8e3c1d8dd4d82dad09ee5e930d58b6c6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimatsu%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DA.%26aulast%3DYoshino%26aufirst%3DH.%26aulast%3DKoyanagi%26aufirst%3DN.%26aulast%3DKitoh%26aufirst%3DK.%26atitle%3DMechanism%2520of%2520action%2520of%2520E7010%252C%2520an%2520orally%2520active%2520sulfonamide%2520antitumor%2520agent%253A%2520inhibition%2520of%2520mitosis%2520by%2520binding%2520to%2520the%2520colchicine%2520site%2520of%2520tubulin%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D3208%26epage%3D3213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kuppens, I. E.</span><span> </span><span class="NLM_article-title">Current state of the art of new tubulin inhibitors in the clinic</span> <span class="citation_source-journal">Curr. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.2174/157488406775268200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F157488406775268200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=18666378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFOgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=57-70&author=I.+E.+Kuppens&title=Current+state+of+the+art+of+new+tubulin+inhibitors+in+the+clinic&doi=10.2174%2F157488406775268200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Current state of the art of new tubulin inhibitors in the clinic</span></div><div class="casAuthors">Kuppens, Isa E. L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CCPUC5</span>;
        ISSN:<span class="NLM_cas:issn">1574-8847</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For years the microtubule stabilizing agents docetaxel and paclitaxel belong to the most successful clin. chemotherapeutic agents.  Several attempts have been made over the years to equal and better these drugs.  Both taxanes are assocd. with the notorious side effect neurotoxicity and are often accompanied with increased drug resistance and cross resistance with other chemotherapeutic agents.  In addn. their high lipophilicity demands use of co-solvents, which are assocd. with less favorable side effects such as hypersensitivity.  To prevent these disadvantages and improve the clin. application of the taxanes several new agents have entered clin. testing.  The agents that are discussed are the drug class of the discodermolides; XAA296A and the epothilones; BMS-247550, BMS-310705, epo906, kos-862 and the agents ABT-751 and D-24851.  Here we present an overview of recently performed clin. studies to det. the current state of the art of the tubulin inhibitors which are intended to enlarge and improve the clin. use of the taxanes docetaxel and paclitaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiAXF3Hrb0ubVg90H21EOLACvtfcHk0lg2vJIDW3ZGug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFOgu7c%253D&md5=e0ab529443ebf69c924de9d76ccc685d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F157488406775268200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488406775268200%26sid%3Dliteratum%253Aachs%26aulast%3DKuppens%26aufirst%3DI.%2BE.%26atitle%3DCurrent%2520state%2520of%2520the%2520art%2520of%2520new%2520tubulin%2520inhibitors%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D1%26spage%3D57%26epage%3D70%26doi%3D10.2174%2F157488406775268200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Rudin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smakal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juergens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spelda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wertheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeegan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradhan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krivoshik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, G.</span><span> </span><span class="NLM_article-title">Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1200/JCO.2010.32.5944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1200%2FJCO.2010.32.5944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=21300929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1075-1082&author=C.+M.+Rudinauthor=A.+Mauerauthor=M.+Smakalauthor=R.+Juergensauthor=S.+Speldaauthor=M.+Wertheimauthor=A.+Coatesauthor=E.+McKeeganauthor=P.+Ansellauthor=X.+Zhouauthor=J.+Qianauthor=R.+Pradhanauthor=B.+Dowellauthor=A.+Krivoshikauthor=G.+Gordon&title=Phase+I%2FII+study+of+pemetrexed+with+or+without+ABT-751+in+advanced+or+metastatic+non-small-cell+lung+cancer&doi=10.1200%2FJCO.2010.32.5944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer</span></div><div class="casAuthors">Rudin, Charles M.; Mauer, Ann; Smakal, Martin; Juergens, Rosalyn; Spelda, Stanislav; Wertheim, Michael; Coates, Andrew; McKeegan, Evelyn; Ansell, Peter; Zhou, Xiangdong; Qian, Jane; Pradhan, Rajendra; Dowell, Barry; Krivoshik, Andrew; Gordon, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1075-1082</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: ABT-751 is an antimitotic and vascular disrupting agent with potent preclin. anticancer activity.  We conducted a phase I and randomized double-blind phase II study of pemetrexed with ABT-751 or placebo in patients with recurrent advanced or metastatic non-small-cell lung cancer (NSCLC).  Methods: One hundred seventy-one patients received i.v. pemetrexed 500 mg/m2 day 1 and oral ABT-751 or placebo days 1 to 14 of 21-day cycles.  The primary end point was progression-free survival (PFS).  Secondary end point included overall survival (OS); pharmacokinetic and pharmacodynamic parameters were also analyzed.  Results: The recommended phase II dose of ABT-751 with pemetrexed is 200 mg.  Fatigue, constipation, anemia, nausea, and diarrhea were the most common toxicities in both study arms.  No pharmacokinetic interactions were obsd.  Median PFS in the ABT-751 arm was 2.3 mo vs. 1.9 for placebo (P = .819, log-rank) for the intention-to-treat population.  However, differences in PFS (P = .112, log-rank) and OS (P = .034, log-rank; median 3.3 v 8.1 mo) favoring ABT-751 were seen in the squamous NSCLC subgroup.  Baseline circulating tumor cell concns. were predictive of improved OS (P = .013).  Changes from baseline of greater than 20% in plasma levels of placenta growth factor (P = .056), squamous cell carcinoma antigen (P = .03), and cytokeratin 19 fragment antigen 21-1 (P = .01) were markers best assocd. with improved OS.  Conclusion: Addn. of ABT-751 to pemetrexed is well-tolerated, but does not improve outcome in unselected patients with recurrent NSCLC.  ABT-751 may have therapeutic potential in squamous NSCLC.  Exploratory cellular and mol. analyses in this study identified biomarkers that may correlate with survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmZjmrm3J4rVg90H21EOLACvtfcHk0liopQifMZWNdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslOhsb8%253D&md5=634b7d9cd090d61725ff922e080cd983</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.32.5944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.32.5944%26sid%3Dliteratum%253Aachs%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DMauer%26aufirst%3DA.%26aulast%3DSmakal%26aufirst%3DM.%26aulast%3DJuergens%26aufirst%3DR.%26aulast%3DSpelda%26aufirst%3DS.%26aulast%3DWertheim%26aufirst%3DM.%26aulast%3DCoates%26aufirst%3DA.%26aulast%3DMcKeegan%26aufirst%3DE.%26aulast%3DAnsell%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DPradhan%26aufirst%3DR.%26aulast%3DDowell%26aufirst%3DB.%26aulast%3DKrivoshik%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DG.%26atitle%3DPhase%2520I%252FII%2520study%2520of%2520pemetrexed%2520with%2520or%2520without%2520ABT-751%2520in%2520advanced%2520or%2520metastatic%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D1075%26epage%3D1082%26doi%3D10.1200%2FJCO.2010.32.5944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Nugiel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidwans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etzkorn, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doleniak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">5232</span><span class="refDoi"> DOI: 10.1021/jm020171+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020171%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5224-5232&author=D.+A.+Nugielauthor=A.+Vidwansauthor=A.-M.+Etzkornauthor=K.+A.+Rossiauthor=P.+A.+Benfieldauthor=C.+R.+Burtonauthor=S.+Coxauthor=D.+Doleniakauthor=S.+P.+Seitz&title=Synthesis+and+evaluation+of+indenopyrazoles+as+cyclin-dependent+kinase+inhibitors.+2.+Probing+the+indeno+ring+substituent+pattern&doi=10.1021%2Fjm020171%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm020171%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020171%252B%26sid%3Dliteratum%253Aachs%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DVidwans%26aufirst%3DA.%26aulast%3DEtzkorn%26aufirst%3DA.-M.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DBenfield%26aufirst%3DP.%2BA.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DDoleniak%26aufirst%3DD.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520indenopyrazoles%2520as%2520cyclin-dependent%2520kinase%2520inhibitors.%25202.%2520Probing%2520the%2520indeno%2520ring%2520substituent%2520pattern%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5224%26epage%3D5232%26doi%3D10.1021%2Fjm020171%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMeo, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugiel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benware, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grafstrom, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boylan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5233</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span><span class="refDoi"> DOI: 10.1021/jm0201722</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0201722" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5233-5248&author=E.+W.+Yueauthor=C.+A.+Higleyauthor=S.+V.+DiMeoauthor=D.+J.+Cariniauthor=D.+A.+Nugielauthor=C.+Benwareauthor=P.+A.+Benfieldauthor=C.+R.+Burtonauthor=S.+Coxauthor=R.+H.+Grafstromauthor=D.+M.+Sharpauthor=L.+M.+Siskauthor=J.+F.+Boylanauthor=J.+K.+Muckelbauerauthor=A.+M.+Smallwoodauthor=H.+Chenauthor=C.-H.+Changauthor=S.+P.+Seitzauthor=G.+L.+Trainor&title=Synthesis+and+evaluation+of+indenopyrazoles+as+cyclin-dependent+kinase+inhibitors.+3.+Structure+activity+relationships+at+C3&doi=10.1021%2Fjm0201722"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm0201722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0201722%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DHigley%26aufirst%3DC.%2BA.%26aulast%3DDiMeo%26aufirst%3DS.%2BV.%26aulast%3DCarini%26aufirst%3DD.%2BJ.%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DBenware%26aufirst%3DC.%26aulast%3DBenfield%26aufirst%3DP.%2BA.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DGrafstrom%26aufirst%3DR.%2BH.%26aulast%3DSharp%26aufirst%3DD.%2BM.%26aulast%3DSisk%26aufirst%3DL.%2BM.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520indenopyrazoles%2520as%2520cyclin-dependent%2520kinase%2520inhibitors.%25203.%2520Structure%2520activity%2520relationships%2520at%2520C3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5233%26epage%3D5248%26doi%3D10.1021%2Fjm0201722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludovici, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharoof, U. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strobel, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andraka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominovich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruninger, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.</span><span> </span><span class="NLM_article-title">6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: Platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8163</span><span class="NLM_x">–</span> <span class="NLM_lpage">8173</span><span class="refDoi"> DOI: 10.1021/jm050680m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050680m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=8163-8173&author=C.+Y.+Hoauthor=D.+W.+Ludoviciauthor=U.+S.+M.+Maharoofauthor=J.+Meiauthor=J.+L.+Sechlerauthor=R.+W.+Tumanauthor=E.+D.+Strobelauthor=L.+Andrakaauthor=H.-K.+Yenauthor=G.+Leoauthor=J.+Liauthor=H.+Almondauthor=H.+Luauthor=A.+DeVineauthor=R.+M.+Tominovichauthor=J.+Bakerauthor=S.+Emanuelauthor=R.+H.+Gruningerauthor=S.+A.+Middletonauthor=D.+L.+Johnsonauthor=R.+A.+Galemmo&title=6%2C7-Dimethoxy-2%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazol-3-yl%29phenylamines%3A+Platelet-derived+growth+factor+receptor+tyrosine+kinase+inhibitors+with+broad+antiproliferative+activity+against+tumor+cells&doi=10.1021%2Fjm050680m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm050680m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050680m%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DC.%2BY.%26aulast%3DLudovici%26aufirst%3DD.%2BW.%26aulast%3DMaharoof%26aufirst%3DU.%2BS.%2BM.%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DSechler%26aufirst%3DJ.%2BL.%26aulast%3DTuman%26aufirst%3DR.%2BW.%26aulast%3DStrobel%26aufirst%3DE.%2BD.%26aulast%3DAndraka%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DH.-K.%26aulast%3DLeo%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAlmond%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DDeVine%26aufirst%3DA.%26aulast%3DTominovich%26aufirst%3DR.%2BM.%26aulast%3DBaker%26aufirst%3DJ.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DGruninger%26aufirst%3DR.%2BH.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BL.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26atitle%3D6%252C7-Dimethoxy-2%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazol-3-yl%2529phenylamines%253A%2520Platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520with%2520broad%2520antiproliferative%2520activity%2520against%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D8163%26epage%3D8173%26doi%3D10.1021%2Fjm050680m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4308</span><span class="NLM_x">–</span> <span class="NLM_lpage">4315</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmcl.2007.05.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4308-4315&author=Z.-F.+Taoauthor=G.+Liauthor=Y.+Tongauthor=Z.+Chenauthor=P.+Mertaauthor=P.+Kovarauthor=H.+Zhangauthor=S.-H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.-H.+Lin&title=Synthesis+and+biological+evaluation+of+4%E2%80%B2-%286%2C7-disubstituted-2%2C4-dihydro-indeno%5B1%2C2-c%5Dpyrazol-3-yl%29-biphenyl-4-ol+as+potent+Chk1+inhibitors&doi=10.1016%2Fj.bmcl.2007.05.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.-H.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204%25E2%2580%25B2-%25286%252C7-disubstituted-2%252C4-dihydro-indeno%255B1%252C2-c%255Dpyrazol-3-yl%2529-biphenyl-4-ol%2520as%2520potent%2520Chk1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4308%26epage%3D4315%26doi%3D10.1016%2Fj.bmcl.2007.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Discovery of 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4′-(1,4-dihydro-indeno[1,2-c]-pyrazol-3-yl)-pyridine-2′-carbonitriles as potent checkpointkinase 1 (Chk1) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">–</span> <span class="NLM_lpage">5951</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmcl.2007.07.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5944-5951&author=Z.-F.+Taoauthor=G.+Liauthor=Y.+Tongauthor=K.+D.+Stewartauthor=Z.+Chenauthor=M.-H.+Buiauthor=P.+Mertaauthor=C.+Parkauthor=P.+Kovarauthor=H.+Zhangauthor=H.+L.+Shamauthor=S.+H.+Rosenbergauthor=T.+J.+Sowinauthor=N.-H.+Lin&title=Discovery+of+4%E2%80%B2-%281%2C4-dihydro-indeno%5B1%2C2-c%5Dpyrazol-3-yl%29-benzonitriles+and+4%E2%80%B2-%281%2C4-dihydro-indeno%5B1%2C2-c%5D-pyrazol-3-yl%29-pyridine-2%E2%80%B2-carbonitriles+as+potent+checkpointkinase+1+%28Chk1%29+inhibitors&doi=10.1016%2Fj.bmcl.2007.07.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.102%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DBui%26aufirst%3DM.-H.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DDiscovery%2520of%25204%25E2%2580%25B2-%25281%252C4-dihydro-indeno%255B1%252C2-c%255Dpyrazol-3-yl%2529-benzonitriles%2520and%25204%25E2%2580%25B2-%25281%252C4-dihydro-indeno%255B1%252C2-c%255D-pyrazol-3-yl%2529-pyridine-2%25E2%2580%25B2-carbonitriles%2520as%2520potent%2520checkpointkinase%25201%2520%2528Chk1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5944%26epage%3D5951%26doi%3D10.1016%2Fj.bmcl.2007.07.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Usui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirokawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmcl.2007.10.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=285-288&author=T.+Usuiauthor=H.+S.+Banauthor=J.+Kawadaauthor=T.+Hirokawaauthor=H.+Nakamura&title=Discovery+of+indenopyrazoles+as+EGFR+and+VEGFR-2+tyrosine+kinase+inhibitors+by+in+silico+high-throughput+screening&doi=10.1016%2Fj.bmcl.2007.10.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.084%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DKawada%26aufirst%3DJ.%26aulast%3DHirokawa%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520indenopyrazoles%2520as%2520EGFR%2520and%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%2520by%2520in%2520silico%2520high-throughput%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D285%26epage%3D288%26doi%3D10.1016%2Fj.bmcl.2007.10.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Minegishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukashiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Discovery of indenopyrazoles as new class of hyposia inducible factor (HIF)-1 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1021/ml3004632</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3004632" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=297-301&author=H.+Minegishiauthor=S.+Fukashiroauthor=H.+S.+Banauthor=H.+Nakamura&title=Discovery+of+indenopyrazoles+as+new+class+of+hyposia+inducible+factor+%28HIF%29-1+inhibitor&doi=10.1021%2Fml3004632"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fml3004632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3004632%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DFukashiro%26aufirst%3DS.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520indenopyrazoles%2520as%2520new%2520class%2520of%2520hyposia%2520inducible%2520factor%2520%2528HIF%2529-1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D297%26epage%3D301%26doi%3D10.1021%2Fml3004632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Minegishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukashiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Methyl 3-((6-Methoxy-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-3-yl)amino)benzoate (GN39482) as a tubulin polymerization inhibitor identified by MorphoBase and ChemProteoBase profiling methods</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4230</span><span class="NLM_x">–</span> <span class="NLM_lpage">4241</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvV2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4230-4241&author=H.+Minegishiauthor=y.+Futamuraauthor=S.+Fukashiroauthor=M.+Muroiauthor=M.+Kawataniauthor=H.+Osadaauthor=H.+Nakamura&title=Methyl+3-%28%286-Methoxy-1%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazol-3-yl%29amino%29benzoate+%28GN39482%29+as+a+tubulin+polymerization+inhibitor+identified+by+MorphoBase+and+ChemProteoBase+profiling+methods&doi=10.1021%2Facs.jmedchem.5b00035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl 3-((6-Methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate (GN39482) as a Tubulin Polymerization Inhibitor Identified by MorphoBase and ChemProteoBase Profiling Methods</span></div><div class="casAuthors">Minegishi, Hidemitsu; Futamura, Yushi; Fukashiro, Shinji; Muroi, Makoto; Kawatani, Makoto; Osada, Hiroyuki; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4230-4241</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of indenopyrazoles was synthesized from the corresponding indanones and Ph isothiocyanates in two steps.  Among the compds. synthesized, Me 3-((6-methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate 6m (I, GN39482) was found to possess a promising antiproliferative activity toward human cancer cells without affecting any antimicrobial and antimalarial activities at 100 nM.  Both a methoxy group at R1 position and a methoxycarbonyl group at R2 position of the anilinoindenopyrazole framework are essential for the high cell growth inhibition.  Both MorphoBase and ChemProteoBase profiling analyses suggested that compd. 6m was classified as a tubulin inhibitor.  Indeed, compd. 6m inhibited the acetylated tubulin accumulation and the microtubule formation and induced G2/M cell cycle arrest in HeLa cells, revealing that a promising antiproliferative activity of compd. 6m toward human cancer cells is probably caused by the tubulin polymn. inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFRlvMc-6TSLVg90H21EOLACvtfcHk0lj2Zqzo5cNEoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvV2msrg%253D&md5=efe5c14b97d7e75356b9f0810f8aeb07</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00035%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DFutamura%26aufirst%3Dy.%26aulast%3DFukashiro%26aufirst%3DS.%26aulast%3DMuroi%26aufirst%3DM.%26aulast%3DKawatani%26aufirst%3DM.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DMethyl%25203-%2528%25286-Methoxy-1%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazol-3-yl%2529amino%2529benzoate%2520%2528GN39482%2529%2520as%2520a%2520tubulin%2520polymerization%2520inhibitor%2520identified%2520by%2520MorphoBase%2520and%2520ChemProteoBase%2520profiling%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4230%26epage%3D4241%26doi%3D10.1021%2Facs.jmedchem.5b00035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Clarke, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, L. A.</span><span> </span><span class="NLM_article-title">Cell-cycle control in the face of damage–a matter of life or death</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.tcb.2008.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.tcb.2008.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=19168356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVWkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=89-98&author=P.+R.+Clarkeauthor=L.+A.+Allan&title=Cell-cycle+control+in+the+face+of+damage%E2%80%93a+matter+of+life+or+death&doi=10.1016%2Fj.tcb.2008.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle control in the face of damage - A matter of life or death</span></div><div class="casAuthors">Clarke, Paul R.; Allan, Lindsey A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cells respond to DNA damage or defects in the mitotic spindle by activating checkpoints that arrest the cell cycle.  Alternatively, damaged cells can undergo cell death by the process of apoptosis.  The correct balance between these pathways is important for the maintenance of genomic integrity while preventing unnecessary cell death.  Although the mol. mechanisms of the cell cycle and apoptosis have been elucidated, the links between them have not been clear.  Recent work, however, indicates that common components directly link the regulation of apoptosis with cell-cycle checkpoints operating during interphase, whereas in mitosis, the control of apoptosis is directly coupled to the cell-cycle machinery.  These findings shed new light on how the balance between cell-cycle progression and cell death is controlled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd8UcTnip3h7Vg90H21EOLACvtfcHk0lhv7VdPS6BYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVWkurw%253D&md5=5637aa86c33cbdf73dff163acb558f76</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2008.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2008.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DP.%2BR.%26aulast%3DAllan%26aufirst%3DL.%2BA.%26atitle%3DCell-cycle%2520control%2520in%2520the%2520face%2520of%2520damage%25E2%2580%2593a%2520matter%2520of%2520life%2520or%2520death%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2009%26volume%3D19%26spage%3D89%26epage%3D98%26doi%3D10.1016%2Fj.tcb.2008.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Cheng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.-Y.</span><span> </span><span class="NLM_article-title">MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mRNA through decreasing nuclear–cytoplasmic translocation of RNA-binding protein HuR</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1158%2F1535-7163.MCT-12-0778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23619299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1202-1212&author=Y.-C.+Chengauthor=J.-P.+Liuauthor=C.-P.+Kuoauthor=W.-Y.+Laiauthor=K.-H.+Shihauthor=C.-Y.+Changauthor=W.-Y.+Panauthor=J.+T.+Tsengauthor=J.-Y.+Chang&title=MPT0B098%2C+a+novel+microtubule+inhibitor+that+destabilizes+the+hypoxia-inducible+factor-1%CE%B1+mRNA+through+decreasing+nuclear%E2%80%93cytoplasmic+translocation+of+RNA-binding+protein+HuR&doi=10.1158%2F1535-7163.MCT-12-0778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear-Cytoplasmic Translocation of RNA-Binding Protein HuR</span></div><div class="casAuthors">Cheng, Yun-Ching; Liou, Jing-Ping; Kuo, Ching-Chuan; Lai, Wen-Yang; Shih, Kuang-Hsing; Chang, Chi-Yen; Pan, Wen-Yu; Tseng, Joseph T.; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1202-1212</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Microtubule inhibitors were shown to inhibit hypoxia-inducible factor-1α (HIF-1α) expression through inhibition translation or enhancing protein degrdn.  Little is known of the effect of microtubule inhibitors on the stability of HIF-1α mRNA.  We recently discovered a novel indoline-sulfonamide compd., 7-aryl-indoline-1-benzene-sulfonamide (MPT0B098), as a potent microtubule inhibitor through binding to the colchicine-binding site of tubulin.  MPT0B098 is active against the growth of various human cancer cells, including chemoresistant cells with IC50 values ranging from 70 to 150 nmol/L.  However, normal cells, such as human umbilical vein endothelial cells (HUVEC), exhibit less susceptibility to the inhibitory effect of MPT0B098 with IC50 of 510 nmol/L.  Similar to typical microtubule inhibitors, MPT0B098 arrests cells in the G2-M phase and subsequently induces cell apoptosis.  In addn., MPT0B098 effectively suppresses VEGF-induced cell migration and capillary-like tube formation of HUVECs.  Distinguished from other microtubule inhibitors, MPT0B098 not only inhibited the expression levels of HIF-1α protein but also destabilized HIF-1α mRNA.  The mechanism of causing unstable of HIF-1α mRNA by MPT0B098 is through decreasing RNA-binding protein, HuR, translocation from the nucleus to the cytoplasm.  Notably, MPT0B098 effectively suppresses tumor growth and microvessel d. of tumor specimens in vivo.  Taken together, our results provide a novel mechanism of inhibiting HIF-1α of a microtubule inhibitor MPT0B098.  MPT0B098 is a promising anticancer drug candidate with potential for the treatment of human malignancies.  Mol Cancer Ther; 12(7); 1202-12. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPksmggcBGLVg90H21EOLACvtfcHk0lhv7VdPS6BYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfO&md5=703796adc14620915d98dd2a146c3648</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0778%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DLiu%26aufirst%3DJ.-P.%26aulast%3DKuo%26aufirst%3DC.-P.%26aulast%3DLai%26aufirst%3DW.-Y.%26aulast%3DShih%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DC.-Y.%26aulast%3DPan%26aufirst%3DW.-Y.%26aulast%3DTseng%26aufirst%3DJ.%2BT.%26aulast%3DChang%26aufirst%3DJ.-Y.%26atitle%3DMPT0B098%252C%2520a%2520novel%2520microtubule%2520inhibitor%2520that%2520destabilizes%2520the%2520hypoxia-inducible%2520factor-1%25CE%25B1%2520mRNA%2520through%2520decreasing%2520nuclear%25E2%2580%2593cytoplasmic%2520translocation%2520of%2520RNA-binding%2520protein%2520HuR%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1202%26epage%3D1212%26doi%3D10.1158%2F1535-7163.MCT-12-0778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottamal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFerrin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3369</span><span class="NLM_x">–</span> <span class="NLM_lpage">3381</span><span class="refDoi"> DOI: 10.1021/jm500002k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500002k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVCrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3369-3381&author=S.+Zhengauthor=Q.+Zhongauthor=M.+Mottamalauthor=Q.+Zhangauthor=C.+Zhangauthor=E.+LeMelleauthor=H.+McFerrinauthor=G.+Wang&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+pyridine-bridged+analogues+of+combretastatin-A4+as+anticancer+agents&doi=10.1021%2Fjm500002k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents</span></div><div class="casAuthors">Zheng, Shilong; Zhong, Qiu; Mottamal, Madhusoodanan; Zhang, Qiang; Zhang, Changde; LeMelle, Elise; McFerrin, Harris; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3369-3381</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyridine-bridged analogs of combretastatin-A4 (CA-4) were designed and synthesized.  As expected, the 4-atom linker configuration retained little cytotoxicities.  Activities of the analogs with 3-atom linker varied widely depending on the Ph ring substitutions, and the 3-atom linker contg. nitrogen represents the more favorable linker structure.  Among them, three analogs (4h, 4s, and 4t; I - III, resp.) potently inhibited cell survival and growth, arrested cell cycle, and blocked angiogenesis and vasculature formation in vivo in ways comparable to CA-4.  The superposition of 4h and 4s in the colchicine-binding pocket of tubulin shows the binding posture of CA-4, 4h, and 4s are similar, as confirmed by the competitive binding assay where the ability of the ligands to replace tubulin-bound colchicine was measured.  The binding data are consistent with the obsd. biol. activities in antiproliferation and suppression of angiogenesis but are not predictive of their antitubulin polymn. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe8RTj0wT9RLVg90H21EOLACvtfcHk0lhv7VdPS6BYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVCrsLc%253D&md5=818f0a1793ce803a0b48e827004aa1e5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm500002k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500002k%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DMottamal%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLeMelle%26aufirst%3DE.%26aulast%3DMcFerrin%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520pyridine-bridged%2520analogues%2520of%2520combretastatin-A4%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3369%26epage%3D3381%26doi%3D10.1021%2Fjm500002k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Da, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluball, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellogg, G. E.</span><span> </span><span class="NLM_article-title">Developing novel C-4 analogues of pyrrole-based antitubulin agents: weak but critical hydrogen bonding in the colchicine site</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1039/c2md20320k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1039%2Fc2md20320k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=417-421&author=C.+Daauthor=N.+Telangauthor=K.+Hallauthor=E.+Kluballauthor=P.+Barelliauthor=K.+Finzelauthor=X.+Jiaauthor=J.+T.+Guptonauthor=S.+L.+Mooberryauthor=G.+E.+Kellogg&title=Developing+novel+C-4+analogues+of+pyrrole-based+antitubulin+agents%3A+weak+but+critical+hydrogen+bonding+in+the+colchicine+site&doi=10.1039%2Fc2md20320k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1039%2Fc2md20320k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20320k%26sid%3Dliteratum%253Aachs%26aulast%3DDa%26aufirst%3DC.%26aulast%3DTelang%26aufirst%3DN.%26aulast%3DHall%26aufirst%3DK.%26aulast%3DKluball%26aufirst%3DE.%26aulast%3DBarelli%26aufirst%3DP.%26aulast%3DFinzel%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DGupton%26aufirst%3DJ.%2BT.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DKellogg%26aufirst%3DG.%2BE.%26atitle%3DDeveloping%2520novel%2520C-4%2520analogues%2520of%2520pyrrole-based%2520antitubulin%2520agents%253A%2520weak%2520but%2520critical%2520hydrogen%2520bonding%2520in%2520the%2520colchicine%2520site%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D417%26epage%3D421%26doi%3D10.1039%2Fc2md20320k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lun Wang, Yunhua Zheng, Dan Li, Jianhong Yang, Lei Lei, Wei Yan, Wei Zheng, Minghai Tang, Mingsong Shi, Ruijia Zhang, Xiaoying Cai, Hengfan Ni, Xu Ma, Na Li, Feng Hong, Haoyu Ye, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8127-8141. <a href="https://doi.org/10.1021/acs.jmedchem.0c01961" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01961%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBioactivity%252BEvaluation%252Bof%252BDual-Target%252BInhibitors%252Bof%252BTubulin%252Band%252BSrc%252BKinase%252BGuided%252Bby%252BCrystal%252BStructure%26aulast%3DWang%26aufirst%3DLun%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12112020%26date%3D03062021%26volume%3D64%26issue%3D12%26spage%3D8127%26epage%3D8141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ying-Jie Cui, Chao Liu, Chen-Chen Ma, Ya-Ting Ji, Yi-Li Yao, Long-Qian Tang, Cheng-Mei Zhang, Jing-De Wu, <span class="NLM_string-name hlFld-ContribAuthor">Zhao-Peng Liu</span>. </span><span class="cited-content_cbyCitation_article-title">SAR Investigation and Discovery of Water-Soluble 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as Potent Tubulin Polymerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14840-14866. <a href="https://doi.org/10.1021/acs.jmedchem.0c01345" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01345%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSAR%252BInvestigation%252Band%252BDiscovery%252Bof%252BWater-Soluble%252B1-Methyl-1%25252C4-dihydroindeno%25255B1%25252C2-c%25255Dpyrazoles%252Bas%252BPotent%252BTubulin%252BPolymerization%252BInhibitors%26aulast%3DCui%26aufirst%3DYing-Jie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01082020%26date%3D17112020%26volume%3D63%26issue%3D23%26spage%3D14840%26epage%3D14866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dinabandhu Sar, Indrajit Srivastava, Santosh K. Misra, Fatemeh Ostadhossein, Parinaz Fathi, <span class="NLM_string-name hlFld-ContribAuthor">Dipanjan Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Syntheses of Pyrene-Pyrazole Pharmacophores and Structure Activity Studies for Tubulin Polymerization. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (6)
                                     , 6378-6387. <a href="https://doi.org/10.1021/acsomega.8b00320" title="DOI URL">https://doi.org/10.1021/acsomega.8b00320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b00320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b00320%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DCopper-Catalyzed%252BSyntheses%252Bof%252BPyrene-Pyrazole%252BPharmacophores%252Band%252BStructure%252BActivity%252BStudies%252Bfor%252BTubulin%252BPolymerization%26aulast%3DSar%26aufirst%3DDinabandhu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22022018%26date%3D05062018%26volume%3D3%26issue%3D6%26spage%3D6378%26epage%3D6387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanqing  Pang</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Lanlan  Lou</span>, <span class="hlFld-ContribAuthor ">Junsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, and <span class="hlFld-ContribAuthor ">Sheng  Yin</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7300-7314. <a href="https://doi.org/10.1021/acs.jmedchem.7b00480" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00480%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BSelenium-Containing%252BIsocombretastatins%252Band%252BPhenstatins%252Bas%252BAntitumor%252BAgents%26aulast%3DPang%26aufirst%3DYanqing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D31032017%26date%3D23082017%26date%3D14092017%26date%3D09082017%26volume%3D60%26issue%3D17%26spage%3D7300%26epage%3D7314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaochao  Huang</span>, <span class="hlFld-ContribAuthor ">Rizhen  Huang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>, <span class="hlFld-ContribAuthor ">Zhimei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhixin  Liao</span>, and <span class="hlFld-ContribAuthor ">Hengshan  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (9)
                                     , 2132-2148. <a href="https://doi.org/10.1021/acs.bioconjchem.6b00353" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.6b00353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.6b00353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.6b00353%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DCombretastatin%252BA-4%252BAnalogue%25253A%252BA%252BDual-Targeting%252Band%252BTubulin%252BInhibitor%252BContaining%252BAntitumor%252BPt%252528IV%252529%252BMoiety%252Bwith%252Ba%252BUnique%252BMode%252Bof%252BAction%26aulast%3DHuang%26aufirst%3DXiaochao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29062016%26date%3D27072016%26date%3D15082016%26date%3D21092016%26date%3D05082016%26volume%3D27%26issue%3D9%26spage%3D2132%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janet Sabina  Xavier</span>, <span class="hlFld-ContribAuthor ">Karthikeyan  Jayabalan</span>, <span class="hlFld-ContribAuthor ">V.  Ragavendran</span>, <span class="hlFld-ContribAuthor ">Muthu Tamizh  Manoharan</span>, <span class="hlFld-ContribAuthor ">A.  Nityananda Shetty</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual and experimental high throughput screening of substituted hydrazones on β-Tubulin polymerization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105094. <a href="https://doi.org/10.1016/j.bioorg.2021.105094" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DVirtual%252Band%252Bexperimental%252Bhigh%252Bthroughput%252Bscreening%252Bof%252Bsubstituted%252Bhydrazones%252Bon%252B%2525CE%2525B2-Tubulin%252Bpolymerization%26aulast%3DXavier%26aufirst%3DJanet%2BSabina%26date%3D2021%26volume%3D114%26spage%3D105094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moran  Sun</span>, <span class="hlFld-ContribAuthor ">Yixin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinling  Qin</span>, <span class="hlFld-ContribAuthor ">Mengyu  Ba</span>, <span class="hlFld-ContribAuthor ">Yongfang  Yao</span>, <span class="hlFld-ContribAuthor ">Yongtao  Duan</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>, <span class="hlFld-ContribAuthor ">Dequan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 104988. <a href="https://doi.org/10.1016/j.bioorg.2021.104988" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104988%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B2-methoxyestradiol%252Bderivatives%25253A%252BPotent%252Binhibitors%252Bof%252Bangiogenesis%252Band%252Btubulin%252Bpolymerization%26aulast%3DSun%26aufirst%3DMoran%26date%3D2021%26volume%3D113%26spage%3D104988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xian-Sen  Huo</span>, <span class="hlFld-ContribAuthor ">Xie-Er  Jian</span>, <span class="hlFld-ContribAuthor ">Jie  Ou-Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Dong-Xin  Lv</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Jin-Jun  Rao</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113449. <a href="https://doi.org/10.1016/j.ejmech.2021.113449" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113449%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bhighly%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure-activity%252Brelationships%252Bof%252Bnovel%252B2%25252C7-diaryl-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyrimidines%26aulast%3DHuo%26aufirst%3DXian-Sen%26date%3D2021%26volume%3D220%26spage%3D113449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linghua  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuqin  Jiang</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of tetracyclic indenopyrazolopyrazolones through cascade reactions of aryl azomethine imines with propargyl alcohols. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (14)
                                     , 3734-3739. <a href="https://doi.org/10.1039/D1QO00025J" title="DOI URL">https://doi.org/10.1039/D1QO00025J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00025J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00025J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthesis%252Bof%252Btetracyclic%252Bindenopyrazolopyrazolones%252Bthrough%252Bcascade%252Breactions%252Bof%252Baryl%252Bazomethine%252Bimines%252Bwith%252Bpropargyl%252Balcohols%26aulast%3DZhang%26aufirst%3DLinghua%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D14%26spage%3D3734%26epage%3D3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irfan  Khan</span>, <span class="hlFld-ContribAuthor ">Thipparapu  Ganapathi</span>, <span class="hlFld-ContribAuthor ">MD. Muzaffar-ur-  Rehman</span>, <span class="hlFld-ContribAuthor ">Mohd Adil  Shareef</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">New indenopyrazole linked oxadiazole conjugates as anti-pancreatic cancer agents: Design, synthesis, in silico studies including 3D-QSAR analysis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>44 </em>, 128094. <a href="https://doi.org/10.1016/j.bmcl.2021.128094" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bindenopyrazole%252Blinked%252Boxadiazole%252Bconjugates%252Bas%252Banti-pancreatic%252Bcancer%252Bagents%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bin%252Bsilico%252Bstudies%252Bincluding%252B3D-QSAR%252Banalysis%26aulast%3DKhan%26aufirst%3DIrfan%26date%3D2021%26volume%3D44%26spage%3D128094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Man</span>, <span class="hlFld-ContribAuthor ">Zhuzhu  Wu</span>, <span class="hlFld-ContribAuthor ">Rui  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Guan</span>, <span class="hlFld-ContribAuthor ">Zengqiang  Li</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Weige  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingliang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">W436, a novel SMART derivative, exhibits anti‐hepatocarcinoma activity by inducing apoptosis and G2/M cell cycle arrest in vitro and in vivo and induces protective autophagy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biochemical and Molecular Toxicology</span><span> <strong>2021,</strong> <em>2 </em><a href="https://doi.org/10.1002/jbt.22831" title="DOI URL">https://doi.org/10.1002/jbt.22831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jbt.22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjbt.22831%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biochemical%2520and%2520Molecular%2520Toxicology%26atitle%3DW436%25252C%252Ba%252Bnovel%252BSMART%252Bderivative%25252C%252Bexhibits%252Banti%2525E2%252580%252590hepatocarcinoma%252Bactivity%252Bby%252Binducing%252Bapoptosis%252Band%252BG2%25252FM%252Bcell%252Bcycle%252Barrest%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Band%252Binduces%252Bprotective%252Bautophagy%26aulast%3DMan%26aufirst%3DShuai%26date%3D2021%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gopathi  Ramu</span>, <span class="hlFld-ContribAuthor ">Bheeshma Geetanjali  Kodiripaka</span>, <span class="hlFld-ContribAuthor ">Kalakonda  Raga Chaitanya</span>, <span class="hlFld-ContribAuthor ">Bathini  Nagendra Babu</span>. </span><span class="cited-content_cbyCitation_article-title">A facile and metal-free domino reaction of TsDAM and 2-alkenylarylaldehyde: An easy access to 8-hydroxy-2,8-dihydro indeno [2,1-
              c
              ]pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (18)
                                     , 4118-4125. <a href="https://doi.org/10.1039/D1OB00262G" title="DOI URL">https://doi.org/10.1039/D1OB00262G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00262G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00262G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bfacile%252Band%252Bmetal-free%252Bdomino%252Breaction%252Bof%252BTsDAM%252Band%252B2-alkenylarylaldehyde%25253A%252BAn%252Beasy%252Baccess%252Bto%252B8-hydroxy-2%25252C8-dihydro%252Bindeno%252B%25255B2%25252C1-%252Bc%252B%25255Dpyrazoles%26aulast%3DRamu%26aufirst%3DGopathi%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D18%26spage%3D4118%26epage%3D4125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaprak Dilber  Şimay Demir</span>, <span class="hlFld-ContribAuthor ">Aysun  Özdemir</span>, <span class="hlFld-ContribAuthor ">Reyhan Gönbe  Özdemir</span>, <span class="hlFld-ContribAuthor ">Setenay Cemre  Cevher</span>, <span class="hlFld-ContribAuthor ">Burcu  Çalışkan</span>, <span class="hlFld-ContribAuthor ">Mustafa  Ark</span>. </span><span class="cited-content_cbyCitation_article-title">Antimigratory effect of pyrazole derivatives through the induction of STAT1 phosphorylation in A549 cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2021,</strong> <em>73 </em>
                                    (6)
                                     , 808-815. <a href="https://doi.org/10.1093/jpp/rgab022" title="DOI URL">https://doi.org/10.1093/jpp/rgab022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jpp/rgab022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjpp%2Frgab022%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DAntimigratory%252Beffect%252Bof%252Bpyrazole%252Bderivatives%252Bthrough%252Bthe%252Binduction%252Bof%252BSTAT1%252Bphosphorylation%252Bin%252BA549%252Bcancer%252Bcells%26aulast%3D%25C5%259Eimay%2BDemir%26aufirst%3DYaprak%2BDilber%26date%3D2021%26date%3D2021%26volume%3D73%26issue%3D6%26spage%3D808%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Limei  Yang</span>, <span class="hlFld-ContribAuthor ">Yuchen  Tan</span>, <span class="hlFld-ContribAuthor ">Tiandong  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Dong-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113316. <a href="https://doi.org/10.1016/j.ejmech.2021.113316" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113316%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BN-benzylbenzamide%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Bactivities%26aulast%3DZhu%26aufirst%3DHuajian%26date%3D2021%26volume%3D216%26spage%3D113316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shibo  Lin</span>, <span class="hlFld-ContribAuthor ">Yuru  Liang</span>, <span class="hlFld-ContribAuthor ">Jiayi  Cheng</span>, <span class="hlFld-ContribAuthor ">Feng  Pan</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113256. <a href="https://doi.org/10.1016/j.ejmech.2021.113256" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113256%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bdiaryl-2H-azirines%25253A%252BAntitumor%252Bhybrids%252Bfor%252Bdual-targeting%252Btubulin%252Band%252BDNA%26aulast%3DLin%26aufirst%3DShibo%26date%3D2021%26volume%3D214%26spage%3D113256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yilin  Fang</span>, <span class="hlFld-ContribAuthor ">Zhilin  Wu</span>, <span class="hlFld-ContribAuthor ">Mengwu  Xiao</span>, <span class="hlFld-ContribAuthor ">Li  Wei</span>, <span class="hlFld-ContribAuthor ">Kangming  Li</span>, <span class="hlFld-ContribAuthor ">Yuting  Tang</span>, <span class="hlFld-ContribAuthor ">Jiao  Ye</span>, <span class="hlFld-ContribAuthor ">Jiannan  Xiang</span>, <span class="hlFld-ContribAuthor ">Aixi  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104469. <a href="https://doi.org/10.1016/j.bioorg.2020.104469" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104469%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnew%252B2-oxoquinoline%252Barylaminothiazole%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DFang%26aufirst%3DYilin%26date%3D2021%26volume%3D106%26spage%3D104469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fu‐Lian  Gong</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Lu‐Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Yi‐Fan  Dang</span>, <span class="hlFld-ContribAuthor ">Xiao‐Ning  Jiang</span>, <span class="hlFld-ContribAuthor ">Lin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiu‐Li  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">DHPAC, a novel microtubule depolymerizing agent, suppresses angiogenesis and vasculogenic mimicry formation of human non‐small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2020,</strong> <em>121 </em>
                                    (12)
                                     , 4756-4771. <a href="https://doi.org/10.1002/jcb.29690" title="DOI URL">https://doi.org/10.1002/jcb.29690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.29690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.29690%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DDHPAC%25252C%252Ba%252Bnovel%252Bmicrotubule%252Bdepolymerizing%252Bagent%25252C%252Bsuppresses%252Bangiogenesis%252Band%252Bvasculogenic%252Bmimicry%252Bformation%252Bof%252Bhuman%252Bnon%2525E2%252580%252590small%252Bcell%252Blung%252Bcancer%26aulast%3DGong%26aufirst%3DFu%25E2%2580%2590Lian%26date%3D2020%26date%3D2020%26volume%3D121%26issue%3D12%26spage%3D4756%26epage%3D4771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weifeng  Ma</span>, <span class="hlFld-ContribAuthor ">Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiansen  Huo</span>, <span class="hlFld-ContribAuthor ">Yufeng  Ma</span>, <span class="hlFld-ContribAuthor ">Yanhong  Li</span>, <span class="hlFld-ContribAuthor ">Pengcheng  Diao</span>, <span class="hlFld-ContribAuthor ">Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Shengquan  Zheng</span>, <span class="hlFld-ContribAuthor ">Mengjin  Hu</span>, <span class="hlFld-ContribAuthor ">Wenwei  You</span>, <span class="hlFld-ContribAuthor ">Peiliang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112847. <a href="https://doi.org/10.1016/j.ejmech.2020.112847" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112847%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Btriazolothiadiazine%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitors%25253A%252BStructure-activity%252Brelationship%25252C%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bstudy%26aulast%3DMa%26aufirst%3DWeifeng%26date%3D2020%26volume%3D208%26spage%3D112847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Xie-Er  Jian</span>, <span class="hlFld-ContribAuthor ">Peng-Cheng  Diao</span>, <span class="hlFld-ContribAuthor ">Xian-Sen  Huo</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112625. <a href="https://doi.org/10.1016/j.ejmech.2020.112625" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112625%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C6-diaryl-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyridine%252Banalogues%252Bas%252Bnew%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DYang%26aufirst%3DFang%26date%3D2020%26volume%3D204%26spage%3D112625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Xinnan  Li</span>, <span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Feijie  Xu</span>, <span class="hlFld-ContribAuthor ">Lixue  Lu</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Limei  Yang</span>, <span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112308. <a href="https://doi.org/10.1016/j.ejmech.2020.112308" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112308%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bproperties%252Bof%252Bisocombretapyridines%252Bas%252Bpotent%252Bcolchicine%252Bbinding%252Bsite%252Binhibitors%26aulast%3DShuai%26aufirst%3DWen%26date%3D2020%26volume%3D197%26spage%3D112308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Hu</span>, <span class="hlFld-ContribAuthor ">Lu  Li</span>, <span class="hlFld-ContribAuthor ">Qiangsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanzhan  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Xia</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103695. <a href="https://doi.org/10.1016/j.bioorg.2020.103695" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103695%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Btubulin%252Binhibitor%252BSKLB0565%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%26aulast%3DHu%26aufirst%3DXi%26date%3D2020%26volume%3D97%26spage%3D103695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanming  Wang</span>, <span class="hlFld-ContribAuthor ">Lianqi  Liu</span>, <span class="hlFld-ContribAuthor ">Shiyong  Fan</span>, <span class="hlFld-ContribAuthor ">Dian  Xiao</span>, <span class="hlFld-ContribAuthor ">Fei  Xie</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>, <span class="hlFld-ContribAuthor ">Xinbo  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (3)
                                     , 744. <a href="https://doi.org/10.3390/cancers12030744" title="DOI URL">https://doi.org/10.3390/cancers12030744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12030744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12030744%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DAntibody-Drug%252BConjugate%252BUsing%252BIonized%252BCys-Linker-MMAE%252Bas%252Bthe%252BPotent%252BPayload%252BShows%252BOptimal%252BTherapeutic%252BSafety%26aulast%3DWang%26aufirst%3DYanming%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing-De  Wu</span>, <span class="hlFld-ContribAuthor ">Ying-Jie  Cui</span>, <span class="hlFld-ContribAuthor ">Yi-Gang  Zhou</span>, <span class="hlFld-ContribAuthor ">Long-Qian  Tang</span>, <span class="hlFld-ContribAuthor ">Cheng-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2020,</strong> <em>38 </em>
                                    (1)
                                     , 29-38. <a href="https://doi.org/10.1007/s10637-019-00753-z" title="DOI URL">https://doi.org/10.1007/s10637-019-00753-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-019-00753-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-019-00753-z%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DTubulin%252Bcolchicine%252Bsite%252Bbinding%252Bagent%252BLL01%252Bdisplays%252Bpotent%252Bantitumor%252Befficiency%252Bboth%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bwith%252Bsuitable%252Bdrug-like%252Bproperties%26aulast%3DWu%26aufirst%3DJing-De%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D1%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Jie  Cui</span>, <span class="hlFld-ContribAuthor ">Chen-Chen  Ma</span>, <span class="hlFld-ContribAuthor ">Cheng-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Long-Qian  Tang</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111968. <a href="https://doi.org/10.1016/j.ejmech.2019.111968" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111968%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bnovel%252Bindazole%252Bderivatives%252Bas%252Btubulin%252Bcolchicine%252Bsite%252Bbinding%252Bagents%252Bthat%252Bdisplayed%252Bpotent%252Bantitumor%252Bactivity%252Bboth%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DCui%26aufirst%3DYing-Jie%26date%3D2020%26volume%3D187%26spage%3D111968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irfan  Khan</span>, <span class="hlFld-ContribAuthor ">Mohd Adil  Shareef</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on the synthetic and medicinal perspectives of indenopyrazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 1-12. <a href="https://doi.org/10.1016/j.ejmech.2019.05.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bon%252Bthe%252Bsynthetic%252Band%252Bmedicinal%252Bperspectives%252Bof%252Bindenopyrazoles%26aulast%3DKhan%26aufirst%3DIrfan%26date%3D2019%26volume%3D178%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subramani  Kandhasamy</span>, <span class="hlFld-ContribAuthor ">N.  Arthi</span>, <span class="hlFld-ContribAuthor ">Raj Pranap  Arun</span>, <span class="hlFld-ContribAuthor ">Rama Shanker  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and fabrication of novel quinone-based chromenopyrazole antioxidant-laden silk fibroin nanofibers scaffold for tissue engineering applications. </span><span class="cited-content_cbyCitation_journal-name">Materials Science and Engineering: C</span><span> <strong>2019,</strong> <em>102 </em>, 773-787. <a href="https://doi.org/10.1016/j.msec.2019.04.076" title="DOI URL">https://doi.org/10.1016/j.msec.2019.04.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.msec.2019.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.msec.2019.04.076%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Science%2520and%2520Engineering%253A%2520C%26atitle%3DSynthesis%252Band%252Bfabrication%252Bof%252Bnovel%252Bquinone-based%252Bchromenopyrazole%252Bantioxidant-laden%252Bsilk%252Bfibroin%252Bnanofibers%252Bscaffold%252Bfor%252Btissue%252Bengineering%252Bapplications%26aulast%3DKandhasamy%26aufirst%3DSubramani%26date%3D2019%26volume%3D102%26spage%3D773%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bensu  Karahalil</span>, <span class="hlFld-ContribAuthor ">Sevgi  Yardım-Akaydin</span>, <span class="hlFld-ContribAuthor ">Sultan  Nacak Baytas</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of microtubule targeting agents for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Archives of Industrial Hygiene and Toxicology</span><span> <strong>2019,</strong> <em>70 </em>
                                    (3)
                                     , 160-172. <a href="https://doi.org/10.2478/aiht-2019-70-3258" title="DOI URL">https://doi.org/10.2478/aiht-2019-70-3258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2478/aiht-2019-70-3258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2478%2Faiht-2019-70-3258%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Industrial%2520Hygiene%2520and%2520Toxicology%26atitle%3DAn%252Boverview%252Bof%252Bmicrotubule%252Btargeting%252Bagents%252Bfor%252Bcancer%252Btherapy%26aulast%3DKarahalil%26aufirst%3DBensu%26date%3D2019%26date%3D2019%26volume%3D70%26issue%3D3%26spage%3D160%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-He  Luo</span>, <span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Jian-Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Juan-Juan  Gao</span>, <span class="hlFld-ContribAuthor ">Xin-Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Zhao-Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino acid derivatives of 5-alkoxy-3,4-dihalo-2(5
              H
              )-furanones and their preliminary bioactivity investigation as linkers. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (20)
                                     , 5138-5147. <a href="https://doi.org/10.1039/C9OB00736A" title="DOI URL">https://doi.org/10.1039/C9OB00736A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00736A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00736A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bacid%252Bderivatives%252Bof%252B5-alkoxy-3%25252C4-dihalo-2%2525285%252BH%252B%252529-furanones%252Band%252Btheir%252Bpreliminary%252Bbioactivity%252Binvestigation%252Bas%252Blinkers%26aulast%3DLuo%26aufirst%3DShi-He%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D20%26spage%3D5138%26epage%3D5147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Yin</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Feijie  Xu</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Keguang  Cheng</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 380-390. <a href="https://doi.org/10.1016/j.bioorg.2018.10.027" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.10.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.10.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bquinazolines%252Bas%252Bpotential%252Banti-tubulin%252Bagents%252Boccupying%252Bthree%252Bzones%252Bof%252Bcolchicine%252Bdomain%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2019%26volume%3D83%26spage%3D380%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irfan  Khan</span>, <span class="hlFld-ContribAuthor ">Koteswara Rao  Garikapati</span>, <span class="hlFld-ContribAuthor ">Aravind  Setti</span>, <span class="hlFld-ContribAuthor ">Anver Basha  Shaik</span>, <span class="hlFld-ContribAuthor ">Venkata Krishna  Kanth Makani</span>, <span class="hlFld-ContribAuthor ">Mohd Adil  Shareef</span>, <span class="hlFld-ContribAuthor ">Hemshikha  Rajpurohit</span>, <span class="hlFld-ContribAuthor ">Namratha  Vangara</span>, <span class="hlFld-ContribAuthor ">Manika  Pal-Bhadra</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1,4-dihydroindeno[1,2-c]pyrazole chalcone as EGFR /Akt pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 636-648. <a href="https://doi.org/10.1016/j.ejmech.2018.12.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%252Bsilico%252Bpharmacokinetics%252Bprediction%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C4-dihydroindeno%25255B1%25252C2-c%25255Dpyrazole%252Bchalcone%252Bas%252BEGFR%252B%25252FAkt%252Bpathway%252Binhibitors%26aulast%3DKhan%26aufirst%3DIrfan%26date%3D2019%26volume%3D163%26spage%3D636%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Jie  Cui</span>, <span class="hlFld-ContribAuthor ">Long-Qian  Tang</span>, <span class="hlFld-ContribAuthor ">Cheng-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Pyrazole Derivatives and Their Tumor Cell Growth Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (2)
                                     , 279. <a href="https://doi.org/10.3390/molecules24020279" title="DOI URL">https://doi.org/10.3390/molecules24020279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24020279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24020279%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252BNovel%252BPyrazole%252BDerivatives%252Band%252BTheir%252BTumor%252BCell%252BGrowth%252BInhibitory%252BActivity%26aulast%3DCui%26aufirst%3DYing-Jie%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D2%26spage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Fan</span>, <span class="hlFld-ContribAuthor ">Xiang  Ma</span>, <span class="hlFld-ContribAuthor ">Ya-Juan  Qin</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 722-737. <a href="https://doi.org/10.1016/j.ejmech.2018.07.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bnicotinoyl%252Bpyrazoline%252Bderivates%252Bbearing%252BN-methyl%252Bindole%252Bmoiety%252Bas%252Bantitumor%252Bagents%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bevaluation%26aulast%3DChen%26aufirst%3DKun%26date%3D2018%26volume%3D156%26spage%3D722%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Di  Yang</span>, <span class="hlFld-ContribAuthor ">Zexin  Hong</span>, <span class="hlFld-ContribAuthor ">Su  Guo</span>, <span class="hlFld-ContribAuthor ">Moyi  Liu</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Dandan  Ge</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Deyu  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4,6-diphenyl-2-(1H-pyrrol-1-yl)nicotinonitrile analogues of crolibulin and combretastatin A-4. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 185-193. <a href="https://doi.org/10.1016/j.ejmech.2018.01.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4%25252C6-diphenyl-2-%2525281H-pyrrol-1-yl%252529nicotinonitrile%252Banalogues%252Bof%252Bcrolibulin%252Band%252Bcombretastatin%252BA-4%26aulast%3DLiu%26aufirst%3DYajing%26date%3D2018%26volume%3D146%26spage%3D185%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Zi-Lin  Hu</span>, <span class="hlFld-ContribAuthor ">Ren-Hao  Li</span>, <span class="hlFld-ContribAuthor ">Yi-Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Zhuang-Ping  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole synthesis
              via
              a cascade Sonogashira coupling/cyclization of
              N
              -propargyl sulfonylhydrazones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (2)
                                     , 197-201. <a href="https://doi.org/10.1039/C7OB02576A" title="DOI URL">https://doi.org/10.1039/C7OB02576A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02576A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02576A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPyrazole%252Bsynthesis%252Bvia%252Ba%252Bcascade%252BSonogashira%252Bcoupling%25252Fcyclization%252Bof%252BN%252B-propargyl%252Bsulfonylhydrazones%26aulast%3DYang%26aufirst%3DYing%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D2%26spage%3D197%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Bing  Xin</span>, <span class="hlFld-ContribAuthor ">Jia-Jun  Li</span>, <span class="hlFld-ContribAuthor ">Hong-Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Ma</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Gong</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterisation of (
              Z
              )-styrylbenzene derivatives as potential selective anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1554-1564. <a href="https://doi.org/10.1080/14756366.2018.1513925" title="DOI URL">https://doi.org/10.1080/14756366.2018.1513925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1513925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1513925%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bcharacterisation%252Bof%252B%252528%252BZ%252B%252529-styrylbenzene%252Bderivatives%252Bas%252Bpotential%252Bselective%252Banticancer%252Bagents%26aulast%3DXin%26aufirst%3DYa-Bing%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1554%26epage%3D1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Fu-Lian  Gong</span>, <span class="hlFld-ContribAuthor ">Zhen-Ning  Lu</span>, <span class="hlFld-ContribAuthor ">Hong-Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Na  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Lu-Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Hui-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiu-Li  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">DHPAC, a novel synthetic microtubule destabilizing agent, possess high anti-tumor activity in vincristine-resistant oral epidermoid carcinoma in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">The International Journal of Biochemistry & Cell Biology</span><span> <strong>2017,</strong> <em>93 </em>, 1-11. <a href="https://doi.org/10.1016/j.biocel.2017.10.012" title="DOI URL">https://doi.org/10.1016/j.biocel.2017.10.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biocel.2017.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biocel.2017.10.012%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520International%2520Journal%2520of%2520Biochemistry%2520%2526%2520Cell%2520Biology%26atitle%3DDHPAC%25252C%252Ba%252Bnovel%252Bsynthetic%252Bmicrotubule%252Bdestabilizing%252Bagent%25252C%252Bpossess%252Bhigh%252Banti-tumor%252Bactivity%252Bin%252Bvincristine-resistant%252Boral%252Bepidermoid%252Bcarcinoma%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DZhang%26aufirst%3DYing%26date%3D2017%26volume%3D93%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Ling  Fu</span>, <span class="hlFld-ContribAuthor ">Ying-Chao  Liu</span>, <span class="hlFld-ContribAuthor ">Jun-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Bing-Kai  Han</span>, <span class="hlFld-ContribAuthor ">Xiao-Rui  Li</span>, <span class="hlFld-ContribAuthor ">Chuang  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Song</span>, <span class="hlFld-ContribAuthor ">Bing  Zhao</span>, <span class="hlFld-ContribAuthor ">Ruo-Wang  Mao</span>, <span class="hlFld-ContribAuthor ">Ruo-Han  Zhao</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-12912-4" title="DOI URL">https://doi.org/10.1038/s41598-017-12912-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-12912-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-12912-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DStructure-Activity%252BRelationship%252BStudies%252Bof%252B%2525CE%2525B2-Lactam-azide%252BAnalogues%252Bas%252BOrally%252BActive%252BAntitumor%252BAgents%252BTargeting%252Bthe%252BTubulin%252BColchicine%252BSite%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Shao-Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Xiu-Li  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2017,</strong> <em>96 </em>, 659-666. <a href="https://doi.org/10.1016/j.biopha.2017.10.041" title="DOI URL">https://doi.org/10.1016/j.biopha.2017.10.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2017.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2017.10.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DNew%252Binsights%252Binto%252BVinca%252Balkaloids%252Bresistance%252Bmechanism%252Band%252Bcircumvention%252Bin%252Blung%252Bcancer%26aulast%3DZhang%26aufirst%3DYing%26date%3D2017%26volume%3D96%26spage%3D659%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anver Basha  Shaik</span>, <span class="hlFld-ContribAuthor ">Garikapati Koteswara  Rao</span>, <span class="hlFld-ContribAuthor ">G. Bharath  Kumar</span>, <span class="hlFld-ContribAuthor ">Nibeditha  Patel</span>, <span class="hlFld-ContribAuthor ">Vangala Santhosh  Reddy</span>, <span class="hlFld-ContribAuthor ">Irfan  Khan</span>, <span class="hlFld-ContribAuthor ">Sunitha Rani  Routhu</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Immadi  Veena</span>, <span class="hlFld-ContribAuthor ">Kunta  Chandra Shekar</span>, <span class="hlFld-ContribAuthor ">Madan  Barkume</span>, <span class="hlFld-ContribAuthor ">Shailesh  Jadhav</span>, <span class="hlFld-ContribAuthor ">Aarti  Juvekar</span>, <span class="hlFld-ContribAuthor ">Jyoti  Kode</span>, <span class="hlFld-ContribAuthor ">Manika  Pal-Bhadra</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 305-324. <a href="https://doi.org/10.1016/j.ejmech.2017.07.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrazolochalcones%252Bas%252Bpotential%252Bmodulators%252Bof%252BPI3K%25252FAkt%25252FmTOR%252Bpathway%252Band%252Binducers%252Bof%252Bapoptosis%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DShaik%26aufirst%3DAnver%2BBasha%26date%3D2017%26volume%3D139%26spage%3D305%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Cheng  Wu</span>, <span class="hlFld-ContribAuthor ">Shi-He  Luo</span>, <span class="hlFld-ContribAuthor ">Wen-Jie  Mei</span>, <span class="hlFld-ContribAuthor ">Liang  Cao</span>, <span class="hlFld-ContribAuthor ">Han-Qing  Wu</span>, <span class="hlFld-ContribAuthor ">Zhao-Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4-biphenylamino-5-halo-2( 5H )-furanones as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 84-94. <a href="https://doi.org/10.1016/j.ejmech.2017.08.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-biphenylamino-5-halo-2%252528%252B5H%252B%252529-furanones%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DWu%26aufirst%3DYan-Cheng%26date%3D2017%26volume%3D139%26spage%3D84%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Honghao  Sun</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (15)
                                     , 1765-1794. <a href="https://doi.org/10.4155/fmc-2017-0100" title="DOI URL">https://doi.org/10.4155/fmc-2017-0100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0100%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTubulin%252Binhibitors%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%25253A%252Ba%252Bperspective%252Bof%252Bprivileged%252Bstructures%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2017%26volume%3D9%26issue%3D15%26spage%3D1765%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rasha Z.  Batran</span>, <span class="hlFld-ContribAuthor ">Dina H.  Dawood</span>, <span class="hlFld-ContribAuthor ">Samia A.  El-Seginy</span>, <span class="hlFld-ContribAuthor ">Mamdouh M.  Ali</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Maher</span>, <span class="hlFld-ContribAuthor ">Kuljeet S.  Gugnani</span>, <span class="hlFld-ContribAuthor ">Alejandro N.  Rondon-Ortiz</span>. </span><span class="cited-content_cbyCitation_article-title">New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (9)
                                     , 1700064. <a href="https://doi.org/10.1002/ardp.201700064" title="DOI URL">https://doi.org/10.1002/ardp.201700064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700064%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DNew%252BCoumarin%252BDerivatives%252Bas%252BAnti-Breast%252Band%252BAnti-Cervical%252BCancer%252BAgents%252BTargeting%252BVEGFR-2%252Band%252Bp38%2525CE%2525B1%252BMAPK%26aulast%3DBatran%26aufirst%3DRasha%2BZ.%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D9%26spage%3D1700064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaochao  Huang</span>, <span class="hlFld-ContribAuthor ">Rizhen  Huang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>, <span class="hlFld-ContribAuthor ">Zhimei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhixin  Liao</span>, <span class="hlFld-ContribAuthor ">Hengshan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (17)
                                     , 4686-4700. <a href="https://doi.org/10.1016/j.bmc.2017.07.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPlatinum%252528IV%252529%252Bcomplexes%252Bconjugated%252Bwith%252Bphenstatin%252Banalogue%252Bas%252Binhibitors%252Bof%252Bmicrotubule%252Bpolymerization%252Band%252Breverser%252Bof%252Bmultidrug%252Bresistance%26aulast%3DHuang%26aufirst%3DXiaochao%26date%3D2017%26volume%3D25%26issue%3D17%26spage%3D4686%26epage%3D4700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara Man  Kadayat</span>, <span class="hlFld-ContribAuthor ">Suhrid  Banskota</span>, <span class="hlFld-ContribAuthor ">Pallavi  Gurung</span>, <span class="hlFld-ContribAuthor ">Ganesh  Bist</span>, <span class="hlFld-ContribAuthor ">Til Bahadur  Thapa Magar</span>, <span class="hlFld-ContribAuthor ">Aarajana  Shrestha</span>, <span class="hlFld-ContribAuthor ">Jung-Ae  Kim</span>, <span class="hlFld-ContribAuthor ">Eung-Seok  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1 H -inden-1-one and benzofuran-3(2 H )-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>137 </em>, 575-597. <a href="https://doi.org/10.1016/j.ejmech.2017.06.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bstructure-activity%252Brelationship%252Bstudies%252Bof%252B2-benzylidene-2%25252C3-dihydro-1%252BH%252B-inden-1-one%252Band%252Bbenzofuran-3%2525282%252BH%252B%252529-one%252Bderivatives%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotential%252Btherapeutics%252Bfor%252Binflammatory%252Bbowel%252Bdisease%26aulast%3DKadayat%26aufirst%3DTara%2BMan%26date%3D2017%26volume%3D137%26spage%3D575%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Xiaoqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Tianfang  Zeng</span>, <span class="hlFld-ContribAuthor ">Xiuxiu  Yang</span>, <span class="hlFld-ContribAuthor ">Tongfei  Jing</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep43398" title="DOI URL">https://doi.org/10.1038/srep43398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep43398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep43398%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BNovel%252B5-Indolyl-7-arylimidazo%25255B1%25252C2-a%25255Dpyridine-8-carbonitrile%252BDerivatives%252Bas%252BPotent%252BAntitubulin%252BAgents%252BTargeting%252BColchicine-binding%252BSite%26aulast%3DZhai%26aufirst%3DXin%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shun  Zhang</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis and evaluation of new benzophenone derivatives as tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (91)
                                     , 88453-88462. <a href="https://doi.org/10.1039/C6RA16948A" title="DOI URL">https://doi.org/10.1039/C6RA16948A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA16948A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA16948A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DThe%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bbenzophenone%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DZhang%26aufirst%3DShun%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D91%26spage%3D88453%26epage%3D88462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Colchicine site ligands (<b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b> and the designed indenopyrazoles) with their binding modes with tubulin (zone 1 in red, zone 2 in blue, zone 3 in pink, the predicted new binding region in zone 1 in green, and the bridge in thin black).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1-Methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles <b>6a</b>–<b>p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (EtO)<sub>2</sub>SO<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C, 9 h; (b) TBSCl, imidazole, DMF, 1 h; (c) LHMDS, 3-EtOPhNCS, THF, −78 °C to rt, 16 h; (d) CH<sub>3</sub>NHNH<sub>2</sub>, 1,4-dioxane/EtOH (1:1), 0 °C to rt, 84 h; (e) TBAF, THF, 1 h; (f) ClCH<sub>2</sub>CO<sub>2</sub>Me, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 14 h; (g) R<sup>1</sup>R<sup>2</sup>NH, MeOH, reflux, 1–12 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Growth inhibitory effects of <b>6a</b> on NSCLC cell lines by colony formation assay and trypan blue staining. Representative colony formation images on A549 cells (A) and NCI-H460 cells (B) after exposed to <b>6a</b> for 9 days. The results were denoted as a percentage of the vehicle-treated cells. (C) The cytotoxicity of <b>6a</b> on A549 cells was estimated by trypan blue exclusion. After exposed to <b>6a</b> for 24 h, A549 cells were harvested and stained with trypan blue solution. Arrows indicated the dead cells. The results were expressed as a percentage based on the ratio of the number of viable treated cells to that of vehicle control. Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>6a</b> and <b>6n</b> on tubulin polymerization in vitro. Purified tubulin protein at 2 mg/mL in a reaction buffer was incubated at 37 °C in the presence of 1% DMSO, test compounds (<b>6a</b> or <b>6n</b> at 1.25, 2.5, 5, or 10 μM) or <b>1</b> (20 μM). Polymerizations were followed by an increase in fluorescence emission at 460 nm over a 60 min period at 37 °C. The experiments were performed three times.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of <b>6a</b> on the organizations of cellular microtubule network. A549 cells were treated with (a) 0.1% DMSO, (b) <b>6a</b> (40 nM), (c) <b>1</b> (40 nM) for 24 h. Microtubules were visualized with an anti-α-tubulin antibody (red), and the cell nucleus was visualized with Hoechst 33342 (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking of <b>6a</b> (gray) and <b>1</b> (green) into the tubulin colchicine binding site and overlapping with <b>5</b> (red). In comparison with <b>1</b>, which only occupied the zones 1 and 2, <b>6a</b> formed hydrophobic interaction with all the three zones. In addition, the 7-oxoacetamide substituent occupied an additional region in zone 1, and its amide nitrogen formed critical hydrogen bonding with Serα178 at the interfacial surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Effects of <b>6a</b> on A549 cell cycle progress. Cells were treated with different concentrations of <b>6a</b> or <b>1</b> (40 nM) for 24 h and then analyzed by flow cytometry. (B) Effects of <b>6a</b> on G2/M regulatory protein. A549 cells were treated for 24 h with the indicated concentration of <b>6a</b>. The cells were harvested and lysed for the detection of cyclin B1, p-cdc2. Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>6a</b> induces cell apoptosis. Exposed to <b>6a</b> or <b>1</b> at 40 nM for 24 h, A549 and NCI-H460 cellular (A) and nuclear (B) morphological changes were imaged. Arrows indicated characteristics of apoptotic cells. (C) Detection of apoptotic cells after Annexin-V/PI staining by flow cytometry analysis. Exposed to <b>6a</b> or <b>1</b> for 24 h, A549 cells were harvested and stained with Annexin-V/PI for analysis. The different cell stages were assigned as live (Q1-LL), early apoptotic (Q1-LR), late apoptotic (Q1-UR), and necrotic cells (Q1-UL). (D) Western blotting analysis of the expression of cleaved caspase-3 and cleaved PARP. Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>6a</b> inhibits capillary tube formation of HUVECs. HUVECs were plated on Matrigel and allowed to form capillary tubes followed by exposure to different concentrations of compound <b>6a</b>. HUVECs were seeded into 96-well plate which had been precoated with Matrigel and incubated with <b>6a</b> for 8 h. Cultures were photographed, and the number of capillary tube networks was counted under a microscope (original magnification of 100×). Data are presented as mean ± SD from three independent experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/medium/jm-2016-00071k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <b>6a</b> inhibits the growth of human NSCLC xenografts in athymic mice. The images (A) and weights (B) of excised tumors from each group. Inhibition rates were defined as a percentage of vehicle-treated tumor weight. The tumor volumes (C) and body weights (D) were detected every 3 days. Data are presented as mean ± SD of 6 mice. *<i>P</i> < 0.05 vs the vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-11/acs.jmedchem.6b00071/20160603/images/large/jm-2016-00071k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00071&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Heald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogales, E.</span><span> </span><span class="NLM_article-title">Microtubule dynamics</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=11801717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVejsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2002&pages=3-4&author=R.+Healdauthor=E.+Nogales&title=Microtubule+dynamics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule dynamics</span></div><div class="casAuthors">Heald, Rebecca; Nogales, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-4</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDLiwcMnFurbVg90H21EOLACvtfcHk0lgcTXKp7J2a2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVejsg%253D%253D&md5=6a9501a826ccf37961fda924297e75b7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeald%26aufirst%3DR.%26aulast%3DNogales%26aufirst%3DE.%26atitle%3DMicrotubule%2520dynamics%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2002%26volume%3D115%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">McIntosh, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grishchuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R. R.</span><span> </span><span class="NLM_article-title">Chromosome–microtubule interactions during mitosis</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1146/annurev.cellbio.18.032002.132412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1146%2Fannurev.cellbio.18.032002.132412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=193-219&author=J.+R.+McIntoshauthor=E.+Grishchukauthor=R.+R.+West&title=Chromosome%E2%80%93microtubule+interactions+during+mitosis&doi=10.1146%2Fannurev.cellbio.18.032002.132412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.18.032002.132412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.18.032002.132412%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DJ.%2BR.%26aulast%3DGrishchuk%26aufirst%3DE.%26aulast%3DWest%26aufirst%3DR.%2BR.%26atitle%3DChromosome%25E2%2580%2593microtubule%2520interactions%2520during%2520mitosis%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2002%26volume%3D18%26spage%3D193%26epage%3D219%26doi%3D10.1146%2Fannurev.cellbio.18.032002.132412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Vindya, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethiraj, K. R.</span><span> </span><span class="NLM_article-title">Tubulins–the target for anticancer therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.2174/1568026615666150112115805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F1568026615666150112115805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=25579568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=73-82&author=N.+G.+Vindyaauthor=N.+Sharmaauthor=M.+Yadavauthor=K.+R.+Ethiraj&title=Tubulins%E2%80%93the+target+for+anticancer+therapy&doi=10.2174%2F1568026615666150112115805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulins - The Target for Anticancer Therapy</span></div><div class="casAuthors">Vindya, N. G.; Sharma, Nishant; Yadav, Mukesh; Ethiraj, K. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Tubulin has picked up great focus as a major target in drug discovery and consequently, tubulin inhibitors have pulling in a considerable attention as anticancer agents.  Numerable naturally occurring agents have focused on tubulin system act as an imperative target of cancer chemotherapy.  Substantial no. of tubulin inhibitors has been discovered so far and these agents are classified as indicated by their interaction.  They are colchicine site binder, vinca- alkaloid related drugs and those interacting with the Taxol binding site and functioning as stabilizing agents.  We review the recent advances in the advancement of tubulin interfering agents and will render the current trend in the improvement of tubulin inhibitors as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tIyc1PffELVg90H21EOLACvtfcHk0lgcTXKp7J2a2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKgsbo%253D&md5=8805a32e1f038693336ceb464c67193d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150112115805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150112115805%26sid%3Dliteratum%253Aachs%26aulast%3DVindya%26aufirst%3DN.%2BG.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DYadav%26aufirst%3DM.%26aulast%3DEthiraj%26aufirst%3DK.%2BR.%26atitle%3DTubulins%25E2%2580%2593the%2520target%2520for%2520anticancer%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D73%26epage%3D82%26doi%3D10.2174%2F1568026615666150112115805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Barbier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsvetkov, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuzard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devred, F.</span><span> </span><span class="NLM_article-title">Deciphering the molecular mechanisms of anti-tubulin plant derived drugs</span> <span class="citation_source-journal">Phytochem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1007/s11101-013-9302-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1007%2Fs11101-013-9302-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislCksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=157-169&author=P.+Barbierauthor=P.+O.+Tsvetkovauthor=G.+Breuzardauthor=F.+Devred&title=Deciphering+the+molecular+mechanisms+of+anti-tubulin+plant+derived+drugs&doi=10.1007%2Fs11101-013-9302-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the molecular mechanisms of anti-tubulin plant derived drugs</span></div><div class="casAuthors">Barbier, P.; Tsvetkov, P. O.; Breuzard, G.; Devred, F.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-169</span>CODEN:
                <span class="NLM_cas:coden">PRHEBS</span>;
        ISSN:<span class="NLM_cas:issn">1568-7767</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Even though commercialized anticancer drugs are now produced by pharmaceutical companies, most of them were originally obtained from natural sources, and more particularly from plants.  Indeed, many structurally diverse compds. isolated from plants or marine flora have been purified and synthesized for their anticancer bioactivity.  Among these, several mols. belong to the class of anticancer drugs which target the microtubule cytoskeleton, either by stabilizing it or destabilizing it.  To characterize the activity of these drugs and to understand in which physiol. context they are more likely to be used as therapeutic agents, it is necessary to fully det. their interaction with tubulin.  Understanding the mol. basis of their effects on microtubule cytoskeleton is an important step in designing analogs with greater pharmacol. activity and with fewer side effects.  In addn., knowing the mol. mechanism of action of each drug that is already used in chemotherapy protocols will also help to find strategies to circumvent resistance.  By taking examples of known anti-tubulin plant derived drugs, we show how identification of microtubule targeting agents and further characterization of their activity can be achieved combining biophys. and biochem. approaches.  We also illustrate how continuing in depth study of mols. with already known primary mechanisms of action can lead to the discovery of new targets or biomarkers which can open new perspectives in anticancer strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi3RE25Y1WjLVg90H21EOLACvtfcHk0lhT9z6Vlbp8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislCksb0%253D&md5=080159383138e7ed1f86783ed272d360</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs11101-013-9302-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11101-013-9302-8%26sid%3Dliteratum%253Aachs%26aulast%3DBarbier%26aufirst%3DP.%26aulast%3DTsvetkov%26aufirst%3DP.%2BO.%26aulast%3DBreuzard%26aufirst%3DG.%26aulast%3DDevred%26aufirst%3DF.%26atitle%3DDeciphering%2520the%2520molecular%2520mechanisms%2520of%2520anti-tubulin%2520plant%2520derived%2520drugs%26jtitle%3DPhytochem.%2520Rev.%26date%3D2014%26volume%3D13%26spage%3D157%26epage%3D169%26doi%3D10.1007%2Fs11101-013-9302-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mukhtar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhami, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhtar, H.</span><span> </span><span class="NLM_article-title">Targeting microtubules by natural agents for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1158%2F1535-7163.MCT-13-0791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=24435445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=275-284&author=E.+Mukhtarauthor=V.+M.+Adhamiauthor=H.+Mukhtar&title=Targeting+microtubules+by+natural+agents+for+cancer+therapy&doi=10.1158%2F1535-7163.MCT-13-0791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Microtubules by Natural Agents for Cancer Therapy</span></div><div class="casAuthors">Mukhtar, Eiman; Adhami, Vaqar Mustafa; Mukhtar, Hasan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-284</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Natural compds. that target microtubules and disrupt the normal function of the mitotic spindle have proven to be one of the best classes of cancer chemotherapeutic drugs available in clinics to date.  There is increasing evidence showing that even minor alteration of microtubule dynamics can engage the spindle checkpoint, arresting cell-cycle progression at mitosis and subsequently leading to cell death.  Our improved understanding of tumor biol. and our continued appreciation for what the microtubule targeting agents (MTAs) can do have helped pave the way for a new era in the treatment of cancer.  The effectiveness of these agents for cancer therapy has been impaired, however, by various side effects and drug resistance.  Several new MTAs have shown potent activity against the proliferation of various cancer cells, including resistance to the existing MTAs.  Sustained investigation of the mechanisms of action of MTAs, development and discovery of new drugs, and exploring new treatment strategies that reduce side effects and circumvent drug resistance could provide more effective therapeutic options for patients with cancer.  This review focuses on the successful cancer chemotherapy from natural compds. in clin. settings and the challenges that may abort their usefulness.  Mol Cancer Ther; 13(2); 275-84. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSZOcnk6gaB7Vg90H21EOLACvtfcHk0lhT9z6Vlbp8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWmsLg%253D&md5=0a14655cff81c9d3a73c0b4514e45112</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0791%26sid%3Dliteratum%253Aachs%26aulast%3DMukhtar%26aufirst%3DE.%26aulast%3DAdhami%26aufirst%3DV.%2BM.%26aulast%3DMukhtar%26aufirst%3DH.%26atitle%3DTargeting%2520microtubules%2520by%2520natural%2520agents%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D275%26epage%3D284%26doi%3D10.1158%2F1535-7163.MCT-13-0791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nepali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, P. M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, K. L.</span><span> </span><span class="NLM_article-title">Tubulin inhibitors: A patent survey</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.2174/15748928113089990042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F15748928113089990042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=176-220&author=K.+Nepaliauthor=R.+Ojhaauthor=S.+Sharmaauthor=P.+M.+S.+Bediauthor=K.+L.+Dhar&title=Tubulin+inhibitors%3A+A+patent+survey&doi=10.2174%2F15748928113089990042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F15748928113089990042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15748928113089990042%26sid%3Dliteratum%253Aachs%26aulast%3DNepali%26aufirst%3DK.%26aulast%3DOjha%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBedi%26aufirst%3DP.%2BM.%2BS.%26aulast%3DDhar%26aufirst%3DK.%2BL.%26atitle%3DTubulin%2520inhibitors%253A%2520A%2520patent%2520survey%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D176%26epage%3D220%26doi%3D10.2174%2F15748928113089990042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Prota, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargsten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurwerra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Díaz, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetz, M. O.</span><span> </span><span class="NLM_article-title">Molecular mechanism of action of microtubule-stabilizing anticancer agents</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1126/science.1230582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1126%2Fscience.1230582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23287720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=587-590&author=A.+E.+Protaauthor=K.+Bargstenauthor=D.+Zurwerraauthor=J.+J.+Fieldauthor=J.+F.+D%C3%ADazauthor=K.-H.+Altmannauthor=M.+O.+Steinmetz&title=Molecular+mechanism+of+action+of+microtubule-stabilizing+anticancer+agents&doi=10.1126%2Fscience.1230582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents</span></div><div class="casAuthors">Prota, Andrea E.; Bargsten, Katja; Zurwerra, Didier; Field, Jessica J.; Diaz, Jose Fernando; Altmann, Karl-Heinz; Steinmetz, Michel O.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6119</span>),
    <span class="NLM_cas:pages">587-590</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer.  Despite the importance of MSAs for medical applications and basic research, their mol. mechanisms of action on tubulin and microtubules remain elusive.  We detd. high-resoln. crystal structures of αβ-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A.  Both compds. were bound to the taxane pocket of β-tubulin and used their resp. side chains to induce structuring of the M-loop into a short helix.  Because the M-loop establishes lateral tubulin contacts in microtubules, these findings explain how taxane-site MSAs promote microtubule assembly and stability.  Further, our results offer fundamental structural insights into the control mechanisms of microtubule dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_p8NfCWTU-rVg90H21EOLACvtfcHk0lhT9z6Vlbp8Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGrsrw%253D&md5=b253c015f75f5eac4857d01e34d65f54</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1230582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1230582%26sid%3Dliteratum%253Aachs%26aulast%3DProta%26aufirst%3DA.%2BE.%26aulast%3DBargsten%26aufirst%3DK.%26aulast%3DZurwerra%26aufirst%3DD.%26aulast%3DField%26aufirst%3DJ.%2BJ.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BF.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DSteinmetz%26aufirst%3DM.%2BO.%26atitle%3DMolecular%2520mechanism%2520of%2520action%2520of%2520microtubule-stabilizing%2520anticancer%2520agents%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D587%26epage%3D590%26doi%3D10.1126%2Fscience.1230582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Stanton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aneja, R.</span><span> </span><span class="NLM_article-title">Drugs that target dynamic microtubules: A new molecular perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1002/med.20242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1002%2Fmed.20242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=21381049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=443-481&author=R.+A.+Stantonauthor=K.+M.+Gernertauthor=J.+H.+Nettlesauthor=R.+Aneja&title=Drugs+that+target+dynamic+microtubules%3A+A+new+molecular+perspective&doi=10.1002%2Fmed.20242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs that target dynamic microtubules: A new molecular perspective</span></div><div class="casAuthors">Stanton, Richard A.; Gernert, Kim M.; Nettles, James H.; Aneja, Ritu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-481</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle app.  As such, there is a wide variety of compds. currently in clin. use and in development that act as antimitotic agents by altering microtubule dynamics.  Although these diverse mols. are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research.  In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biol. function relative to the mol. vectors of microtubule assembly or disassembly.  These "biol. vectors" can thus be used as a spatiotemporal context to describe mol. mechanisms by which microtubule-targeting drugs work. © 2011 Wiley Periodicals, Inc.  Med Res Rev, 31, No. 3, 443-481, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6_lcUQbXYrVg90H21EOLACvtfcHk0liD_EjoKNgXZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D&md5=acce5b9cc89581a7dab0236072b68c72</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmed.20242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20242%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DGernert%26aufirst%3DK.%2BM.%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DAneja%26aufirst%3DR.%26atitle%3DDrugs%2520that%2520target%2520dynamic%2520microtubules%253A%2520A%2520new%2520molecular%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2011%26volume%3D31%26spage%3D443%26epage%3D481%26doi%3D10.1002%2Fmed.20242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span> </span><span class="NLM_article-title">Microtubule-binding agents: a dynamic field of cancer therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1038/nrd3253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnrd3253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=20885410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=790-803&author=C.+Dumontetauthor=M.+A.+Jordan&title=Microtubule-binding+agents%3A+a+dynamic+field+of+cancer+therapeutics&doi=10.1038%2Fnrd3253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-binding agents: a dynamic field of cancer therapeutics</span></div><div class="casAuthors">Dumontet, Charles; Jordan, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">790-803</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an important therapeutic target in tumor cells.  Agents that bind to microtubules have been part of the pharmacopoeia of anticancer therapy for decades and until the advent of targeted therapy, microtubules were the only alternative to DNA as a therapeutic target in cancer.  The screening of a range of botanical species and marine organisms has yielded promising new antitubulin agents with novel properties.  In the current search for novel microtubule-binding agents, enhanced tumor specificity, reduced neurotoxicity and insensitivity to chemoresistance mechanisms are the three main objectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ43DyXjdN7rVg90H21EOLACvtfcHk0liD_EjoKNgXZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI&md5=9fc6fd966859785605936ecbe6dca44e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3253%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DMicrotubule-binding%2520agents%253A%2520a%2520dynamic%2520field%2520of%2520cancer%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D790%26epage%3D803%26doi%3D10.1038%2Fnrd3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1038/nature02393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+tubulin+regulation+from+a+complex+with+colchicine+and+a+stathmin-like+domain&doi=10.1038%2Fnature02393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lj94cf1GpusMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520tubulin%2520regulation%2520from%2520a%2520complex%2520with%2520colchicine%2520and%2520a%2520stathmin-like%2520domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202%26doi%3D10.1038%2Fnature02393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bohlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, B.</span><span> </span><span class="NLM_article-title">Podophyllotoxin derivatives: drug discovery and development</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1016/1359-6446(96)10028-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2F1359-6446%2896%2910028-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADyaK28XlvVWkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=343-351&author=L.+Bohlinauthor=B.+Rosen&title=Podophyllotoxin+derivatives%3A+drug+discovery+and+development&doi=10.1016%2F1359-6446%2896%2910028-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Podophyllotoxin derivatives: Drug discovery and development</span></div><div class="casAuthors">Bohlin, Lars; Rosen, Boerje</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">343-351</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The exploration and exploitation of podophyllin formulations provide an example of how a plant ext. with established ethnomedical use, but also causing toxicity, can provide a basis for new drug discovery and development.  Applications and potential applications include the treatment of venereal warts, psoriasis, rheumatoid arthritis, malaria and Alzheimer's disease.  This review, with 64 refs., addresses the history and pharmacol. action of these natural products and outlines the preclin. development and clin. trials of drugs in the pipeline and with marketing approval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiOJLfQu7z7bVg90H21EOLACvtfcHk0lj94cf1GpusMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvVWkt7k%253D&md5=8d7f0d6a912eb1d5aeba253a25d685c3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2F1359-6446%2896%2910028-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1359-6446%252896%252910028-3%26sid%3Dliteratum%253Aachs%26aulast%3DBohlin%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DB.%26atitle%3DPodophyllotoxin%2520derivatives%253A%2520drug%2520discovery%2520and%2520development%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1996%26volume%3D1%26spage%3D343%26epage%3D351%26doi%3D10.1016%2F1359-6446%2896%2910028-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herald, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohavanijaya, P.</span><span> </span><span class="NLM_article-title">Isolation and structure of combretastatin</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1374</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span><span class="refDoi"> DOI: 10.1139/v82-202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1139%2Fv82-202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1982&pages=1374-1376&author=G.+R.+Pettitauthor=G.+M.+Craggauthor=D.+L.+Heraldauthor=J.+M.+Schmidtauthor=P.+Lohavanijaya&title=Isolation+and+structure+of+combretastatin&doi=10.1139%2Fv82-202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1139%2Fv82-202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv82-202%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DLohavanijaya%26aufirst%3DP.%26atitle%3DIsolation%2520and%2520structure%2520of%2520combretastatin%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1982%26volume%3D60%26spage%3D1374%26epage%3D1376%26doi%3D10.1139%2Fv82-202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Neuss, N.; Neuss, M. N.</span><span> </span><span class="NLM_article-title">The therapeutic use of bisindole alkaloids from Catharanthus</span>. In  <span class="citation_source-book">The Alkaloids</span>; <span class="NLM_contrib-group">Brossi, A.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">37</span>, pp  <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=229-240&author=N.+Neuss&author=M.+N.+Neussauthor=A.+Brossi&title=The+Alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNeuss%26aufirst%3DN.%26atitle%3DThe%2520therapeutic%2520use%2520of%2520bisindole%2520alkaloids%2520from%2520Catharanthus%26btitle%3DThe%2520Alkaloids%26aulast%3DBrossi%26aufirst%3DA.%26pub%3DAcademic%2520Press%26date%3D1990%26volume%3D37%26spage%3D229%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Pearce, H. L.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of bisindole alkaloids from Catharanthus</span>. In  <span class="citation_source-book">The Alkaloids</span>; <span class="NLM_contrib-group">Brossi, A.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">37</span>, pp  <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=145-204&author=H.+L.+Pearceauthor=A.+Brossi&title=The+Alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPearce%26aufirst%3DH.%2BL.%26atitle%3DMedicinal%2520chemistry%2520of%2520bisindole%2520alkaloids%2520from%2520Catharanthus%26btitle%3DThe%2520Alkaloids%26aulast%3DBrossi%26aufirst%3DA.%26pub%3DAcademic%2520Press%26date%3D1990%26volume%3D37%26spage%3D145%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kuehne, M. E.; Marko, I.</span><span> </span><span class="NLM_article-title">Syntheses of vinblastine-type alkaloids</span>. In  <span class="citation_source-book">The Alkaloids</span>; <span class="NLM_contrib-group">Brossi, A.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">37</span>, pp  <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=77-132&author=M.+E.+Kuehne&author=I.+Markoauthor=A.+Brossi&title=The+Alkaloids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKuehne%26aufirst%3DM.%2BE.%26atitle%3DSyntheses%2520of%2520vinblastine-type%2520alkaloids%26btitle%3DThe%2520Alkaloids%26aulast%3DBrossi%26aufirst%3DA.%26pub%3DAcademic%2520Press%26date%3D1990%26volume%3D37%26spage%3D77%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Negi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luqman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konwar, R.</span><span> </span><span class="NLM_article-title">Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmc.2014.12.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=373-389&author=A.+S.+Negiauthor=Y.+Gautamauthor=S.+Alamauthor=D.+Chandaauthor=S.+Luqmanauthor=J.+Sarkarauthor=F.+Khanauthor=R.+Konwar&title=Natural+antitubulin+agents%3A+Importance+of+3%2C4%2C5-trimethoxyphenyl+fragment&doi=10.1016%2Fj.bmc.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DNegi%26aufirst%3DA.%2BS.%26aulast%3DGautam%26aufirst%3DY.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DLuqman%26aufirst%3DS.%26aulast%3DSarkar%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DF.%26aulast%3DKonwar%26aufirst%3DR.%26atitle%3DNatural%2520antitubulin%2520agents%253A%2520Importance%2520of%25203%252C4%252C5-trimethoxyphenyl%2520fragment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D373%26epage%3D389%26doi%3D10.1016%2Fj.bmc.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">An overview of tubulin inhibitors that interact with the colchicine binding site</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2943</span><span class="NLM_x">–</span> <span class="NLM_lpage">2971</span><span class="refDoi"> DOI: 10.1007/s11095-012-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1007%2Fs11095-012-0828-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=22814904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2943-2971&author=Y.+Luauthor=J.+Chenauthor=M.+Xiaoauthor=W.+Liauthor=D.+D.+Miller&title=An+overview+of+tubulin+inhibitors+that+interact+with+the+colchicine+binding+site&doi=10.1007%2Fs11095-012-0828-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span></div><div class="casAuthors">Lu, Yan; Chen, Jianjun; Xiao, Min; Li, Wei; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2943-2971</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tubulin dynamics is a promising target for new chemotherapeutic agents.  The colchicine binding site is one of the most important pockets for potential tubulin polymn. destabilizers.  Colchicine binding site inhibitors (CBSI) exert their biol. effects by inhibiting tubulin assembly and suppressing microtubule formation.  A large no. of mols. interacting with the colchicine binding site have been designed and synthesized with significant structural diversity.  CBSIs have been modified as to chem. structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers.  CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin.  The present review is a synopsis of compds. that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrFQVgeCbBbVg90H21EOLACvtfcHk0ljcWONNoFRLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN&md5=dfe42e8eb1f0ff22b256641aaa8c17ab</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DAn%2520overview%2520of%2520tubulin%2520inhibitors%2520that%2520interact%2520with%2520the%2520colchicine%2520binding%2520site%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D2943%26epage%3D2971%26doi%3D10.1007%2Fs11095-012-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkoshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, M.</span><span> </span><span class="NLM_article-title">Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2378</span><span class="NLM_x">–</span> <span class="NLM_lpage">2389</span><span class="refDoi"> DOI: 10.1021/jm501859j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501859j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2ntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2378-2389&author=K.+Nakagawa-Gotoauthor=A.+Odaauthor=E.+Hamelauthor=E.+Ohkoshiauthor=K.-H.+Leeauthor=M.+Goto&title=Development+of+a+novel+class+of+tubulin+inhibitor+from+desmosdumotin+B+with+a+hydroxylated+bicyclic+B-ring&doi=10.1021%2Fjm501859j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel class of tubulin inhibitors from desmosdumotin B with a hydroxylated bicyclic B-ring</span></div><div class="casAuthors">Nakagawa-Goto, Kyoko; Oda, Akifumi; Hamel, Ernest; Ohkoshi, Emika; Lee, Kuo-Hsiung; Goto, Masuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2378-2389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of newly synthesized hydroxylated analogs of triethyldesmosdumotin B (TEDB) with a bicyclic B-ring exhibited a significantly different mode of action for affecting microtubule dynamics and spindle formation but had the same antiproliferative activity spectrum, including activity against multidrug-resistant tumors.  These analogs efficiently induced cell cycle arrest at prometaphase and caused formation of immature multipolar spindles.  6'-Hydroxyl TEDB-TB (8) disrupted bipolar spindle formation but had a negligible effect on interphase microtubules.  On the basis of the predicted binding modes of the new compds. with tubulin dimer, one particular compd. forms three hydrogen bonds (H-bonds) only with α-tubulin at the colchicine site; in contrast, 8 forms H-bonds with both α- and β-tubulin.  We predict that, when a compd./ligand, such as 8, forms H-bonds to both α- and β-tubulins, spindle formation is disrupted more than the dynamics of interphase microtubules.  This result may reflect the well-known greater dynamicity of spindle microtubules as compared with interphase microtubules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCp6JiuXiVrbVg90H21EOLACvtfcHk0ljcWONNoFRLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2ntro%253D&md5=a0ba9cf3db85402c4f14b6084e3780bf</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm501859j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501859j%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DOhkoshi%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DGoto%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520class%2520of%2520tubulin%2520inhibitor%2520from%2520desmosdumotin%2520B%2520with%2520a%2520hydroxylated%2520bicyclic%2520B-ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2378%26epage%3D2389%26doi%3D10.1021%2Fjm501859j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Taipalensuu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornblom, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einarsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjoqvist, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melhus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjostrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=11561076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=164-170&author=J.+Taipalensuuauthor=H.+Tornblomauthor=G.+Lindbergauthor=C.+Einarssonauthor=F.+Sjoqvistauthor=H.+Melhusauthor=P.+Garbergauthor=B.+Sjostromauthor=B.+Lundgrenauthor=P.+Artursson&title=Correlation+of+gene+expression+of+ten+drug+efflux+proteins+of+the+ATP-binding+cassette+transporter+family+in+normal+human+jejunum+and+in+human+intestinal+epithelial+Caco-2+cell+monolayers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers</span></div><div class="casAuthors">Taipalensuu, Jan; Tornblom, Hans; Lindberg, Greger; Einarsson, Curt; Sjoqvist, Folke; Melhus, Hakan; Garberg, Per; Sjostrom, Brita; Lundgren, Bo; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">164-170</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This investigation describes the expression and interindividual variability in transcript levels of multiple drug efflux systems in the human jejunum and compares the expression profiles in these cells with that of the commonly used Caco-2 cell drug absorption model.  Transcript levels of ten-drug efflux proteins of the ATP-binding cassette (ABC) transporter family [MDR1, MDR3, ABCB5, MRP1-6, and breast cancer resistance protein (BCRP)], lung resistance-related protein (LRP), and CYP3A4 were detd. using quant. polymerase chain reaction in jejunal biopsies from 13 healthy human subjects and in Caco-2 cells.  All genes except ABCB5 were expressed, and transcript levels varied between individuals only by a factor of 2 to 3.  Surprisingly, BCRP and MRP2 transcripts were more abundant in jejunum than MDR1 transcripts.  Jejunal transcript levels of the different ABC transporters spanned a range of three log units with the rank order: BCRP ≈ MRP2 > MDR1 ≈ MRP3 ≈ MRP6 ≈ MRP5 ≈ MRP1 > MRP4 > MDR3.  Furthermore, transcript levels of 9 of 10 ABC transporters correlated well between jejunum and Caco-2 cells (r2 = 0.90).  However, BCRP exhibited a 100-fold lower transcript level in Caco-2 cells compared with jejunum.  Thus, the expression of a no. of efflux protein transcripts in jejunum are equal to, or even higher than, that of MDR1, suggesting that the roles of these proteins (in particular BCRP and MRP2) in intestinal drug efflux have been underestimated.  Also, we tentatively conclude that the Caco-2 cell line is a useful model of jejunal drug efflux, if the low expression of BCRP is taken into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1f-Z1mGAtjbVg90H21EOLACvtfcHk0ljcWONNoFRLkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWlt7Y%253D&md5=1a2ef81848fcaafda43d4980f6987856</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaipalensuu%26aufirst%3DJ.%26aulast%3DTornblom%26aufirst%3DH.%26aulast%3DLindberg%26aufirst%3DG.%26aulast%3DEinarsson%26aufirst%3DC.%26aulast%3DSjoqvist%26aufirst%3DF.%26aulast%3DMelhus%26aufirst%3DH.%26aulast%3DGarberg%26aufirst%3DP.%26aulast%3DSjostrom%26aufirst%3DB.%26aulast%3DLundgren%26aufirst%3DB.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DCorrelation%2520of%2520gene%2520expression%2520of%2520ten%2520drug%2520efflux%2520proteins%2520of%2520the%2520ATP-binding%2520cassette%2520transporter%2520family%2520in%2520normal%2520human%2520jejunum%2520and%2520in%2520human%2520intestinal%2520epithelial%2520Caco-2%2520cell%2520monolayers%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D164%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Microtubules as a target for anticancer drugs</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nrc1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+target+for+anticancer+drugs&doi=10.1038%2Fnrc1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0liejHlUcqdXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520target%2520for%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265%26doi%3D10.1038%2Fnrc1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Seve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1016/S1470-2045(08)70029-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2FS1470-2045%2808%2970029-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=18237851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=168-175&author=P.+Seveauthor=C.+Dumontet&title=Is+class+III+beta-tubulin+a+predictive+factor+in+patients+receiving+tubulin-binding+agents%3F&doi=10.1016%2FS1470-2045%2808%2970029-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?</span></div><div class="casAuthors">Seve, Pascal; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-175</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: On the basis of preclin. studies that show overexpression of class III β-tubulin is assocd. with resistance to tubulin-binding agents, several investigators have addressed the relation between class III β-tubulin and outcome in patients treated with such agents.  High expression of class III β-tubulin has been found to be correlated either with low response rates in patients treated with regimens contg. taxanes or vinorelbine or with reduced survival in patients with non-small-cell lung cancer, in breast, ovarian, and gastric cancers, and in cancers of unknown primary site.  Two studies have shown patients with advanced non-small-cell lung cancer receiving paclitaxel whose tumors expressed high levels of class III β-tubulin had a lower response to paclitaxel and shorter survival, whereas this variable was not found to be predictive in patients receiving regimens without tubulin-binding agents.  Conversely, anal. of samples from patients in the JBR-10 trial, which compared adjuvant chemotherapy to no further therapy in operable non-small-cell lung cancer, showed that chemotherapy seemed to overcome the neg. prognostic effect of high levels of expression of class III β-tubulin and the greatest benefit from cisplatin/vinorelbine was seen in patients with high levels of expression of class III β-tubulin.  Further analyses in operable and advanced non-small-cell lung cancer showed a relation between high expression of class III β-tubulin and baseline factors such as age under 60 years, adenocarcinoma and large-cell carcinoma histologies, and advanced stage of disease.  These results suggest that class III β-tubulin could be both a prognostic and a predictive factor.  Large randomized studies are warranted to det. the prognostic or predictive value of class III β-tubulin in different settings and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopsXLbaFHm3LVg90H21EOLACvtfcHk0liejHlUcqdXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D&md5=4d4adaf4db80a5eb71c771c9f09d74b4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2808%2970029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252808%252970029-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeve%26aufirst%3DP.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DIs%2520class%2520III%2520beta-tubulin%2520a%2520predictive%2520factor%2520in%2520patients%2520receiving%2520tubulin-binding%2520agents%253F%26jtitle%3DLancet%2520Oncol.%26date%3D2008%26volume%3D9%26spage%3D168%26epage%3D175%26doi%3D10.1016%2FS1470-2045%2808%2970029-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Eckford, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">ABC efflux pump-based resistance to chemotherapy drugs</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2989</span><span class="NLM_x">–</span> <span class="NLM_lpage">3011</span><span class="refDoi"> DOI: 10.1021/cr9000226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9000226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2989-3011&author=P.+D.+Eckfordauthor=F.+J.+Sharom&title=ABC+efflux+pump-based+resistance+to+chemotherapy+drugs&doi=10.1021%2Fcr9000226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ABC Efflux Pump-Based Resistance to Chemotherapy Drugs</span></div><div class="casAuthors">Eckford, Paul D. W.; Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over 1 million new cases of all types of cancer are diagnosed each year in the United States alone, and 559, 650 cancer-related deaths were expected to occur in 2007.  Chemotherapeutic treatment of cancers is an important tool to combat this devastating disease.  However, chemotherapy can fail due to the development of tumor cell resistance to multiple drugs, a phenomenon known as multidrug resistance (MDR), and essentially all cancer-related deaths are considered to be a result of chemotherapy failure.  MDR can have many causes, but one important mechanism of drug resistance is the expression of active drug efflux pumps in the membranes of cancer cells.  The efflux pump proteins mediating MDR in human cancers belong to the ATP-Binding Cassette (ABC) superfamily of proteins.  This is a diverse group of (primarily) active membrane transporters and is one of the largest known protein families.  Its members include proteins that mediate a variety of transport processes, in both prokaryotes (e.g., membrane-embedded importers for sugars and amino acids, and drug exporters) and eukaryotes, where only ABC exporters are known.  The 49 ABC proteins identified in the human genome (there appear to be 48 functional proteins) are involved in the efflux of substrates such as phospholipids, sterols, bile salts, and amphipathic drugs.  While as many as 15 ABC transporters have been obsd. to export chemotherapy drugs using in vitro exptl. systems, only 3 transporters have thus far been implicated as major contributors to MDR in cancer.  Discovered over 30 years ago, P-glycoprotein (Pgp; MDR1; ABCB1), was the first mammalian ABC protein to be identified.  Multidrug resistance-assocd. protein 1 (MRP1 or ABCC1) and more recently ABCG2 (also termed the breast cancer resistance protein, BCRP, or mitoxantrone resistance protein, MXR) also appear to function as clin. relevant drug efflux pumps.  All three proteins were discovered as factors over-expressed in MDR cell lines in culture, and they have since been detected in MDR tumors in patients.  Considerable effort has been made to understand the structure and function of these three drug pumps, which possess a unique ability to recognize and transport a broad array of structurally diverse compds. out of the cell.  The development of compds. known as modulators, which are able to reverse MDR by blocking or inhibiting the ATP-dependent transport function of these proteins, is also an important goal of researchers in this field.  This review will summarize our understanding of the substrate specificity of the mammalian drug efflux pumps, their structure, the mol. mechanisms by which they exert their function, and the progress made to date in reversing pump-mediated MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZIkwCqe_qg7Vg90H21EOLACvtfcHk0liejHlUcqdXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D&md5=5009e7a7cac6977a296fd5bbf97d7df7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr9000226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9000226%26sid%3Dliteratum%253Aachs%26aulast%3DEckford%26aufirst%3DP.%2BD.%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520efflux%2520pump-based%2520resistance%2520to%2520chemotherapy%2520drugs%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2989%26epage%3D3011%26doi%3D10.1021%2Fcr9000226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6605489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fsj.bjc.6605489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=20029418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=316-324&author=C.+Stengelauthor=S.+P.+Newmanauthor=M.+P.+Leeseauthor=B.+V.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=Class+III+beta-tubulin+expression+and+in+vitro+resistance+to+microtubule+targeting+agents&doi=10.1038%2Fsj.bjc.6605489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Class III β-tubulin expression and in vitro resistance to microtubule targeting agents</span></div><div class="casAuthors">Stengel, C.; Newman, S. P.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-324</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Class III β-tubulin overexpression is a marker of resistance to microtubule disruptors in vitro, in vivo and in the clinic for many cancers, including breast cancer.  The aims of this study were to develop a new model of class III β-tubulin expression, avoiding the toxicity assocd. with chronic overexpression of class III β-tubulin, and study the efficacy of a panel of clin. and pre-clin. drugs in this model.  Methods: MCF-7 (ER+ve) and MDA-MB-231 (ER-ve) were either transfected with pALTER-TUBB3 or siRNA-tubb3 and 24 h later exposed to test compds. for a further 96 h for proliferation studies.  RT-PCR and immunoblotting were used to monitor the changes in class III β-tubulin mRNA and protein expression.  Results: The model allowed for subtle changes in class III β-tubulin expression to be achieved, which had no direct effect on the viability of the cells.  Class III β-tubulin overexpression conferred resistance to paclitaxel and vinorelbine, whereas downregulation of class III β-tubulin rendered cells more sensitive to these two drugs.  The efficacy of the colchicine-site binding agents, 2-MeOE2, colchicine, STX140, ENMD1198 and STX243 was unaffected by the changes in class III β-tubulin expression.  Conclusion: These data indicate that the effect of class III β-tubulin overexpression may depend on where the drug's binding site is located on the tubulin.  Therefore, this study highlights for the first time the potential key role of targeting the colchicine-binding site, to develop new treatment modalities for taxane-refractory breast cancer.  British Journal of Cancer (2010) 102, 316-324; doi:10.1038/sj.bjc.6605489 www.bjcancer.com Published online 22 Dec. 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hulEpiTJA7Vg90H21EOLACvtfcHk0liejHlUcqdXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKisQ%253D%253D&md5=02d84566d0f23c1781ba74a1add4fed2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605489%26sid%3Dliteratum%253Aachs%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DClass%2520III%2520beta-tubulin%2520expression%2520and%2520in%2520vitro%2520resistance%2520to%2520microtubule%2520targeting%2520agents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D316%26epage%3D324%26doi%3D10.1038%2Fsj.bjc.6605489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Karki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahabi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span> </span><span class="NLM_article-title">βIII-Tubulin: Biomarker of taxane resistance or drug target</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span><span class="refDoi"> DOI: 10.1517/14728222.2013.766170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1517%2F14728222.2013.766170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23379899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFSkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=461-472&issue=4&author=R.+Karkiauthor=M.+Marianiauthor=M.+Andreoliauthor=S.+Heauthor=S.+Scambiaauthor=S.+Shahabiauthor=C.+Ferlini&title=%CE%B2III-Tubulin%3A+Biomarker+of+taxane+resistance+or+drug+target&doi=10.1517%2F14728222.2013.766170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">βIII-Tubulin: biomarker of taxane resistance or drug target?</span></div><div class="casAuthors">Karki, Roshan; Mariani, Marisa; Andreoli, Mirko; He, Shiquan; Scambia, Giovanni; Shahabi, Shohreh; Ferlini, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-472</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: βIII-Tubulin (TUBB3) is predominantly expressed in neurons of the central and peripheral nervous systems, while in normal non-neoplastic tissues it is barely detectable.  By contrast, this cytoskeletal protein is abundant in a wide range of tumors.  βIII-Tubulin is linked to dynamic instability of microtubules (MTs), weakening the effects of agents interfering with MT polymn.  Based on this principle, early studies introduced the classical theory linking βIII-tubulin with a mechanism of counteracting taxane activity and accordingly, prompted its investigation as a predictive biomarker of taxane resistance.Areas covered: We reviewed 59 translational studies, including cohorts from lung, ovarian, breast, gastric, colorectal and various misc. cancers subject to different chemotherapy regimens.Expert opinion: βIII-Tubulin functions more as a prognostic factor than as a predictor of response to chemotherapy.  We believe this view can be explained by βIII-tubulin's assocn. with prosurvival pathways in the early steps of the metastatic process.  Its prognostic response increases if combined with addnl. biomarkers that regulate its expression, since βIII-tubulin can be expressed in conditions, such as estrogen exposure, unrelated to survival mechanisms and without any predictive activity.  Addnl. avenues for therapeutic intervention could emerge if drugs are designed to directly target βIII-tubulin and its mechanism of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPMrdH0yczD7Vg90H21EOLACvtfcHk0lgao1jQM7BGhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFSkt7k%253D&md5=9dfe47636caf65c683e6d067aa6d72b5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F14728222.2013.766170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2013.766170%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DMariani%26aufirst%3DM.%26aulast%3DAndreoli%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DScambia%26aufirst%3DS.%26aulast%3DShahabi%26aufirst%3DS.%26aulast%3DFerlini%26aufirst%3DC.%26atitle%3D%25CE%25B2III-Tubulin%253A%2520Biomarker%2520of%2520taxane%2520resistance%2520or%2520drug%2520target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2013%26volume%3D17%26issue%3D4%26spage%3D461%26epage%3D472%26doi%3D10.1517%2F14728222.2013.766170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fürst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmar, A. M.</span><span> </span><span class="NLM_article-title">A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=478-483&author=R.+F%C3%BCrstauthor=A.+M.+Vollmar&title=A+new+perspective+on+old+drugs%3A+non-mitotic+actions+of+tubulin-binding+drugs+play+a+major+role+in+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26aulast%3DVollmar%26aufirst%3DA.%2BM.%26atitle%3DA%2520new%2520perspective%2520on%2520old%2520drugs%253A%2520non-mitotic%2520actions%2520of%2520tubulin-binding%2520drugs%2520play%2520a%2520major%2520role%2520in%2520cancer%2520treatment%26jtitle%3DPharmazie%26date%3D2013%26volume%3D68%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kretzschmann, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fürst, R.</span><span> </span><span class="NLM_article-title">Plant-derived vascular disrupting agents: Compounds, actions, and clinical trials</span> <span class="citation_source-journal">Phytochem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1007/s11101-013-9304-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1007%2Fs11101-013-9304-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=191-206&author=V.+K.+Kretzschmannauthor=R.+F%C3%BCrst&title=Plant-derived+vascular+disrupting+agents%3A+Compounds%2C+actions%2C+and+clinical+trials&doi=10.1007%2Fs11101-013-9304-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Plant-derived vascular disrupting agents: compounds, actions, and clinical trials</span></div><div class="casAuthors">Kretzschmann, Verena K.; Fuerst, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-206</span>CODEN:
                <span class="NLM_cas:coden">PRHEBS</span>;
        ISSN:<span class="NLM_cas:issn">1568-7767</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The tumor vasculature of solid tumors offers unique characteristics compared to the normal vasculature and, therefore, represents an attractive target in anti-cancer therapy.  Besides the classic anti-angiogenic agents, which inhibit tumor neovascularization, a novel promising class of anti-tumor drugs has emerged in the last years, the vascular-disrupting agents (VDAs).  In contrast to angiogenesis inhibitors, VDAs act on already established tumor blood vessels of large solid tumors and induce a vascular shutdown by targeting tumor endothelial cells.  This results in extensive necrotic tumor cell death.  The sources of VDAs are quite divers, however, the plant-derived compds. represent the largest and most prominent class.  Plant-derived VDAs have undergone extensive preclin. investigations and are now tested in several advanced clin. trials.  In this review we summarize preclin. data, including drug-target relationships as well as functional in vitro and in vivo assays, discuss their mol. way of action, and update the clin. status of the most prominent plant-derived VDAs: FAA/DMXAA, CA-4-P, OXi4503, AVE8062, and ZD6126.  All these data emphasize the value of secondary plant metabolites and their (semi-)synthetic derivs. for current drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro7gqZKoAc2bVg90H21EOLACvtfcHk0lgao1jQM7BGhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislCht7o%253D&md5=e5563128a501c8c462ad9b5545365fad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs11101-013-9304-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11101-013-9304-6%26sid%3Dliteratum%253Aachs%26aulast%3DKretzschmann%26aufirst%3DV.%2BK.%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26atitle%3DPlant-derived%2520vascular%2520disrupting%2520agents%253A%2520Compounds%252C%2520actions%252C%2520and%2520clinical%2520trials%26jtitle%3DPhytochem.%2520Rev.%26date%3D2014%26volume%3D13%26spage%3D191%26epage%3D206%26doi%3D10.1007%2Fs11101-013-9304-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ji, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-P.</span><span> </span><span class="NLM_article-title">Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span><span class="refDoi"> DOI: 10.2174/0929867322666150114163732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F0929867322666150114163732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=25620094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1348-1360&author=Y.-T.+Jiauthor=Y.-N.+Liuauthor=Z.-P.+Liu&title=Tubulin+colchicine+binding+site+inhibitors+as+vascular+disrupting+agents+in+clinical+developments&doi=10.2174%2F0929867322666150114163732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments</span></div><div class="casAuthors">Ji, Ya-Ting; Liu, Yan-Na; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1348-1360</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor vasculature is an important target in cancer treatment.  Two distinct vasculartargeting therapeutic strategies are applied to attack cancer cells indirectly.  The antiangiogenic approach intervenes in the neovascularization processes and blocks the formation of new blood vessels, while th e antivascular approach targets the established tumor blood vessels, making vascular shutdown and resulting in rapid haemorrhagic necrosis and tumor cell death.  A no. of compds. with diverse structural scaffolds have been designed to target tumor vasculature and they are called vascular disrupting agents (VDAs).  The biol. or ligand-directed VDAs utilize antibodies, peptides or growth factors to deliver toxins or pro-coagulants or proapoptotic affectors to tumor-related blood vessels, while the small-mol. VDAs selectively target tumor blood vessels and have little effects on the normal endothelium.  Among the small-mol. VDAs, the tubulin colchicine binding site inhibitors have been extensively studied and many of them have entered the clin. trials, including CA-4P, CA-1P, AVE8062, OXi4503, CKD-516, BNC105P, ABT-751, CYT- 997, ZD6126, NPI-2358, MN-029 and EPC2407.  This review makes a summary of the small-mol. VDAs in clin. developments and highlights some potential VDA leads or candidates for the treatment of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-aHECQeEv7LVg90H21EOLACvtfcHk0lhBE4jponza6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1amurg%253D&md5=65300d3649e348a5c3c66fbc2dac4f07</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150114163732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150114163732%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DY.-T.%26aulast%3DLiu%26aufirst%3DY.-N.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DTubulin%2520colchicine%2520binding%2520site%2520inhibitors%2520as%2520vascular%2520disrupting%2520agents%2520in%2520clinical%2520developments%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D1348%26epage%3D1360%26doi%3D10.2174%2F0929867322666150114163732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mason, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span> </span><span class="NLM_article-title">A perspective on vascular disrupting agents that interact with tubulin: Preclinical tumor imaging and biological assessment</span> <span class="citation_source-journal">Integr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1039/c0ib00135j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1039%2Fc0ib00135j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=375-387&author=R.+P.+Masonauthor=D.+Zhaoauthor=L.+Liuauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=A+perspective+on+vascular+disrupting+agents+that+interact+with+tubulin%3A+Preclinical+tumor+imaging+and+biological+assessment&doi=10.1039%2Fc0ib00135j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment</span></div><div class="casAuthors">Mason, Ralph P.; Zhao, Dawen; Liu, Li; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">IBNIFL</span>;
        ISSN:<span class="NLM_cas:issn">1757-9694</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment provides a rich source of potential targets for selective therapeutic intervention with properly designed anticancer agents.  Significant physiol. differences exist between the microvessels that nourish tumors and those that supply healthy tissue.  Selective drug-mediated damage of these tortuous and chaotic microvessels starves a tumor of necessary nutrients and oxygen and eventually leads to massive tumor necrosis.  Vascular targeting strategies in oncol. are divided into two sep. groups: angiogenesis inhibiting agents (AIAs) and vascular disrupting agents (VDAs).  The mechanisms of action between these two classes of compds. are profoundly distinct.  The AIAs inhibit the actual formation of new vessels, while the VDAs damage and/or destroy existing tumor vasculature.  One subset of small-mol. VDAs functions by inhibiting the assembly of tubulin into microtubules, thus causing morphol. changes to the endothelial cells lining the tumor vasculature, triggered by a cascade of cell signaling events.  Ultimately this results in catastrophic damage to the vessels feeding the tumor.  The rapid emergence and subsequent development of the VDA field over the past decade has led to the establishment of a synergistic combination of preclin. state-of-the-art tumor imaging and biol. evaluation strategies that are often indicative of future clin. efficacy for a given VDA.  This review focuses on an integration of the appropriate biochem. and biol. tools necessary to assess (preclinically) new small-mol., tubulin active VDAs for their potential to be clin. effective anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw2V3dKpQSrLVg90H21EOLACvtfcHk0lhBE4jponza6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFyms7w%253D&md5=b58788fa8f5cdbc4d3abffff4e7eaca5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fc0ib00135j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0ib00135j%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DA%2520perspective%2520on%2520vascular%2520disrupting%2520agents%2520that%2520interact%2520with%2520tubulin%253A%2520Preclinical%2520tumor%2520imaging%2520and%2520biological%2520assessment%26jtitle%3DIntegr.%2520Biol.%26date%3D2011%26volume%3D3%26spage%3D375%26epage%3D387%26doi%3D10.1039%2Fc0ib00135j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span> </span><span class="NLM_article-title">Vascular disrupting agents targeting at tubulin: a novel class of antitumor drug</span> <span class="citation_source-journal">J. Int. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=445-454&author=X.+F.+Wangauthor=L.+Xie&title=Vascular+disrupting+agents+targeting+at+tubulin%3A+a+novel+class+of+antitumor+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DXie%26aufirst%3DL.%26atitle%3DVascular%2520disrupting%2520agents%2520targeting%2520at%2520tubulin%253A%2520a%2520novel%2520class%2520of%2520antitumor%2520drug%26jtitle%3DJ.%2520Int.%2520Pharm.%2520Res.%26date%3D2012%26volume%3D39%26spage%3D445%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liu, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, J.-P.</span><span> </span><span class="NLM_article-title">Tubulin inhibitors: A patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1517/13543776.2014.859247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1517%2F13543776.2014.859247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=24313741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=69-88&author=Y.-M.+Liuauthor=H.-L.+Chenauthor=H.-Y.+Leeauthor=J.-P.+Liou&title=Tubulin+inhibitors%3A+A+patent+review&doi=10.1517%2F13543776.2014.859247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin inhibitors: a patent review</span></div><div class="casAuthors">Liu, Yi-Min; Chen, Hsiao-Ling; Lee, Hsueh-Yun; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-88</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Microtubules play an important role in several cellular processes, particularly in the formation of the mitotic spindle during the process of mitosis.  These highly dynamic mitotic-spindle microtubules have become a successful target of cancer therapy.  Microtubule-targeting agents, such as vinca alkaloids and taxanes, were used in clinic over 50 years.  In past decades, development of new antimicrotubule agents that possess different structure and binding sites of tubulin has shown potent activity against the proliferation of various cancer cells, as well as in multidrug-resistant cancers.  Interestingly, many of these agents represent an attractive ability that targeting the tumor blood vessels results in tumor vascular disruption.  Therefore, exploring new agents and strategies may provide more effective therapeutic options in the related treatment of cancer.  Areas covered: In past few years, there are many chem. compds. that successfully interferes the microtubules and display antitumor effect.  In these, published compds. supply the fresh minds in modification of present drugs and new insights into the development of tubulin inhibitors.  Expert opinion: This article arranges the microtubule-targeting agents that have published in patent in recent years.  It may help in the investigation of new tubulin binding site and development of novel drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtnvpvVK8NmrVg90H21EOLACvtfcHk0lhBE4jponza6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP&md5=e17a15b0f0538911f2a80035edbf89b7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.859247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.859247%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-M.%26aulast%3DChen%26aufirst%3DH.-L.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DLiou%26aufirst%3DJ.-P.%26atitle%3DTubulin%2520inhibitors%253A%2520A%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D69%26epage%3D88%26doi%3D10.1517%2F13543776.2014.859247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bariwal, J.</span><span> </span><span class="NLM_article-title">Recent developments in tubulin polymerization inhibitors: an overview</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.ejmech.2014.09.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=25240869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=89-124&author=R.+Kaurauthor=G.+Kaurauthor=R.+K.+Gillauthor=R.+Soniauthor=J.+Bariwal&title=Recent+developments+in+tubulin+polymerization+inhibitors%3A+an+overview&doi=10.1016%2Fj.ejmech.2014.09.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in tubulin polymerization inhibitors: An overview</span></div><div class="casAuthors">Kaur, Ramandeep; Kaur, Gurneet; Gill, Rupinder Kaur; Soni, Richard; Bariwal, Jitender</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-124</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Microtubules are protein biopolymers formed through polymn. of heterodimers of α- and β-tubulins.  Disruption of microtubules can induce cell cycle arrest in G2-M phase and formation of abnormal mitotic spindles.  Their importance in mitosis and cell division makes microtubules an attractive target for anticancer drug discovery.  A no. of naturally occurring compds. such as paclitaxel, epothilones, vinblastine, combretastatin, and colchicines exert their effect by changing dynamics of tubulin such as polymn. and depolymn.  During past few years, rapid development of the novel tubulin polymn. inhibitors has been witnessed.  Diverse classes of chem. compds. from the natural as well as from the synthetic origin have been extensively studied.  This review highlights the various classes of synthetically derived chem. compds. those have been reported in last few years as potential tubulin polymn. inhibitors.  A brief synthetic methodol. to access these compds. has been highlighted along with the brief SAR studies.  We strongly believe that this review will provide a platform to the synthetic chemists and biologists to design and synthesize new and potent compds. to inhibit the tubulin polymn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV6nQysY8nvbVg90H21EOLACvtfcHk0lhBE4jponza6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOltbzE&md5=2ffd2f9bb073a7830f4aae7c29f070d9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.051%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DGill%26aufirst%3DR.%2BK.%26aulast%3DSoni%26aufirst%3DR.%26aulast%3DBariwal%26aufirst%3DJ.%26atitle%3DRecent%2520developments%2520in%2520tubulin%2520polymerization%2520inhibitors%253A%2520an%2520overview%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D89%26epage%3D124%26doi%3D10.1016%2Fj.ejmech.2014.09.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Nitika, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapil, K.</span><span> </span><span class="NLM_article-title">Microtubule targeting agents: a benchmark in cancer therapy</span> <span class="citation_source-journal">Curr. Drug Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.2174/15748855113086660011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F15748855113086660011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=189-196&author=V.+Nitikaauthor=K.+Kapil&title=Microtubule+targeting+agents%3A+a+benchmark+in+cancer+therapy&doi=10.2174%2F15748855113086660011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F15748855113086660011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15748855113086660011%26sid%3Dliteratum%253Aachs%26aulast%3DNitika%26aufirst%3DV.%26aulast%3DKapil%26aufirst%3DK.%26atitle%3DMicrotubule%2520targeting%2520agents%253A%2520a%2520benchmark%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Drug%2520Ther.%26date%3D2013%26volume%3D8%26spage%3D189%26epage%3D196%26doi%3D10.2174%2F15748855113086660011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Patil, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2115</span><span class="refDoi"> DOI: 10.4155/fmc.12.141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.4155%2Ffmc.12.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23157240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ynsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=2085-2115&author=S.+A.+Patilauthor=R.+Patilauthor=D.+D.+Miller&title=Indole+molecules+as+inhibitors+of+tubulin+polymerization%3A+potential+new+anticancer+agents&doi=10.4155%2Ffmc.12.141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents</span></div><div class="casAuthors">Patil, Shivaputra A.; Patil, Renukadevi; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2085-2115</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Agents that interfere with tubulin function have a broad anti-tumor spectrum and they represent one of the most significant classes of anticancer agents.  In the past few years, several small synthetic mols. that have an indole nucleus as a core structure have been identified as tubulin inhibitors.  Among these, several aroylindoles, arylthioindoles, diarylindoles and indolylglyoxyamides have shown good inhibition towards the tubulin polymn.  This article reviews the synthesis, biol. activities and SARs of these main classes of indoles.  Brief mention has also been made about the fused indole analogs as tubulin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-6yFCbyEmnrVg90H21EOLACvtfcHk0lhpNPthwUdvHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ynsbjP&md5=341d510a2a4fe59892af97fe3d40fbb7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.141%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BA.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DIndole%2520molecules%2520as%2520inhibitors%2520of%2520tubulin%2520polymerization%253A%2520potential%2520new%2520anticancer%2520agents%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D2085%26epage%3D2115%26doi%3D10.4155%2Ffmc.12.141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ramana Reddy, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallireddigari, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallela, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosenza, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billa, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akula, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkata Subbaiah, D. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijaya Bharathi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgaonkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Premkumar Reddy, E.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of (<i>E</i>)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5562</span><span class="NLM_x">–</span> <span class="NLM_lpage">5586</span><span class="refDoi"> DOI: 10.1021/jm400575x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400575x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5562-5586&author=M.+V.+Ramana+Reddyauthor=M.+R.+Mallireddigariauthor=V.+R.+Pallelaauthor=S.+C.+Cosenzaauthor=V.+K.+Billaauthor=B.+Akulaauthor=D.+R.+C.+Venkata+Subbaiahauthor=E.+Vijaya+Bharathiauthor=A.+Padgaonkarauthor=H.+Lvauthor=J.+M.+Galloauthor=E.+Premkumar+Reddy&title=Design%2C+synthesis%2C+and+biological+evaluation+of+%28E%29-N-aryl-2-arylethenesulfonamide+analogues+as+potent+and+orally+bioavailable+microtubule-targeted+anticancer+agents&doi=10.1021%2Fjm400575x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400575x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400575x%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%2BReddy%26aufirst%3DM.%2BV.%26aulast%3DMallireddigari%26aufirst%3DM.%2BR.%26aulast%3DPallela%26aufirst%3DV.%2BR.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26aulast%3DBilla%26aufirst%3DV.%2BK.%26aulast%3DAkula%26aufirst%3DB.%26aulast%3DVenkata%2BSubbaiah%26aufirst%3DD.%2BR.%2BC.%26aulast%3DVijaya%2BBharathi%26aufirst%3DE.%26aulast%3DPadgaonkar%26aufirst%3DA.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DPremkumar%2BReddy%26aufirst%3DE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520%2528E%2529-N-aryl-2-arylethenesulfonamide%2520analogues%2520as%2520potent%2520and%2520orally%2520bioavailable%2520microtubule-targeted%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5562%26epage%3D5586%26doi%3D10.1021%2Fjm400575x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Massarotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span> </span><span class="NLM_article-title">The tubulin colchicine domain: a molecular modeling perspective</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1002/cmdc.201100361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1002%2Fcmdc.201100361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=21990124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12qt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=33-42&author=A.+Massarottiauthor=A.+Colucciaauthor=R.+Silvestriauthor=G.+Sorbaauthor=A.+Brancale&title=The+tubulin+colchicine+domain%3A+a+molecular+modeling+perspective&doi=10.1002%2Fcmdc.201100361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The Tubulin Colchicine Domain: a Molecular Modeling Perspective</span></div><div class="casAuthors">Massarotti, Alberto; Coluccia, Antonio; Silvestri, Romano; Sorba, Giovanni; Brancale, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Computational approaches have been increasingly applied to drug design over the past three decades and have already provided some useful results in the discovery of anticancer drugs.  Given the increased availability of crystal structures in recent years, a growing no. of mol. modeling studies on tubulin have been reported.  Herein we present a brief overview of the role played by computational methods in anti-tubulin research, specifically in the context of colchicine binding agent research.  An overview of current structures is reported, along with a brief discussion on the issues assocd. with the various tubulin isotypes.  Finally, a summary of the most recent and relevant results is presented, highlighting the challenges and opportunities faced by researchers in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpomkM8Gy2eS7Vg90H21EOLACvtfcHk0lhpNPthwUdvHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12qt7zO&md5=84b4f8c78b635c2b7df31bbd1e4a89de</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100361%26sid%3Dliteratum%253Aachs%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DBrancale%26aufirst%3DA.%26atitle%3DThe%2520tubulin%2520colchicine%2520domain%253A%2520a%2520molecular%2520modeling%2520perspective%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D33%26epage%3D42%26doi%3D10.1002%2Fcmdc.201100361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medarde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaez, R.</span><span> </span><span class="NLM_article-title">New ligands of the tubulin colchicine site based on X-ray structures</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2231</span><span class="NLM_x">–</span> <span class="NLM_lpage">2252</span><span class="refDoi"> DOI: 10.2174/1568026614666141130092637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F1568026614666141130092637" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2231-2252&author=R.+Alvarezauthor=M.+Medardeauthor=R.+Pelaez&title=New+ligands+of+the+tubulin+colchicine+site+based+on+X-ray+structures&doi=10.2174%2F1568026614666141130092637"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F1568026614666141130092637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666141130092637%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DMedarde%26aufirst%3DM.%26aulast%3DPelaez%26aufirst%3DR.%26atitle%3DNew%2520ligands%2520of%2520the%2520tubulin%2520colchicine%2520site%2520based%2520on%2520X-ray%2520structures%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D14%26spage%3D2231%26epage%3D2252%26doi%3D10.2174%2F1568026614666141130092637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ranaivoson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berritt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joullie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Structural plasticity of tubulin assembly probed by vinca-domain ligands</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span><span class="refDoi"> DOI: 10.1107/S0907444912017143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1107%2FS0907444912017143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=22868758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKisrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=927-934&author=F.+M.+Ranaivosonauthor=B.+Gigantauthor=S.+Berrittauthor=M.+Joullieauthor=M.+Knossow&title=Structural+plasticity+of+tubulin+assembly+probed+by+vinca-domain+ligands&doi=10.1107%2FS0907444912017143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural plasticity of tubulin assembly probed by vinca-domain ligands</span></div><div class="casAuthors">Ranaivoson, Fanomezana M.; Gigant, Benoit; Berritt, Simon; Joullie, Madeleine; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">927-934</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Vinca-domain ligands are compds. that bind to tubulin at its inter-heterodimeric interface and favor heterogeneous protofilament-like assemblies, giving rise to helixes and rings.  This is the basis for their inhibition of microtubule assembly, for their antimitotic activities and for their use in anticancer chemotherapy.  Ustiloxins are vinca-domain ligands with a well established total synthesis.  A 2.7 Å resoln. structure of ustiloxin D bound to the vinca domain embedded in the complex of two tubulins with the stathmin-like domain of RB3 (T2R) has been detd.  This finding precisely defines the interactions of ustiloxins with tubulin and, taken together with structures of other vinca-ligand complexes, allows structure-based suggestions to be made for improved activity.  These comparisons also provide a rationale for the large-scale polymorphism of the protofilament-like assemblies mediated by vinca-domain ligands based on local differences in their interactions with the two tubulin heterodimers constituting their binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjBXTOaREF57Vg90H21EOLACvtfcHk0lh4q7xQUuMbpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKisrvP&md5=2e408f348576893527bba21143a01d71</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444912017143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912017143%26sid%3Dliteratum%253Aachs%26aulast%3DRanaivoson%26aufirst%3DF.%2BM.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DBerritt%26aufirst%3DS.%26aulast%3DJoullie%26aufirst%3DM.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DStructural%2520plasticity%2520of%2520tubulin%2520assembly%2520probed%2520by%2520vinca-domain%2520ligands%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D927%26epage%3D934%26doi%3D10.1107%2FS0907444912017143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Cormier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span> </span><span class="NLM_article-title">Structural insight into the inhibition of tubulin by vinca domain peptide ligands</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1101</span><span class="NLM_x">–</span> <span class="NLM_lpage">1106</span><span class="refDoi"> DOI: 10.1038/embor.2008.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fembor.2008.171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1101-1106&author=A.+Cormierauthor=M.+Marchandauthor=R.+B.+Ravelliauthor=M.+Knossowauthor=B.+Gigant&title=Structural+insight+into+the+inhibition+of+tubulin+by+vinca+domain+peptide+ligands&doi=10.1038%2Fembor.2008.171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fembor.2008.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2008.171%26sid%3Dliteratum%253Aachs%26aulast%3DCormier%26aufirst%3DA.%26aulast%3DMarchand%26aufirst%3DM.%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DKnossow%26aufirst%3DM.%26aulast%3DGigant%26aufirst%3DB.%26atitle%3DStructural%2520insight%2520into%2520the%2520inhibition%2520of%2520tubulin%2520by%2520vinca%2520domain%2520peptide%2520ligands%26jtitle%3DEMBO%2520Rep.%26date%3D2008%26volume%3D9%26spage%3D1101%26epage%3D1106%26doi%3D10.1038%2Fembor.2008.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1038/nature02393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+tubulin+regulation+from+a+complex+with+colchicine+and+a+stathmin-like+domain&doi=10.1038%2Fnature02393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lh4q7xQUuMbpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520tubulin%2520regulation%2520from%2520a%2520complex%2520with%2520colchicine%2520and%2520a%2520stathmin-like%2520domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202%26doi%3D10.1038%2Fnature02393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nguyen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermone, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span> </span><span class="NLM_article-title">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6107</span><span class="NLM_x">–</span> <span class="NLM_lpage">6116</span><span class="refDoi"> DOI: 10.1021/jm050502t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+common+pharmacophore+for+a+diverse+set+of+colchicine+site+inhibitors+using+a+structure-based+approach&doi=10.1021%2Fjm050502t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0lh4q7xQUuMbpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520common%2520pharmacophore%2520for%2520a%2520diverse%2520set%2520of%2520colchicine%2520site%2520inhibitors%2520using%2520a%2520structure-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6107%26epage%3D6116%26doi%3D10.1021%2Fjm050502t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dorleans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Variations in the colchicine-binding domain provide insight into the structural switch of tubulin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">13775</span><span class="NLM_x">–</span> <span class="NLM_lpage">13779</span><span class="refDoi"> DOI: 10.1073/pnas.0904223106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1073%2Fpnas.0904223106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=19666559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=13775-13779&author=A.+Dorleansauthor=B.+Gigantauthor=R.+B.+Ravelliauthor=P.+Maillietauthor=V.+Mikolauthor=M.+Knossow&title=Variations+in+the+colchicine-binding+domain+provide+insight+into+the+structural+switch+of+tubulin&doi=10.1073%2Fpnas.0904223106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Variations in the colchicine-binding domain provide insight into the structural switch of tubulin</span></div><div class="casAuthors">Dorleans, Audrey; Gigant, Benoit; Ravelli, Raimond B. G.; Mailliet, Patrick; Mikol, Vincent; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13775-13779, S13775/1-S13775/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Structural changes occur in the αβ-tubulin heterodimer during the microtubule assembly/disassembly cycle.  Their most prominent feature is a transition from a straight, microtubular structure to a curved structure.  There is a broad range of small mol. compds. that disturbs the microtubule cycle, a class of which targets the colchicine-binding site and prevents microtubule assembly.  This class includes compds. with very different chem. structures, and it is presently unknown whether they prevent tubulin polymn. by the same mechanism.  To address this issue, we have detd. the structures of tubulin complexed with a set of such ligands and show that they interfere with several of the movements of tubulin subunit structural elements upon its transition from curved to straight.  We also detd. the structure of tubulin unliganded at the colchicine site; this reveals that a β-tubulin loop (termed T7) flips into this site.  As with colchicine site ligands, this prevents a helix which is at the interface with α-tubulin from stacking onto a β-tubulin P sheet as in straight protofilaments.  Whereas in the presence of these ligands the interference with microtubule assembly gets frozen, by flipping in and out, the β-subunit T7 loop participates in a reversible way in the resistance to straightening that opposes microtubule assembly.  Our results suggest that it thereby contributes to microtubule dynamic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDUQBAmYNvbVg90H21EOLACvtfcHk0lj4tnQTcqnTmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrO&md5=6d18732f78ac484b9db09ad1ec52aa5c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0904223106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0904223106%26sid%3Dliteratum%253Aachs%26aulast%3DDorleans%26aufirst%3DA.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DMailliet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DVariations%2520in%2520the%2520colchicine-binding%2520domain%2520provide%2520insight%2520into%2520the%2520structural%2520switch%2520of%2520tubulin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D13775%26epage%3D13779%26doi%3D10.1073%2Fpnas.0904223106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Koyanagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitoh, K.</span><span> </span><span class="NLM_article-title">In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1702</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=1702-1706&author=N.+Koyanagiauthor=T.+Nagasuauthor=F.+Fujitaauthor=T.+Watanabeauthor=K.+Tsukaharaauthor=Y.+Funahashiauthor=M.+Fujitaauthor=T.+Taguchiauthor=H.+Yoshinoauthor=K.+Kitoh&title=In+vivo+tumor+growth+inhibition+produced+by+a+novel+sulfonamide%2C+E7010%2C+against+rodent+and+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoyanagi%26aufirst%3DN.%26aulast%3DNagasu%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DF.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTsukahara%26aufirst%3DK.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DT.%26aulast%3DYoshino%26aufirst%3DH.%26aulast%3DKitoh%26aufirst%3DK.%26atitle%3DIn%2520vivo%2520tumor%2520growth%2520inhibition%2520produced%2520by%2520a%2520novel%2520sulfonamide%252C%2520E7010%252C%2520against%2520rodent%2520and%2520human%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D1702%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yoshimatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitoh, K.</span><span> </span><span class="NLM_article-title">Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3208</span><span class="NLM_x">–</span> <span class="NLM_lpage">3213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=9242451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFKqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=3208-3213&author=K.+Yoshimatsuauthor=A.+Yamaguchiauthor=H.+Yoshinoauthor=N.+Koyanagiauthor=K.+Kitoh&title=Mechanism+of+action+of+E7010%2C+an+orally+active+sulfonamide+antitumor+agent%3A+inhibition+of+mitosis+by+binding+to+the+colchicine+site+of+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin</span></div><div class="casAuthors">Yoshimatsu, Kentaro; Yamaguchi, Atsumi; Yoshino, Hiroshi; Koyanagi, Nozomu; Kitoh, Kyosuke</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3208-3213</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">E7010 (N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide), an orally active sulfonamide antitumor agent that is currently in a Phase I clin. trial, showed rather consistent growth-inhibitory activities against a panel of 26 human tumor cell lines (IC50 = 0.06-0.8 μg/mL), in contrast to vincristine (VCR; IC50 = 0.0002-0.04 μg/mL), 5-fluorouracil (IC50 = 0.2-30 -μg/mL), Adriamycin (IC50 = 0.002-0.7 μg/mL), mitomycin C (IC50 = 0.007-3 μg/mL), 1-β-D-arabionfuranoxylcytosine (IC50 = 0.005 to >30 μg/mL), camptothecin (IC50 = 0.002-0.4 μg/mL), and cisplatin (IC50 = 0.5-20 μg/mL).  It caused a dose-dependent increase in the percentage or mitotic cells in parallel with a decrease in cell proliferation, like VCR.  It also showed a dose-dependent inhibition of tubulin polymn., which correlated well with the cell growth-inhibitory activity.  14C-labeled E7010 bound to purified tubulin, and this binding was inhibited by colchicine but not by VCR.  However, its binding properties were different from those of colchicine, as well as those of VCR.  E7010 was active against two kind of VCR-resistant P388 cell lines, one of which showed multidrug resistance due to the overexpression of P-glycoprotein (resistant to Taxol), and the other did not show multidrug resistance (sensitive to Taxol).  Furthermore, four E7010-resistant P388 cell lines showed no cross-resistance to VCR, a different pattern of resistance to podophyllotoxin, and collateral sensitivity to Taxol.  Therefore, E7010 is a novel tubulin-binding agent that has a wider antitumor spectrum than VCR and has different properties from those of VCR or Taxol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVpxr7g_T5H7Vg90H21EOLACvtfcHk0lj4tnQTcqnTmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFKqs7Y%253D&md5=8e3c1d8dd4d82dad09ee5e930d58b6c6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimatsu%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DA.%26aulast%3DYoshino%26aufirst%3DH.%26aulast%3DKoyanagi%26aufirst%3DN.%26aulast%3DKitoh%26aufirst%3DK.%26atitle%3DMechanism%2520of%2520action%2520of%2520E7010%252C%2520an%2520orally%2520active%2520sulfonamide%2520antitumor%2520agent%253A%2520inhibition%2520of%2520mitosis%2520by%2520binding%2520to%2520the%2520colchicine%2520site%2520of%2520tubulin%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D3208%26epage%3D3213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kuppens, I. E.</span><span> </span><span class="NLM_article-title">Current state of the art of new tubulin inhibitors in the clinic</span> <span class="citation_source-journal">Curr. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.2174/157488406775268200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.2174%2F157488406775268200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=18666378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFOgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=57-70&author=I.+E.+Kuppens&title=Current+state+of+the+art+of+new+tubulin+inhibitors+in+the+clinic&doi=10.2174%2F157488406775268200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Current state of the art of new tubulin inhibitors in the clinic</span></div><div class="casAuthors">Kuppens, Isa E. L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CCPUC5</span>;
        ISSN:<span class="NLM_cas:issn">1574-8847</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For years the microtubule stabilizing agents docetaxel and paclitaxel belong to the most successful clin. chemotherapeutic agents.  Several attempts have been made over the years to equal and better these drugs.  Both taxanes are assocd. with the notorious side effect neurotoxicity and are often accompanied with increased drug resistance and cross resistance with other chemotherapeutic agents.  In addn. their high lipophilicity demands use of co-solvents, which are assocd. with less favorable side effects such as hypersensitivity.  To prevent these disadvantages and improve the clin. application of the taxanes several new agents have entered clin. testing.  The agents that are discussed are the drug class of the discodermolides; XAA296A and the epothilones; BMS-247550, BMS-310705, epo906, kos-862 and the agents ABT-751 and D-24851.  Here we present an overview of recently performed clin. studies to det. the current state of the art of the tubulin inhibitors which are intended to enlarge and improve the clin. use of the taxanes docetaxel and paclitaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiAXF3Hrb0ubVg90H21EOLACvtfcHk0lgG6s-xFb-gSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFOgu7c%253D&md5=e0ab529443ebf69c924de9d76ccc685d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F157488406775268200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488406775268200%26sid%3Dliteratum%253Aachs%26aulast%3DKuppens%26aufirst%3DI.%2BE.%26atitle%3DCurrent%2520state%2520of%2520the%2520art%2520of%2520new%2520tubulin%2520inhibitors%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D1%26spage%3D57%26epage%3D70%26doi%3D10.2174%2F157488406775268200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Rudin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smakal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juergens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spelda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wertheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeegan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradhan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krivoshik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, G.</span><span> </span><span class="NLM_article-title">Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1200/JCO.2010.32.5944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1200%2FJCO.2010.32.5944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=21300929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1075-1082&author=C.+M.+Rudinauthor=A.+Mauerauthor=M.+Smakalauthor=R.+Juergensauthor=S.+Speldaauthor=M.+Wertheimauthor=A.+Coatesauthor=E.+McKeeganauthor=P.+Ansellauthor=X.+Zhouauthor=J.+Qianauthor=R.+Pradhanauthor=B.+Dowellauthor=A.+Krivoshikauthor=G.+Gordon&title=Phase+I%2FII+study+of+pemetrexed+with+or+without+ABT-751+in+advanced+or+metastatic+non-small-cell+lung+cancer&doi=10.1200%2FJCO.2010.32.5944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer</span></div><div class="casAuthors">Rudin, Charles M.; Mauer, Ann; Smakal, Martin; Juergens, Rosalyn; Spelda, Stanislav; Wertheim, Michael; Coates, Andrew; McKeegan, Evelyn; Ansell, Peter; Zhou, Xiangdong; Qian, Jane; Pradhan, Rajendra; Dowell, Barry; Krivoshik, Andrew; Gordon, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1075-1082</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: ABT-751 is an antimitotic and vascular disrupting agent with potent preclin. anticancer activity.  We conducted a phase I and randomized double-blind phase II study of pemetrexed with ABT-751 or placebo in patients with recurrent advanced or metastatic non-small-cell lung cancer (NSCLC).  Methods: One hundred seventy-one patients received i.v. pemetrexed 500 mg/m2 day 1 and oral ABT-751 or placebo days 1 to 14 of 21-day cycles.  The primary end point was progression-free survival (PFS).  Secondary end point included overall survival (OS); pharmacokinetic and pharmacodynamic parameters were also analyzed.  Results: The recommended phase II dose of ABT-751 with pemetrexed is 200 mg.  Fatigue, constipation, anemia, nausea, and diarrhea were the most common toxicities in both study arms.  No pharmacokinetic interactions were obsd.  Median PFS in the ABT-751 arm was 2.3 mo vs. 1.9 for placebo (P = .819, log-rank) for the intention-to-treat population.  However, differences in PFS (P = .112, log-rank) and OS (P = .034, log-rank; median 3.3 v 8.1 mo) favoring ABT-751 were seen in the squamous NSCLC subgroup.  Baseline circulating tumor cell concns. were predictive of improved OS (P = .013).  Changes from baseline of greater than 20% in plasma levels of placenta growth factor (P = .056), squamous cell carcinoma antigen (P = .03), and cytokeratin 19 fragment antigen 21-1 (P = .01) were markers best assocd. with improved OS.  Conclusion: Addn. of ABT-751 to pemetrexed is well-tolerated, but does not improve outcome in unselected patients with recurrent NSCLC.  ABT-751 may have therapeutic potential in squamous NSCLC.  Exploratory cellular and mol. analyses in this study identified biomarkers that may correlate with survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmZjmrm3J4rVg90H21EOLACvtfcHk0lgG6s-xFb-gSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslOhsb8%253D&md5=634b7d9cd090d61725ff922e080cd983</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.32.5944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.32.5944%26sid%3Dliteratum%253Aachs%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DMauer%26aufirst%3DA.%26aulast%3DSmakal%26aufirst%3DM.%26aulast%3DJuergens%26aufirst%3DR.%26aulast%3DSpelda%26aufirst%3DS.%26aulast%3DWertheim%26aufirst%3DM.%26aulast%3DCoates%26aufirst%3DA.%26aulast%3DMcKeegan%26aufirst%3DE.%26aulast%3DAnsell%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DPradhan%26aufirst%3DR.%26aulast%3DDowell%26aufirst%3DB.%26aulast%3DKrivoshik%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DG.%26atitle%3DPhase%2520I%252FII%2520study%2520of%2520pemetrexed%2520with%2520or%2520without%2520ABT-751%2520in%2520advanced%2520or%2520metastatic%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D1075%26epage%3D1082%26doi%3D10.1200%2FJCO.2010.32.5944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Nugiel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidwans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etzkorn, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doleniak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">5232</span><span class="refDoi"> DOI: 10.1021/jm020171+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020171%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5224-5232&author=D.+A.+Nugielauthor=A.+Vidwansauthor=A.-M.+Etzkornauthor=K.+A.+Rossiauthor=P.+A.+Benfieldauthor=C.+R.+Burtonauthor=S.+Coxauthor=D.+Doleniakauthor=S.+P.+Seitz&title=Synthesis+and+evaluation+of+indenopyrazoles+as+cyclin-dependent+kinase+inhibitors.+2.+Probing+the+indeno+ring+substituent+pattern&doi=10.1021%2Fjm020171%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm020171%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020171%252B%26sid%3Dliteratum%253Aachs%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DVidwans%26aufirst%3DA.%26aulast%3DEtzkorn%26aufirst%3DA.-M.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DBenfield%26aufirst%3DP.%2BA.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DDoleniak%26aufirst%3DD.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520indenopyrazoles%2520as%2520cyclin-dependent%2520kinase%2520inhibitors.%25202.%2520Probing%2520the%2520indeno%2520ring%2520substituent%2520pattern%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5224%26epage%3D5232%26doi%3D10.1021%2Fjm020171%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMeo, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugiel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benware, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grafstrom, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boylan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5233</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span><span class="refDoi"> DOI: 10.1021/jm0201722</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0201722" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5233-5248&author=E.+W.+Yueauthor=C.+A.+Higleyauthor=S.+V.+DiMeoauthor=D.+J.+Cariniauthor=D.+A.+Nugielauthor=C.+Benwareauthor=P.+A.+Benfieldauthor=C.+R.+Burtonauthor=S.+Coxauthor=R.+H.+Grafstromauthor=D.+M.+Sharpauthor=L.+M.+Siskauthor=J.+F.+Boylanauthor=J.+K.+Muckelbauerauthor=A.+M.+Smallwoodauthor=H.+Chenauthor=C.-H.+Changauthor=S.+P.+Seitzauthor=G.+L.+Trainor&title=Synthesis+and+evaluation+of+indenopyrazoles+as+cyclin-dependent+kinase+inhibitors.+3.+Structure+activity+relationships+at+C3&doi=10.1021%2Fjm0201722"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm0201722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0201722%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DHigley%26aufirst%3DC.%2BA.%26aulast%3DDiMeo%26aufirst%3DS.%2BV.%26aulast%3DCarini%26aufirst%3DD.%2BJ.%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DBenware%26aufirst%3DC.%26aulast%3DBenfield%26aufirst%3DP.%2BA.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DGrafstrom%26aufirst%3DR.%2BH.%26aulast%3DSharp%26aufirst%3DD.%2BM.%26aulast%3DSisk%26aufirst%3DL.%2BM.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520indenopyrazoles%2520as%2520cyclin-dependent%2520kinase%2520inhibitors.%25203.%2520Structure%2520activity%2520relationships%2520at%2520C3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5233%26epage%3D5248%26doi%3D10.1021%2Fjm0201722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludovici, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharoof, U. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strobel, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andraka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominovich, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruninger, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.</span><span> </span><span class="NLM_article-title">6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: Platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8163</span><span class="NLM_x">–</span> <span class="NLM_lpage">8173</span><span class="refDoi"> DOI: 10.1021/jm050680m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050680m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=8163-8173&author=C.+Y.+Hoauthor=D.+W.+Ludoviciauthor=U.+S.+M.+Maharoofauthor=J.+Meiauthor=J.+L.+Sechlerauthor=R.+W.+Tumanauthor=E.+D.+Strobelauthor=L.+Andrakaauthor=H.-K.+Yenauthor=G.+Leoauthor=J.+Liauthor=H.+Almondauthor=H.+Luauthor=A.+DeVineauthor=R.+M.+Tominovichauthor=J.+Bakerauthor=S.+Emanuelauthor=R.+H.+Gruningerauthor=S.+A.+Middletonauthor=D.+L.+Johnsonauthor=R.+A.+Galemmo&title=6%2C7-Dimethoxy-2%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazol-3-yl%29phenylamines%3A+Platelet-derived+growth+factor+receptor+tyrosine+kinase+inhibitors+with+broad+antiproliferative+activity+against+tumor+cells&doi=10.1021%2Fjm050680m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm050680m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050680m%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DC.%2BY.%26aulast%3DLudovici%26aufirst%3DD.%2BW.%26aulast%3DMaharoof%26aufirst%3DU.%2BS.%2BM.%26aulast%3DMei%26aufirst%3DJ.%26aulast%3DSechler%26aufirst%3DJ.%2BL.%26aulast%3DTuman%26aufirst%3DR.%2BW.%26aulast%3DStrobel%26aufirst%3DE.%2BD.%26aulast%3DAndraka%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DH.-K.%26aulast%3DLeo%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAlmond%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DDeVine%26aufirst%3DA.%26aulast%3DTominovich%26aufirst%3DR.%2BM.%26aulast%3DBaker%26aufirst%3DJ.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DGruninger%26aufirst%3DR.%2BH.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BL.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26atitle%3D6%252C7-Dimethoxy-2%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazol-3-yl%2529phenylamines%253A%2520Platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520with%2520broad%2520antiproliferative%2520activity%2520against%2520tumor%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D8163%26epage%3D8173%26doi%3D10.1021%2Fjm050680m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4308</span><span class="NLM_x">–</span> <span class="NLM_lpage">4315</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmcl.2007.05.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4308-4315&author=Z.-F.+Taoauthor=G.+Liauthor=Y.+Tongauthor=Z.+Chenauthor=P.+Mertaauthor=P.+Kovarauthor=H.+Zhangauthor=S.-H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.-H.+Lin&title=Synthesis+and+biological+evaluation+of+4%E2%80%B2-%286%2C7-disubstituted-2%2C4-dihydro-indeno%5B1%2C2-c%5Dpyrazol-3-yl%29-biphenyl-4-ol+as+potent+Chk1+inhibitors&doi=10.1016%2Fj.bmcl.2007.05.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.-H.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204%25E2%2580%25B2-%25286%252C7-disubstituted-2%252C4-dihydro-indeno%255B1%252C2-c%255Dpyrazol-3-yl%2529-biphenyl-4-ol%2520as%2520potent%2520Chk1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4308%26epage%3D4315%26doi%3D10.1016%2Fj.bmcl.2007.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Discovery of 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4′-(1,4-dihydro-indeno[1,2-c]-pyrazol-3-yl)-pyridine-2′-carbonitriles as potent checkpointkinase 1 (Chk1) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">–</span> <span class="NLM_lpage">5951</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmcl.2007.07.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5944-5951&author=Z.-F.+Taoauthor=G.+Liauthor=Y.+Tongauthor=K.+D.+Stewartauthor=Z.+Chenauthor=M.-H.+Buiauthor=P.+Mertaauthor=C.+Parkauthor=P.+Kovarauthor=H.+Zhangauthor=H.+L.+Shamauthor=S.+H.+Rosenbergauthor=T.+J.+Sowinauthor=N.-H.+Lin&title=Discovery+of+4%E2%80%B2-%281%2C4-dihydro-indeno%5B1%2C2-c%5Dpyrazol-3-yl%29-benzonitriles+and+4%E2%80%B2-%281%2C4-dihydro-indeno%5B1%2C2-c%5D-pyrazol-3-yl%29-pyridine-2%E2%80%B2-carbonitriles+as+potent+checkpointkinase+1+%28Chk1%29+inhibitors&doi=10.1016%2Fj.bmcl.2007.07.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.102%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DBui%26aufirst%3DM.-H.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DDiscovery%2520of%25204%25E2%2580%25B2-%25281%252C4-dihydro-indeno%255B1%252C2-c%255Dpyrazol-3-yl%2529-benzonitriles%2520and%25204%25E2%2580%25B2-%25281%252C4-dihydro-indeno%255B1%252C2-c%255D-pyrazol-3-yl%2529-pyridine-2%25E2%2580%25B2-carbonitriles%2520as%2520potent%2520checkpointkinase%25201%2520%2528Chk1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5944%26epage%3D5951%26doi%3D10.1016%2Fj.bmcl.2007.07.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Usui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirokawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.bmcl.2007.10.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=285-288&author=T.+Usuiauthor=H.+S.+Banauthor=J.+Kawadaauthor=T.+Hirokawaauthor=H.+Nakamura&title=Discovery+of+indenopyrazoles+as+EGFR+and+VEGFR-2+tyrosine+kinase+inhibitors+by+in+silico+high-throughput+screening&doi=10.1016%2Fj.bmcl.2007.10.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.084%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DKawada%26aufirst%3DJ.%26aulast%3DHirokawa%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520indenopyrazoles%2520as%2520EGFR%2520and%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%2520by%2520in%2520silico%2520high-throughput%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D285%26epage%3D288%26doi%3D10.1016%2Fj.bmcl.2007.10.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Minegishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukashiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Discovery of indenopyrazoles as new class of hyposia inducible factor (HIF)-1 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1021/ml3004632</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3004632" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=297-301&author=H.+Minegishiauthor=S.+Fukashiroauthor=H.+S.+Banauthor=H.+Nakamura&title=Discovery+of+indenopyrazoles+as+new+class+of+hyposia+inducible+factor+%28HIF%29-1+inhibitor&doi=10.1021%2Fml3004632"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fml3004632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3004632%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DFukashiro%26aufirst%3DS.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520indenopyrazoles%2520as%2520new%2520class%2520of%2520hyposia%2520inducible%2520factor%2520%2528HIF%2529-1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D297%26epage%3D301%26doi%3D10.1021%2Fml3004632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Minegishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futamura, y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukashiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muroi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawatani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Methyl 3-((6-Methoxy-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-3-yl)amino)benzoate (GN39482) as a tubulin polymerization inhibitor identified by MorphoBase and ChemProteoBase profiling methods</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4230</span><span class="NLM_x">–</span> <span class="NLM_lpage">4241</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvV2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4230-4241&author=H.+Minegishiauthor=y.+Futamuraauthor=S.+Fukashiroauthor=M.+Muroiauthor=M.+Kawataniauthor=H.+Osadaauthor=H.+Nakamura&title=Methyl+3-%28%286-Methoxy-1%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazol-3-yl%29amino%29benzoate+%28GN39482%29+as+a+tubulin+polymerization+inhibitor+identified+by+MorphoBase+and+ChemProteoBase+profiling+methods&doi=10.1021%2Facs.jmedchem.5b00035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Methyl 3-((6-Methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate (GN39482) as a Tubulin Polymerization Inhibitor Identified by MorphoBase and ChemProteoBase Profiling Methods</span></div><div class="casAuthors">Minegishi, Hidemitsu; Futamura, Yushi; Fukashiro, Shinji; Muroi, Makoto; Kawatani, Makoto; Osada, Hiroyuki; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4230-4241</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of indenopyrazoles was synthesized from the corresponding indanones and Ph isothiocyanates in two steps.  Among the compds. synthesized, Me 3-((6-methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)amino)benzoate 6m (I, GN39482) was found to possess a promising antiproliferative activity toward human cancer cells without affecting any antimicrobial and antimalarial activities at 100 nM.  Both a methoxy group at R1 position and a methoxycarbonyl group at R2 position of the anilinoindenopyrazole framework are essential for the high cell growth inhibition.  Both MorphoBase and ChemProteoBase profiling analyses suggested that compd. 6m was classified as a tubulin inhibitor.  Indeed, compd. 6m inhibited the acetylated tubulin accumulation and the microtubule formation and induced G2/M cell cycle arrest in HeLa cells, revealing that a promising antiproliferative activity of compd. 6m toward human cancer cells is probably caused by the tubulin polymn. inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFRlvMc-6TSLVg90H21EOLACvtfcHk0lgPbZqEbVsRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvV2msrg%253D&md5=efe5c14b97d7e75356b9f0810f8aeb07</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00035%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DFutamura%26aufirst%3Dy.%26aulast%3DFukashiro%26aufirst%3DS.%26aulast%3DMuroi%26aufirst%3DM.%26aulast%3DKawatani%26aufirst%3DM.%26aulast%3DOsada%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DMethyl%25203-%2528%25286-Methoxy-1%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazol-3-yl%2529amino%2529benzoate%2520%2528GN39482%2529%2520as%2520a%2520tubulin%2520polymerization%2520inhibitor%2520identified%2520by%2520MorphoBase%2520and%2520ChemProteoBase%2520profiling%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4230%26epage%3D4241%26doi%3D10.1021%2Facs.jmedchem.5b00035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Clarke, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, L. A.</span><span> </span><span class="NLM_article-title">Cell-cycle control in the face of damage–a matter of life or death</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.tcb.2008.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1016%2Fj.tcb.2008.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=19168356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVWkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=89-98&author=P.+R.+Clarkeauthor=L.+A.+Allan&title=Cell-cycle+control+in+the+face+of+damage%E2%80%93a+matter+of+life+or+death&doi=10.1016%2Fj.tcb.2008.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle control in the face of damage - A matter of life or death</span></div><div class="casAuthors">Clarke, Paul R.; Allan, Lindsey A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cells respond to DNA damage or defects in the mitotic spindle by activating checkpoints that arrest the cell cycle.  Alternatively, damaged cells can undergo cell death by the process of apoptosis.  The correct balance between these pathways is important for the maintenance of genomic integrity while preventing unnecessary cell death.  Although the mol. mechanisms of the cell cycle and apoptosis have been elucidated, the links between them have not been clear.  Recent work, however, indicates that common components directly link the regulation of apoptosis with cell-cycle checkpoints operating during interphase, whereas in mitosis, the control of apoptosis is directly coupled to the cell-cycle machinery.  These findings shed new light on how the balance between cell-cycle progression and cell death is controlled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd8UcTnip3h7Vg90H21EOLACvtfcHk0lgPbZqEbVsRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVWkurw%253D&md5=5637aa86c33cbdf73dff163acb558f76</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2008.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2008.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DP.%2BR.%26aulast%3DAllan%26aufirst%3DL.%2BA.%26atitle%3DCell-cycle%2520control%2520in%2520the%2520face%2520of%2520damage%25E2%2580%2593a%2520matter%2520of%2520life%2520or%2520death%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2009%26volume%3D19%26spage%3D89%26epage%3D98%26doi%3D10.1016%2Fj.tcb.2008.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Cheng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.-Y.</span><span> </span><span class="NLM_article-title">MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mRNA through decreasing nuclear–cytoplasmic translocation of RNA-binding protein HuR</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1158%2F1535-7163.MCT-12-0778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=23619299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=1202-1212&author=Y.-C.+Chengauthor=J.-P.+Liuauthor=C.-P.+Kuoauthor=W.-Y.+Laiauthor=K.-H.+Shihauthor=C.-Y.+Changauthor=W.-Y.+Panauthor=J.+T.+Tsengauthor=J.-Y.+Chang&title=MPT0B098%2C+a+novel+microtubule+inhibitor+that+destabilizes+the+hypoxia-inducible+factor-1%CE%B1+mRNA+through+decreasing+nuclear%E2%80%93cytoplasmic+translocation+of+RNA-binding+protein+HuR&doi=10.1158%2F1535-7163.MCT-12-0778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear-Cytoplasmic Translocation of RNA-Binding Protein HuR</span></div><div class="casAuthors">Cheng, Yun-Ching; Liou, Jing-Ping; Kuo, Ching-Chuan; Lai, Wen-Yang; Shih, Kuang-Hsing; Chang, Chi-Yen; Pan, Wen-Yu; Tseng, Joseph T.; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1202-1212</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Microtubule inhibitors were shown to inhibit hypoxia-inducible factor-1α (HIF-1α) expression through inhibition translation or enhancing protein degrdn.  Little is known of the effect of microtubule inhibitors on the stability of HIF-1α mRNA.  We recently discovered a novel indoline-sulfonamide compd., 7-aryl-indoline-1-benzene-sulfonamide (MPT0B098), as a potent microtubule inhibitor through binding to the colchicine-binding site of tubulin.  MPT0B098 is active against the growth of various human cancer cells, including chemoresistant cells with IC50 values ranging from 70 to 150 nmol/L.  However, normal cells, such as human umbilical vein endothelial cells (HUVEC), exhibit less susceptibility to the inhibitory effect of MPT0B098 with IC50 of 510 nmol/L.  Similar to typical microtubule inhibitors, MPT0B098 arrests cells in the G2-M phase and subsequently induces cell apoptosis.  In addn., MPT0B098 effectively suppresses VEGF-induced cell migration and capillary-like tube formation of HUVECs.  Distinguished from other microtubule inhibitors, MPT0B098 not only inhibited the expression levels of HIF-1α protein but also destabilized HIF-1α mRNA.  The mechanism of causing unstable of HIF-1α mRNA by MPT0B098 is through decreasing RNA-binding protein, HuR, translocation from the nucleus to the cytoplasm.  Notably, MPT0B098 effectively suppresses tumor growth and microvessel d. of tumor specimens in vivo.  Taken together, our results provide a novel mechanism of inhibiting HIF-1α of a microtubule inhibitor MPT0B098.  MPT0B098 is a promising anticancer drug candidate with potential for the treatment of human malignancies.  Mol Cancer Ther; 12(7); 1202-12. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPksmggcBGLVg90H21EOLACvtfcHk0lgPbZqEbVsRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGltLfO&md5=703796adc14620915d98dd2a146c3648</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0778%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DLiu%26aufirst%3DJ.-P.%26aulast%3DKuo%26aufirst%3DC.-P.%26aulast%3DLai%26aufirst%3DW.-Y.%26aulast%3DShih%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DC.-Y.%26aulast%3DPan%26aufirst%3DW.-Y.%26aulast%3DTseng%26aufirst%3DJ.%2BT.%26aulast%3DChang%26aufirst%3DJ.-Y.%26atitle%3DMPT0B098%252C%2520a%2520novel%2520microtubule%2520inhibitor%2520that%2520destabilizes%2520the%2520hypoxia-inducible%2520factor-1%25CE%25B1%2520mRNA%2520through%2520decreasing%2520nuclear%25E2%2580%2593cytoplasmic%2520translocation%2520of%2520RNA-binding%2520protein%2520HuR%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D1202%26epage%3D1212%26doi%3D10.1158%2F1535-7163.MCT-12-0778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottamal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFerrin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3369</span><span class="NLM_x">–</span> <span class="NLM_lpage">3381</span><span class="refDoi"> DOI: 10.1021/jm500002k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500002k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVCrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3369-3381&author=S.+Zhengauthor=Q.+Zhongauthor=M.+Mottamalauthor=Q.+Zhangauthor=C.+Zhangauthor=E.+LeMelleauthor=H.+McFerrinauthor=G.+Wang&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+pyridine-bridged+analogues+of+combretastatin-A4+as+anticancer+agents&doi=10.1021%2Fjm500002k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents</span></div><div class="casAuthors">Zheng, Shilong; Zhong, Qiu; Mottamal, Madhusoodanan; Zhang, Qiang; Zhang, Changde; LeMelle, Elise; McFerrin, Harris; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3369-3381</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyridine-bridged analogs of combretastatin-A4 (CA-4) were designed and synthesized.  As expected, the 4-atom linker configuration retained little cytotoxicities.  Activities of the analogs with 3-atom linker varied widely depending on the Ph ring substitutions, and the 3-atom linker contg. nitrogen represents the more favorable linker structure.  Among them, three analogs (4h, 4s, and 4t; I - III, resp.) potently inhibited cell survival and growth, arrested cell cycle, and blocked angiogenesis and vasculature formation in vivo in ways comparable to CA-4.  The superposition of 4h and 4s in the colchicine-binding pocket of tubulin shows the binding posture of CA-4, 4h, and 4s are similar, as confirmed by the competitive binding assay where the ability of the ligands to replace tubulin-bound colchicine was measured.  The binding data are consistent with the obsd. biol. activities in antiproliferation and suppression of angiogenesis but are not predictive of their antitubulin polymn. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe8RTj0wT9RLVg90H21EOLACvtfcHk0lgmmSDccDfISw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVCrsLc%253D&md5=818f0a1793ce803a0b48e827004aa1e5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm500002k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500002k%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DMottamal%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLeMelle%26aufirst%3DE.%26aulast%3DMcFerrin%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520pyridine-bridged%2520analogues%2520of%2520combretastatin-A4%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3369%26epage%3D3381%26doi%3D10.1021%2Fjm500002k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Da, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluball, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellogg, G. E.</span><span> </span><span class="NLM_article-title">Developing novel C-4 analogues of pyrrole-based antitubulin agents: weak but critical hydrogen bonding in the colchicine site</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1039/c2md20320k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;key=10.1039%2Fc2md20320k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=417-421&author=C.+Daauthor=N.+Telangauthor=K.+Hallauthor=E.+Kluballauthor=P.+Barelliauthor=K.+Finzelauthor=X.+Jiaauthor=J.+T.+Guptonauthor=S.+L.+Mooberryauthor=G.+E.+Kellogg&title=Developing+novel+C-4+analogues+of+pyrrole-based+antitubulin+agents%3A+weak+but+critical+hydrogen+bonding+in+the+colchicine+site&doi=10.1039%2Fc2md20320k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1039%2Fc2md20320k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20320k%26sid%3Dliteratum%253Aachs%26aulast%3DDa%26aufirst%3DC.%26aulast%3DTelang%26aufirst%3DN.%26aulast%3DHall%26aufirst%3DK.%26aulast%3DKluball%26aufirst%3DE.%26aulast%3DBarelli%26aufirst%3DP.%26aulast%3DFinzel%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DGupton%26aufirst%3DJ.%2BT.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DKellogg%26aufirst%3DG.%2BE.%26atitle%3DDeveloping%2520novel%2520C-4%2520analogues%2520of%2520pyrrole-based%2520antitubulin%2520agents%253A%2520weak%2520but%2520critical%2520hydrogen%2520bonding%2520in%2520the%2520colchicine%2520site%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D417%26epage%3D421%26doi%3D10.1039%2Fc2md20320k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UT5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UT5','PDB','3UT5'); return false;">PDB: 3UT5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E22" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3E22','PDB','3E22'); return false;">PDB: 3E22</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA1','PDB','1SA1'); return false;">PDB: 1SA1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKD','PDB','3HKD'); return false;">PDB: 3HKD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKC','PDB','3HKC'); return false;">PDB: 3HKC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0','PDB','1SA0'); return false;">PDB: 1SA0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HKE','PDB','3HKE'); return false;">PDB: 3HKE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00071">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81586"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00071">10.1021/acs.jmedchem.6b00071</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_001.pdb">PDB</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_002.pdb">PDB</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_003.pdb">PDB</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_004.pdb">PDB</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_005.pdb">PDB</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_006.pdb">PDB</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_007.pdb">PDB</a>)</p></li><li><p class="inline">Additional compound data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_008.csv">CSV</a>)</p></li><li><p class="inline">In vitro tubulin polymerization assay, molecular modeling, NMR spectra for all screening compounds and synthetic intermediates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf">PDF</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_010.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_001.pdb">jm6b00071_si_001.pdb (122.21 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_002.pdb">jm6b00071_si_002.pdb (112.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_003.pdb">jm6b00071_si_003.pdb (111.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_004.pdb">jm6b00071_si_004.pdb (124.35 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_005.pdb">jm6b00071_si_005.pdb (117.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_006.pdb">jm6b00071_si_006.pdb (118.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_007.pdb">jm6b00071_si_007.pdb (121.82 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_008.csv">jm6b00071_si_008.csv (1.24 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_009.pdf">jm6b00071_si_009.pdf (8.11 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00071/suppl_file/jm6b00071_si_010.pdb">jm6b00071_si_010.pdb (125.93 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00071&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00071%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-11%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00071" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b452189d8d94a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
